var title_f3_24_3456="Contents: Hepatitis";
var content_f3_24_3456=[" <script type=\"text/javascript\">",
"  $$.inlineInitCustomer(",
"	false);",
"	var quirksmode = document.compatMode == \"CSS1Compat\";",
"	if (quirksmode) {",
"		$(\"html\").addClass(\"ie-standards\");",
"	}",
" </script>",
" <div id=\"message-wrap\">",
"  <div id=\"message-bg\">",
"  </div>",
"  <iframe id=\"message-bk\">",
"  </iframe>",
"  <dl id=\"message-container\">",
"   <dt id=\"message-title\">",
"   </dt>",
"   <dd id=\"message-body\">",
"   </dd>",
"   <dd id=\"message-controls\">",
"   </dd>",
"  </dl>",
" </div>",
" <div id=\"topPanel\">",
"  <div id=\"header\">",
"   <div id=\"header_container\">",
"    <h2 id=\"logo\">",
"     <a href=\"./toc\">",
"      Wolters Kluwer Health UpToDate",
"     </a>",
"    </h2>",
"    <div id=\"header_right\">",
"     <div id=\"searchpanel\">",
"      <a href=\"/login\" id=\"loginbutton\">",
"       Log in",
"      </a>",
"      <div id=\"cmsSearchBox\">",
"       <div class=\"header-search\">",
"        <form action=\"./search\" id=\"cmssearch\" method=\"get\" name=\"SearchForm\">",
"         <div class=\"header-search-left\">",
"          <input autocomplete=\"off\" class=\"searchfield\" id=\"cmsTxtBox\" name=\"search\" placeholder=\"Search UpToDate\" type=\"text\"/>",
"         </div>",
"         <div class=\"header-search-right\">",
"          <input alt=\"Search\" id=\"cmsSearchSubmit\" src=\"/sites/all/themes/uptodate/images/search_button.png\" type=\"image\"/>",
"         </div>",
"         <div class=\"clear\">",
"         </div>",
"        </form>",
"       </div>",
"      </div>",
"      <div id=\"cms_lang_dropdown\">",
"       <form accept-charset=\"UTF-8\" action=\"/\" id=\"lang-dropdown-form\" method=\"post\">",
"        <div class=\"form-item form-type-select form-item-lang-dropdown-select\">",
"         <select class=\"lang-dropdown-select-element form-select\" id=\"edit-lang-dropdown-select\" name=\"lang_dropdown_select\" style=\"width:100px\">",
"          <option selected=\"selected\" value=\"en\">",
"           English",
"          </option>",
"          <option value=\"ja\">",
"           ���������������������������",
"          </option>",
"         </select>",
"        </div>",
"        <input name=\"lang_dropdown_type\" type=\"hidden\" value=\"language\">",
"         <input name=\"en\" type=\"hidden\" value=\"/\">",
"          <input name=\"ja\" type=\"hidden\" value=\"/ja\">",
"           <noscript>",
"            <div>",
"             <input class=\"form-submit\" id=\"edit-submit\" name=\"op\" type=\"submit\" value=\"Go\"/>",
"            </div>",
"           </noscript>",
"           <input name=\"form_build_id\" type=\"hidden\" value=\"form-on4lUWpxHun_wp6revUkjCG6rK2IBuCGME9Cw0HXeok\">",
"            <input name=\"form_id\" type=\"hidden\" value=\"lang_dropdown_form\">",
"            </input>",
"           </input>",
"          </input>",
"         </input>",
"        </input>",
"       </form>",
"      </div>",
"      <div class=\"clear\">",
"      </div>",
"     </div>",
"     <ul id=\"utility\">",
"      <li class=\"first\">",
"       <a href=\"/home/about-us\">",
"        About Us",
"       </a>",
"      </li>",
"      <li>",
"       <a href=\"/home/news-events\">",
"        News &amp; Events",
"       </a>",
"      </li>",
"      <li>",
"       <a href=\"/home/contact-us\">",
"        Contact Us",
"       </a>",
"      </li>",
"      <li class=\"last\">",
"       <a href=\"/help\">",
"        Help",
"       </a>",
"      </li>",
"     </ul>",
"    </div>",
"    <div class=\"clear\">",
"    </div>",
"   </div>",
"   <div id=\"nav\">",
"    <ul>",
"     <li id=\"productTab\">",
"      <a href=\"/home/product\">",
"       Product",
"       <span>",
"       </span>",
"      </a>",
"     </li>",
"     <li id=\"editoralTab\">",
"      <a href=\"/home/editorial\">",
"       Editorial",
"       <span>",
"       </span>",
"      </a>",
"     </li>",
"     <li id=\"whyUptodateTab\">",
"      <a href=\"/home/why-uptodate\">",
"       Why UpToDate",
"       <span>",
"       </span>",
"      </a>",
"     </li>",
"     <li id=\"supscriptionOptionsTab\">",
"      <a href=\"/home/subscription-options\">",
"       Subscription Options",
"       <span>",
"       </span>",
"      </a>",
"     </li>",
"     <li>",
"      <a href=\"/store\">",
"       Subscribe",
"       <span>",
"       </span>",
"      </a>",
"     </li>",
"     <li id=\"wkhcsTab\">",
"      <a href=\"/home/wolters-kluwer-health-clinical-solutions\">",
"       Wolters Kluwer Health Clinical Solutions",
"       <span>",
"       </span>",
"      </a>",
"     </li>",
"    </ul>",
"    <div class=\"clear\">",
"    </div>",
"   </div>",
"   <div id=\"greyBar\">",
"    <div id=\"greyBarTitle\">",
"     <span class=\"emphasis\">",
"      <a href=\"UTD.htm?3/3/3134\">",
"       Contents",
"      </a>",
"     </span>",
"     <img src=\"./../images/space_arrows.myextg\">",
"      <a href=\"UTD.htm?15/21/15710\">",
"       Infectious Diseases",
"      </a>",
"      <img src=\"./../images/space_arrows.myextg\">",
"       Hepatitis",
"      </img>",
"     </img>",
"    </div>",
"    <div id=\"greyBarButtons\">",
"     <div id=\"printGB\">",
"      <a class=\"icontxt\" href=\"?view=print\">",
"       <img align=\"middle\" alt=\"Print this page\" border=\"0\" height=\"20\" src=\"./../images/icn_print.myextg\" width=\"24\"/>",
"      </a>",
"      <a class=\"icontxt\" href=\"?view=print\" title=\"Print this page\">",
"       Print",
"      </a>",
"     </div>",
"    </div>",
"   </div>",
"   <!-- menuMessage.jsp -->",
"   <!-- /menuMessage.jsp -->",
"  </div>",
"  <!-- header -->",
" </div>",
" <!-- topPanel -->",
" <div id=\"leftPanel\">",
"  <ul>",
"   <li>",
"    <a href=\"UTD.htm?3/45/3806\">",
"     Specialties",
"    </a>",
"   </li>",
"   <li>",
"    <a href=\"UTD.htm?18/22/18798\">",
"     Patient Information",
"    </a>",
"   </li>",
"   <li>",
"    <a href=\"UTD.htm?3/13/3294\">",
"     What's New",
"    </a>",
"   </li>",
"   <li>",
"    <a href=\"UTD.htm?0/37/606\">",
"     Calculators",
"    </a>",
"   </li>",
"   <li>",
"    <a href=\"UTD.htm?0/40/654\">",
"     Authors and Editors",
"    </a>",
"   </li>",
"  </ul>",
" </div>",
" <!-- leftPanel -->",
" <div id=\"rightPanel\">",
"  <noscript>",
"   <div id=\"javascriptDisabled\">",
"    It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"   </div>",
"  </noscript>",
"  <div id=\"printHeader\">",
"   <div id=\"printHeaderLogo\">",
"    <img alt=\"UpToDate\" src=\"./../images/wk_utd-rgb.myextg\" width=\"220px\">",
"    </img>",
"   </div>",
"   <div id=\"printHeaderText\">",
"    Official reprint from UpToDate",
"    <sup>",
"     &reg;",
"    </sup>",
"    <a href=\"file://www.uptodate.com\">",
"     www.uptodate.com",
"    </a>",
"    <br>",
"     &copy;2013 UpToDate",
"     <sup>",
"      &reg;",
"     </sup>",
"    </br>",
"   </div>",
"   <div id=\"printHeaderLinks\">",
"    <a href=\"#\" id=\"printHeaderPrint\" rel=\"\" title=\"Click here to print\">",
"     Print",
"    </a>",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"     Back",
"    </a>",
"   </div>",
"  </div>",
"  <div class=\"toctable\" border=\"0\" cellpadding=\"0\" cellspacing=\"0\" id=\"tocTable\" width=\"100%\">",
"   <trs>",
"    <tds>",
"     <h1>",
"      Contents:",
"			Hepatitis",
"     </h1>",
"    </tds>",
"   </trs>",
"   <trs>",
"    <tds>",
"    </tds>",
"   </trs>",
"   <trs>",
"    <tds valign=\"top\">",
"     <div class=\"toctable\" border=\"0\" cellpadding=\"0\" cellspacing=\"0\" width=\"100%\">",
"      <trs>",
"       <tds>",
"        <strong>",
"         Autoimmune hepatitis",
"        </strong>",
"        <ul>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?26/32/27140\">",
"           Classification of autoimmune hepatitis",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?34/44/35528\">",
"           Clinical manifestations and diagnosis of autoimmune hepatitis",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?35/4/35911\">",
"           Definition and treatment of variants of autoimmune hepatitis",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?31/4/31812\">",
"           Extrahepatic manifestations of autoimmune hepatitis",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?19/8/19590\">",
"           Pathogenesis of autoimmune hepatitis",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?41/57/42902\">",
"           Serologic markers of autoimmune hepatitis",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?39/7/40058\">",
"           Treatment of autoimmune hepatitis",
"          </a>",
"         </li>",
"        </ul>",
"        <strong>",
"         Drug-induced hepatitis",
"        </strong>",
"        <ul>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?34/3/34871\">",
"           Halothane hepatitis",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?25/2/25642\">",
"           Hepatotoxicity due to herbal medications and dietary supplements",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?40/61/41943\">",
"           Isoniazid hepatotoxicity",
"          </a>",
"         </li>",
"        </ul>",
"        <strong>",
"         Hepatitis A virus",
"        </strong>",
"        <ul>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?32/13/32980\">",
"           Atypical manifestations of hepatitis A virus infection",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?6/55/7033\">",
"           Epidemiology, clinical manifestations, and diagnosis of hepatitis B in the HIV-infected patient",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?1/38/1641\">",
"           Hepatitis A virus vaccination and postexposure prophylaxis",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?7/26/7591\">",
"           Overview of hepatitis A virus infection in adults",
"          </a>",
"         </li>",
"        </ul>",
"        <strong>",
"         Hepatitis B virus",
"        </strong>",
"        <ul>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?35/59/36792\">",
"           Adefovir dipivoxil in the treatment of chronic hepatitis B virus infection",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?36/22/37223\">",
"           Antiviral medications for the treatment of hepatitis B in the HIV-infected patient",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?20/35/21045\">",
"           Characteristics of the hepatitis B virus and pathogenesis of infection",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?29/26/30122\">",
"           Clinical manifestations and natural history of hepatitis B virus infection",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?6/6/6250\">",
"           Clinical significance and molecular characteristics of common hepatitis B virus variants",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?35/52/36681\">",
"           Clinical significance of hepatitis B virus genotypes",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?12/29/12760\">",
"           Combination therapy for chronic hepatitis B virus infection",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?11/30/11752\">",
"           Entecavir in the treatment of chronic hepatitis B virus infection",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?6/55/7033\">",
"           Epidemiology, clinical manifestations, and diagnosis of hepatitis B in the HIV-infected patient",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?4/31/4602\">",
"           Epidemiology, transmission, and prevention of hepatitis B virus infection",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?42/63/44020\">",
"           Evaluation of chronic hepatitis B virus infection in the HIV-infected patient",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?2/61/3033\">",
"           Hepatitis B and pregnancy",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?1/37/1625\">",
"           Hepatitis B virus infection in renal transplant recipients",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?25/25/26009\">",
"           Hepatitis B virus reactivation associated with immunosuppression",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?30/60/31690\">",
"           Hepatitis B virus vaccination",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?22/31/23030\">",
"           Investigational treatments of chronic hepatitis B virus infection",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?6/24/6538\">",
"           Lamivudine monotherapy for chronic hepatitis B virus infection",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?15/2/15402\">",
"           Liver transplantation for chronic hepatitis B virus infection",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?22/55/23416\">",
"           Management of healthcare workers exposed to hepatitis B virus or hepatitis C virus",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?5/62/6119\">",
"           Monitoring the HIV-infected patient with chronic hepatitis B virus infection",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?23/51/24378\">",
"           Overview of the management of hepatitis B and case examples",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?39/10/40104\">",
"           Prevention of hepatitis B virus infection in the HIV-infected adult",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?43/28/44488\">",
"           Renal disease associated with hepatitis B virus infection",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?41/18/42279\">",
"           Serologic diagnosis of hepatitis B virus infection",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?13/60/14281\">",
"           Standard and pegylated interferon for chronic hepatitis B virus infection",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?25/9/25750\">",
"           Telbivudine in the treatment of chronic hepatitis B virus infection",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?28/9/28822\">",
"           Tenofovir disoproxil fumarate in the treatment of adults with chronic HBV infection who do not have HIV infection",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?15/51/16185\">",
"           Treatment of hepatitis B in the HIV-infected patient",
"          </a>",
"         </li>",
"        </ul>",
"        <strong>",
"         Hepatitis C virus",
"        </strong>",
"        <ul>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?15/30/15847\">",
"           Approach to patients with chronic hepatitis C virus infection and normal serum aminotransferases",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?29/5/29780\">",
"           Characteristics of the hepatitis C virus",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?33/15/34040\">",
"           Clinical manifestations and diagnosis of the mixed cryoglobulinemia syndrome (essential mixed cryoglobulinemia)",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?30/50/31530\">",
"           Clinical manifestations and natural history of chronic hepatitis C virus infection",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?18/7/18554\">",
"           Clinical manifestations, diagnosis, and treatment of acute hepatitis C in adults",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?37/40/38536\">",
"           Clinical trials in treatment of chronic hepatitis C virus infection in HIV-infected patients",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?1/1/1048\">",
"           Diagnosis of hepatitis C virus infection in patients on dialysis",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?2/7/2169\">",
"           Epidemiology and transmission of hepatitis C virus infection",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?29/32/30218\">",
"           Epidemiology, natural history, and diagnosis of hepatitis C in the HIV-infected patient",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?11/36/11848\">",
"           Evaluation of the HIV-infected patient with chronic hepatitis C virus infection",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?15/8/15498\">",
"           Extrahepatic manifestations of hepatitis C virus infection",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?4/56/4999\">",
"           Hepatitis C and transfusion: A 'lookback' primer",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?30/35/31289\">",
"           Hepatitis C virus infection and renal transplantation",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?30/24/31114\">",
"           Hepatitis C virus infection in patients on maintenance dialysis",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?38/30/39398\">",
"           Histologic scoring systems for chronic liver disease",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?37/30/38378\">",
"           Investigational therapies for hepatitis C virus infection",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?16/5/16474\">",
"           Liver transplantation for hepatitis C virus infection",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?22/55/23416\">",
"           Management of healthcare workers exposed to hepatitis B virus or hepatitis C virus",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?16/9/16538\">",
"           Management of the side effects of peginterferon and ribavirin being used for treatment of chronic hepatitis C virus infection",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?40/23/41337\">",
"           Mechanism of action and efficacy of peginterferon for the treatment of chronic hepatitis C virus infection",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?27/33/28184\">",
"           Mechanism of action and efficacy of ribavirin for the treatment of chronic hepatitis C virus infection",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?34/59/35768\">",
"           Mechanism of action and efficacy of standard interferon alfa for the treatment of chronic hepatitis C virus infection",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?35/31/36345\">",
"           Monitoring the HIV-infected patient taking hepatitis C therapy",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?23/62/24551\">",
"           Neuropsychiatric side effects associated with interferon-alfa plus ribavirin therapy: Recognition and risk factors",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?1/40/1674\">",
"           Neuropsychiatric side effects associated with interferon-alfa plus ribavirin therapy: Treatment and prevention",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?42/45/43735\">",
"           Overview of the management of chronic hepatitis C virus infection",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?37/59/38841\">",
"           Patient selection for antiviral therapy for chronic hepatitis C virus infection",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?29/45/30421\">",
"           Porphyria cutanea tarda and hepatitis C virus infection",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?14/8/14474\">",
"           Predictors of a sustained virologic response following treatment with peginterferon and ribavirin for chronic hepatitis C virus infection",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?39/58/40870\">",
"           Predictors of response to hepatitis C treatment in HIV-infected patients",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?35/41/36505\">",
"           Principles of interferon therapy in liver disease and the induction of autoimmunity",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?3/53/3928\">",
"           Renal disease associated with hepatitis C virus after renal transplantation",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?36/30/37353\">",
"           Renal disease associated with hepatitis C virus infection",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?27/21/27990\">",
"           Response-guided therapy for chronic hepatitis C virus infection",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?40/55/41849\">",
"           Screening for and diagnosis of chronic hepatitis C virus infection",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?15/26/15785\">",
"           Studies of telaprevir and boceprevir in the treatment of chronic hepatitis C virus genotype 1",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?17/38/18026\">",
"           Treatment of hepatitis C virus infection in the HIV-infected patient",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?35/52/36682\">",
"           Treatment of the mixed cryoglobulinemia syndrome",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?23/47/24314\">",
"           Treatment regimens for chronic hepatitis C virus genotype 1",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?0/37/600\">",
"           Treatment regimens for chronic hepatitis C virus genotypes 2, 3, and 4",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?26/19/26936\">",
"           Vertical transmission of hepatitis C virus",
"          </a>",
"         </li>",
"        </ul>",
"        <strong>",
"         Hepatitis D virus",
"        </strong>",
"        <ul>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?13/57/14230\">",
"           Diagnosis of hepatitis D virus infection",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?3/29/3543\">",
"           Hepatitis D virus reinfection following liver transplantation",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?15/11/15543\">",
"           Pathogenesis, epidemiology, natural history, and clinical manifestations of hepatitis D virus infection",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?22/3/22583\">",
"           Treatment and prevention of hepatitis D virus infection",
"          </a>",
"         </li>",
"        </ul>",
"        <strong>",
"         Hepatitis E virus",
"        </strong>",
"        <ul>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?33/11/33976\">",
"           Hepatitis E virus infection",
"          </a>",
"         </li>",
"        </ul>",
"        <strong>",
"         Hepatitis G virus",
"        </strong>",
"        <ul>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?7/24/7557\">",
"           GB virus C (hepatitis G) infection",
"          </a>",
"         </li>",
"        </ul>",
"        <strong>",
"         Transfusion-transmitted virus",
"        </strong>",
"        <ul>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?1/17/1303\">",
"           TT and other anelloviruses",
"          </a>",
"         </li>",
"        </ul>",
"       </tds>",
"      </trs>",
"     </div>",
"    </tds>",
"   </trs>",
"   <trs>",
"    <tds>",
"     <img height=\"10\" src=\"./../images/spacer.myextg\" width=\"1\"/>",
"    </tds>",
"   </trs>",
"  </div>",
"  <div id=\"footer\">",
"   <div id=\"footerNav\">",
"    <ul>",
"     <li>",
"      <a href=\"file://www.wolterskluwerhealth.com/\" rel=\"nofollow\" target=\"_blank\">",
"       Wolters Kluwer Health",
"      </a>",
"     </li>",
"     <li>",
"      <a href=\"file://www.factsandcomparisons.com/\" rel=\"nofollow\" target=\"_blank\">",
"       Facts &amp; Comparisons&reg;",
"      </a>",
"     </li>",
"     <li>",
"      <a href=\"file://www.medispan.com\" rel=\"nofollow\" target=\"_blank\">",
"       Medi-Span&reg;",
"      </a>",
"     </li>",
"     <li>",
"      <a href=\"file://www.provationordersets.com\" rel=\"nofollow\" target=\"_blank\">",
"       ProVation&reg; Order Sets",
"      </a>",
"     </li>",
"     <li>",
"      <a href=\"file://www.provationmedical.com\" rel=\"nofollow\" target=\"_blank\">",
"       ProVation&reg; Medical",
"      </a>",
"     </li>",
"     <li>",
"      <a href=\"file://pharmacyonesource.com/\" rel=\"nofollow\" target=\"_blank\">",
"       Pharmacy OneSource&reg;",
"      </a>",
"     </li>",
"     <li>",
"      <a href=\"file://www.medicom.com.cn/\" rel=\"nofollow\" target=\"_blank\">",
"       Medicom",
"      </a>",
"     </li>",
"     <li>",
"      <a href=\"file://www.lexi.com/\" rel=\"nofollow\" target=\"_blank\">",
"       Lexicomp",
"      </a>",
"     </li>",
"     <li class=\"last\">",
"      <a href=\"/home/privacy-policy\">",
"       Privacy Policy",
"      </a>",
"     </li>",
"    </ul>",
"   </div>",
"   <div id=\"footerLogo\">",
"    <a href=\"./toc\">",
"     Wolters Kluwer Health | UpToDate",
"    </a>",
"   </div>",
"   <div id=\"supportFooter\">",
"    <span class=\"sfInfo\">",
"     &copy; 2013 UpToDate, Inc. All rights reserved.",
"    </span>",
"    <span class=\"sfInfo\">",
"     <span class=\"pipeSpace\">",
"      |",
"     </span>",
"     Release: 21.3 - C21.34",
"    </span>",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    <span class=\"sfInfo\">",
"     <a href=\"/home/terms-use\">",
"      Terms of Use",
"     </a>",
"    </span>",
"    <br/>",
"    <span class=\"sfInfo\">",
"     Licensed to:",
"     <span class=\"emphasis\">",
"      UpToDate Marketing Professional",
"     </span>",
"    </span>",
"    <span class=\"sfInfo\">",
"     <span class=\"pipeSpace\">",
"      |",
"     </span>",
"     Support Tag: [0605-95.154.198.148-B5503CC6F6-14]",
"     <br/>",
"    </span>",
"   </div>",
"  </div>",
" </div>",
" <!-- rightPanel -->",
"</body>"].join("\n");
var script_f3_24_3456=[""].join("\n");
var outline_f3_24_3456=null;
var title_f3_24_3457="Vacuum suction pressure";
var content_f3_24_3457=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=OBGYN%2F57936&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=OBGYN%2F57936&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 560px\">",
"   <div class=\"ttl\">",
"    Vacuum delivery pressure",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 540px; height: 360px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Reproduced with permission from: Aron Schuftan, MD. &copy; Aron Schuftan, MD.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f3_24_3457=[""].join("\n");
var outline_f3_24_3457=null;
var title_f3_24_3458="Traumatic hyphema";
var content_f3_24_3458=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=PC%2F62031&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=PC%2F62031&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Hyphema associated with trauma",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 340px; height: 248px; background-image: url(data:image/jpeg;base64,/9j/4AAQSkZJRgABAQAAAQABAAD/2wBDAAYEBQYFBAYGBQYHBwYIChAKCgkJChQODwwQFxQYGBcUFhYaHSUfGhsjHBYWICwgIyYnKSopGR8tMC0oMCUoKSj/2wBDAQcHBwoIChMKChMoGhYaKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCj/wAARCAD4AVQDASIAAhEBAxEB/8QAHwAAAQUBAQEBAQEAAAAAAAAAAAECAwQFBgcICQoL/8QAtRAAAgEDAwIEAwUFBAQAAAF9AQIDAAQRBRIhMUEGE1FhByJxFDKBkaEII0KxwRVS0fAkM2JyggkKFhcYGRolJicoKSo0NTY3ODk6Q0RFRkdISUpTVFVWV1hZWmNkZWZnaGlqc3R1dnd4eXqDhIWGh4iJipKTlJWWl5iZmqKjpKWmp6ipqrKztLW2t7i5usLDxMXGx8jJytLT1NXW19jZ2uHi4+Tl5ufo6erx8vP09fb3+Pn6/8QAHwEAAwEBAQEBAQEBAQAAAAAAAAECAwQFBgcICQoL/8QAtREAAgECBAQDBAcFBAQAAQJ3AAECAxEEBSExBhJBUQdhcRMiMoEIFEKRobHBCSMzUvAVYnLRChYkNOEl8RcYGRomJygpKjU2Nzg5OkNERUZHSElKU1RVVldYWVpjZGVmZ2hpanN0dXZ3eHl6goOEhYaHiImKkpOUlZaXmJmaoqOkpaanqKmqsrO0tba3uLm6wsPExcbHyMnK0tPU1dbX2Nna4uPk5ebn6Onq8vP09fb3+Pn6/9oADAMBAAIRAxEAPwDj3kJYqgycZAz0qu+3HzBWyT7f/rp7H5uCoB/ixxmmsR95ieOcH+GuLY+ueoiFH7beOQe1SI8SIcruz3PFRNKoXcoBGemOBxVSZ1dssxYr1FXy825m5W2L1xdq0nAUbce+feqdxcBWIyW3HpjrVf5zlRncOuPX60sa7j97AHcjBq0kkZNtsX7Q7DaOEx0H4f1qFpssNxBIJXBFWo7dhnk8nHGOaBaQiVc5JPbrTUkifZsgBdshcZHT2/Gnw2UjFWOOOmOn41pW9rkBVVmIHOBWraafNKdsURYDnkfpUSq22NlRjvIyobbaDtAZhk5I6Vcjgd26MOmSe/tg10tn4Z1F08/7IEQ8Ybg/lW1B4QmSRPtskarJjaw5HuKj3mDrU4HJ21pI0W5wWU5H1NdXomgXc0bSJE5XjkgZH9a6ezs4LWKJLaHMiHlsCteTUJF3bISdoB6ADNCh3OSpipS0ijnP+Eff5hMFCY+f5e9bFtYxRaZucvlem0HBGao3eq3UCszRMyyLy2PX3rC1LxBdz2zQ291CIUHzDcAV5/xp3jEiMKlQ6KW/soFEayMGOS2T6VyWteNwqzQ2jvjaVLZzz+VcZe6v5twhfdKUON+7vWeV1XV5pJi5dSOVACqw+g+lLWWmx1+wjTV5akl94huJd8i3LNz0bPU9v/rVgzS3N1L+8O5j0zzXceGfCEzyw3V3biSJnBCbuo+n5fhXaaR4Jt7edLlVMdxHIsiyRxDcWHIAHI2iuqnTtokctfFLY8sfwlqKQ2bSQfPdoZIlH3to5Y468AV0Hh3whp1xpWqXuo6gsK2C/vnlUxrGGbCMP7+SCMDocetbvibw4jxMkVulxPJKoknlfcxJJ+857fWsm18JaVeaZdJeWFrLJCCxSNR5gUcEqQMjBxyK2fu2ucLk56oyrPSBe2YXTbaaVGJ8y6dSqKRjgZ6nHXHrWRrWltpqZt43mlZCj77gxjODg/hnNbT+J9d8O2MGn6gU1PTYwVt5k4YAnjzGOMHtnoeay7jxHeXt7FqF3pVm9rCciCS6+SRh2baORnr69KVvIad9zn/9KsdP+1XMFvJID8nn3jvvyOFCAY9OtO0PRvs9w95cxwvdOeiLgID0x6/WnwoXun1DUGSWdssoACxQk/3V6ADOKh1DxZplqrKtxJNJkErAMj6ZyB+tDdtAslrI7LT2hwWH+sGCBgjnvzV+LUI45Gw4dckcjqTXjt347ui23T7aKFOgMp3nHbjgD9aw7zxHrF2T52oTgHqsbeWPyXFSJ4iK2PpCPxCkKBnU4BIyeOvA6+lRjxhaROzi4VW5G55FHA79a+YJHZyWkZnYnkscmmDqNoBP0ouyfrMV9n8f+AfTQ+INlGxJvbXzBg4Nwv5Dmph8QbWQt5d5a7gTjMqnv0xXy+ME9OtHBGAB+VTaXcpYyK+x+J9a6V40jkeNCVY9PMT1/DNa0Pia0lLKjctwc5GT/WvjUZUBhkeh6Vsad4l1jT8eTeSsuPuy/Ov69KV5rVMuOKoyfvRt6H2BHqMDRniPafm2nqaW8nmZQIShjG7r27ACvnHw78S54pFW+h28AFoTkH6qT/I16bovjK1u4SYm85QecDAGexXtSc2l7yOukoT1pu56FA48h1fAfcfwFPmkHlnIxjO08HAx+tYlvcwXcKMxPHzfKep7enFbEMskqNviwFJBfFWmmE421MrUVV2VnUyYAZF2jnvyK8/8UW++Zi4O3lgWAIAA546CvRr9w7LtAKAfeXnt69q5PXoluIssoJ4yNo7e1TJjirnnMpugGhtZYHCqNqn5efqvHf0rmrnS5w8rahYyngbJYNmUx6gdR+Ga6nWdEt5Xk85BHg5XYMHn61iPp19p7iWzuJigHVGJKr/un/PFXCa2TOetQd+aUdPvKtlfeImtY47LUpHtIcxxLNcopRQc7QrHIGSTj3NFacVy8675b3QpW6br2xzL+J2nP50UO99vzJUI2+J/ejduJMAEHA6Z4Jzj/wDXUH2j5juXaoxjIPemBmZVwcHH3cZxTWXcM457DFcqSPVcmxZHjcnaRk9RSxjLBQBycZ9KFgIBOzAJA3f/AKquJacbgBg8kGm2kCi2yqkbfeDADHOeakjhZTkZfd0BrRjtI3ZQd2AecDt9K0Ire1jHyq7OcnJHAqJVDRQszHht5AwLx7cnjd3rQjt03AhOGGOnTHetMLERGqoHx1I9ferHkF5gsMUjKAOinFQ5XKukVbWzkmCi2JA6FQv8zW/ptmfLxJIR8vIBwSPYZ5p2naTdSrI4zAFGC2CAfrWtYaIgultxPGZOSQRz+PpSRzVakXpc1tLW5mgSOCNjF1B3HA/E1oy6XdRttLA7gWz1x7Vm2ouFjECyoiqcYZgMAVnX/iG2sQsbzmRVyCEbp1zWl0lqcfJKcvdNpoZ41IklSNW7kjt7Vj6zq9vZxBo7hpJOCwUdMVxOueLTNhLONnOcLvb/ADmsq0j1PWrpETc8jcBI1IAx7Cpcux2U8I0uao7I3tW8VS38iwxNIAflGVwM/Ss/Q/DWqeIL6TyonZIwTIzDaAPbPU12nhbwURqKz6vuuCMHG0jDdR19DXqFxZwWqE2sKxufveXwWGB1xxWtOi5ayMK2NjR9yivmeZ6d8ONLiklS6WWQKxwwfAb0HsK6W30iMOFEceEAJJXGTjnn9K6KLLD52KrtwBjOf8+tSWC+ZhtqjbyQ3Uj2rrjCMdjzalec/iZStdPCxGSSMARnChQCSfpWDqfiS40YzNPoeo3cfyjzbVQ5WMg7jtByMEAnrkGtXXZ1lUxx3EluCxLSRnlffBrgfEniDUtKjZmubPUIWkWNLi3YRyLjn50JyCQeo44qnO2iIVNy1ZzvibxJBrEsd34eupYrqFt+8woQpGRh42PXk9eR1rkIPEmq6Q8UgxcXCAD7VCcso75Q4z/I0viHVINa1lZbeIeaiZmmZljbI5JyDzWRb/2p4n1NbLw3bPrWqO2DGi8Rpjq78Kg9yQKlvm+Iu6hqiLVfE0V/cSLdXLDfuZty7EAJ+7tH+Nc1qPiKQN5VoqJAo+RWbIB9cVWvNEW0vri3v5xdXUblMWsgkiUg8gydD/wHI96gFnFjbsVADgcZ5+tVYn2kpLcqXd7dXWDNM0qc5B4H5VTERUkABseldDHZtJKAoOAOMYyRW1a6GMkMGIxkHbjJ78UcplJ66nEi2bHzYx6GpFtDKpZSNoPTBxXfQeH42bySmcEZ5xn8K2P+EeVbVVaIKCOu3+tFoozbseVyaZKoBwAD+lQNZv8Ae429q9Xm0RZUxHGikd8dSKhOkoZAPK3YPLbTjH0pqMWS5o8raB1BBjHPeo2jYH7uB9eteoXmhwqNxj+ZeARgY/zisa+0dXBZeXPTmn7K4KaZxDRMI94B2dN3vjNM4ORXS3OjbI2fIXOen+H+elYtxZvEpIB9TmplTaHdMqAlHz3FdHomoyQSrJA+JBjJzwR6H2rnjGVzu5C1PYu6XAHrUx7M3oVHCaPZPDvigyDyzuDryy9T+FdtY6styil5GAznAGM+w9K8OsrkhhInyyIc4xgGut0nVDIiOh9iN2Ah9fesalPk1jse7Tmqi13PW47lIht2MpA3KM5bHvWVqM/mx4QfKATkA4Jz7dO1c7BftJje2D/EAeDxxzWg8wIBL7vqe9ZuV1Zmns7HPalHJu86BogN250bO1/x6j681hPdOJAqqbS4yMxytwx7lG6N+FdPfQeaHG4sp4wP8+1c9cNuV7a8jOGOIywyjH056GnF6Eyhyu8Xa/8AXyMe6topJ3aaxnhfOCI3Kg++MfqKKtPEIG2Rw3ar6R3BVfyzRXQprscbw93d2+42YEH8YAPXIHU+tTRoPvOgJH8WPeriQL5aHGM/3R71dtdMuZrZ5UQMkY3MCw6f/Wrz3M9XlUdytaxBwAVUc9WOAfX+dXHgDsAMYJwSRgCpbfTn8sNjerNwucEYxVuOFE2o+Fx6np6dKi4nJdBkcSxw7BIocNgKi/hnNbNjpoa3JuJoxCQQG4DE9eneixxGPldWflVJHI49PpUlsFM6yJFvY8DcOmOtF+pjJtliPRoFUTW5jKkAZc4FXtOil8hPLe1iz8uTJz+IosZdPh+1faZHTaAYkjHDE8HJNVHv7OOZ4ViNyWG5Y1Y5U47Ac0+YxalLTcuXbbRsF+xjHJUDbn1NUZNQ02zgdYo5ZbpsDzTJtVahms9XheVLiFbeQQB/3zhiVPXp0NcvqAdGAlnEgz9xTgDHtRdmlOlGTtf7hdT1VWgMQDsxY4wdw/GsOSSd7pJFdHBHAAyMehBrqtF8OtqcL3FwzW1pGwUqF5bgnjJ7kAYxW94Y8LyfaUkmj2wsv7sgdjwSP5fnTSubSr06V/I5/wAL+D572YvLE20kdugz6V7DoWh2mmRGS2jW2Z48YByef4Qe3atiws4LSKGOGJEKYBAzzwcf/qoZBAMITwSSP6muunTUdWeJiMXOu7bIuOqEb5Ai/KAQBg5A5qnL5fTOPccVFcXAY4JDMfT/ADxWXqbztayNaXMUMyKSrSjcpOOM98fStefoc0abL3mGMAiRTt5Gc/ka5bUPEjWVxfW1y0Sxo27crMDg9OD0Hvn8KqXXim6sNPzqdn5SSruF1bEzQOD3AxuQZ9R+Neeax4gMmpTzRXcSxvHy67jjH0P9Kyc3LY7KOHvrIveItallvhc2F+SoXaUeQMjDOcAn+Vef+JdfMjiR50HlqRk4B/Ed+ayNb8SW13csyJ5kkYLGeMlVU9NvI/xrlZLia6ffEGCx5GSu48jv7+9bQhbUipUSVkdLYajod/PbR+Ihqs9jCzSrp1kcy3czYAXJOI1JxlsFiBgDoR293bXNnpeoWvi6ZvBGgRrFdW/hvTI1F1qCys+0OxbcxAjwWkzt/ur0rzzwnc3fh7XLXV9KuIY7+2fdDLJGGUMylTgHjoTye9b17HbarBNqGqXWoXGrbg32yWXzDO3dCSOBjP0OBWijrqcEtyreqdXukPh/QJdK0uZkht4RK029hhfmkbGWJIzjAGRUi+GZo5o4p0+yl22sJGA2nJBz36itrQLPX/ESXNno66heW6KvmxpgLjgKGHTPyjPrjNdBr8er+HLNrXW9MuZJpbfKm5Xm1YP1DrneuFPU/wAVUlchzs7JnOwaSse0RBGhHBbO3cAcHB+uas7Ut4dkEhGGw23JLD8frWLZ65BBcBY5FaQqcqw456jmtVJhKhYBV3HI5H/6xUvcqFOUmLpsZeZWbgBtuT1HOe1ehWFvbXNuiPIMqAWAPpx+VcRp4SEZGSSeAG469sfjV4aosG6OOTI5DYPNZSVzWtRtFHQaqsVshMIGRgqeuR/Q1zomjf8AdhsEyZLjnGasvftfpFGQyhc5bpu5HfFLPYkEOT5cWMdBj6kdTVQVjklG2rM68hWcl1AKg4z0/TP0rPuraGNFWQqD1U5yK27vy41PmAYJAGDxn1B/Os2Y+YqMMccAnn8MV0xdyOZLYyZ7JZU2p8wwCD15xWRqGiMGcSD7p3fL0Peu3tlyF5CkHkFhjHY//WqC5hQT+YQHBzjIwGq4q61D2jvoeXXekZc5Xy09+1ZJg8qdWc8L2P8AKvUtRtCcSOiHkjBOM8//AKq5DWdPLbjHjjkqe9ZyijeMriWkDom9CeCcY7fjVqxY286sMqu75wOAR7mp/De+a3ijlXkA/KR1rZ1TSdyCSLDvg5GM1FRK1j08JNy0JtOuyh+XbtI4zzW/Fd7mHlrsDE7QTkfXnmuG01ykjRSMAV6L7V01jIpSMzx7k7bm71xTjyux60Z3RpsNxARSdnIL9P8APtWDrEMjqyrEs3y5ZWPUZ/n1roFZJP8AUsGjDAkE8cdeKqXsICFQBnluH7emPqDU/DqEldWbOMS4iQbYtSe3Uf8ALK4j3svsCe1FaUsnluUEYbHc4orb5fl/kcns5Lqvvf8AmdfBasXjWMFjgcoOCfrV2OKYDblkDcHPGfbitNrlpLVYPKCxAgYhjVSMe9aXkqYLWzwixhQxDDk565PPNead8qjW6MhLTKbpJCsnUlydo9ffNTwW8OyTcqyMv3WXnmtyDTbaK3ldiqhXBSFhuZx2PvWza6dJeP5kgSIHl3KhEA9NoFNRbOeddI52ysEmfhCsIGXctj8v0qS20u9Pyx3PlyKSW34CjI7EdeO1dallZiLAInkl+UhThc+oHenXkptbYLbxw2qOVVgUUY9Dg8itOS25z/WG3aJhz6HpVrZlrgXOoXOwMS/7uME+gGD6d6rxy6bYyTmSCOSPaAhT5cNjJJbIOB9aq67ragugkE9xApJlaThgOoGeD16VkaDp95r9+qXitHpqHMiKMMw6YHuajmSehvGlJwc6rsv62JrrWrvUpBa6TbIsh3I0i8lifc5rb0LwZ5ILalBMbpvmV1YMCMYIHB59/wD9dd5pPhm002CKxhhjUAmNpjjLMAOvtzir0scdmoSCQLcFtgG0DbxjHoB71tGk95nHUxq+CirI599Ptzdor/uY4UBCQpgMe65H863dMtAITI2NoGBt7L7U+OGNWESLKsKKSGLZLnpu9qWeYxL5ezjHO0df8TW8Ut2cUm5aBcSEQhd43N3z0FZ93djzAwfJJJAPPb2pt/eImBIMAcHmudur8eY0kmYxztPY9etTOp2NqVFs0ZNRhSUCWQDeSBuYLk+nvXK+JvEcdoV3PmPdsZivyqx6Z9OnesrxTImoabCksCPaySYjdTyHXrgjlSOuP51wXi3V5dOs7izulkvwYw6leGlU8gsvqPXn161Mff0OxUVTjzSNO51qx0wST6k00dtklvIlC569AwIJzjgDnFeZ654htNSmZ0jkZTnMgYp5g44I7e9YF/cXOqyQXFzM7gfKITyEx/PNTPaYLhYye6gHGOa6adNxOatied+6rIS7kNww81VVeSoHb2I/rSx2rsgKBPKA5UHk1egsnlBBXbnGDyM/WrdzbrpULSNhi0e0dfXrx3rZI4pSuzHnuVSE2yOASNysRjBHJWup8Dae19q1pbO+9ZY1ZARxkkHj1PWvOZ7gvcGYgKScjHaut8NazE9sLOYpC5wokwcH24HB56+1CfNdIyk9D9ANJ0+20TSrazs4FjihRU2oPQdz3+tVvGlpa33hbUo76OOaFIWlIkJAG0Zzxz2rgPAXxZ0V9Ds7PVpZUu4Y1j3eWSHwOD+WKp/FX4jabc+GrrTtIZpfPAV5M7eM8j/H2pUYSunaxzyWjR8neOo4Y9YuZ7VJIllmdwryFioJ4XPU49ap6F4gks5Fium/ctgM2MkAf/qpfF12J7lz0PU8Zz+P1rmSNzgEgZPJPanWdpG8JOOx7Npd1DcQI0L/ACv2X61pWYhSUh9pbIwv8815T4Q1d7S9WBypik45zwa9HgcbQxC8rlRgEEdzmotdXOlfvEdHpU8crsoLEBgQFwOeMZyOlbeojzYN0kmAOgArkbO7SyeLzkG0HA5zmugk1GO4tY1tyM8ds4xz+JqGmtTCtSSjczNQEmQuVGOSSRg+1c/e3DfaFZHACYGQa19RYzM23LN3yBmsK6iYjGMquMMR3rpjsckTTSdJYw0TIuBgt+PektpJHjwcNHnjnp6VnWfz5Rcdcc8Z96stbyJEwglPUHa3HP8AUVfqNpi310WAZiqqSWUkdf0rIuZElV8KdxHJOOTU5R2LRbMheSS3b0xUMkYjKlOMnJx+eKmWppC63M/RWCau0Y+QMd454HevT4Yo5YoQI8Bmwc4PGO3FeVWswGqLjaX245Ga9a05lOm7lPMWBk/xHtzUz2PQwTamjnfGHhtrOQXVlCcD5mC8j8KytNdmZQQyH+MEdPwr16S2F7YQuYyrFBkYAOfpXnGuaO+m3JuY13Qs5BwuOeuM1FeneCnE9ilLVphGzuQW2EZxtBwxGOpqvNc7V+5gMMcccUQyq6KwYBjzgdaLuNVPAUk9WI6fSuHc3cSoxjc5ZFc+pNFL+6JbdsyDg7mOaKu7MeVdj1aLRL3CmRlKh9uFPy7sfp0roB4clUosF1ayNgEtECzAnnbnvioDp6x4drtZFYDCryffk+9XUeSKPySFgV18tWk3GRfViB0NcsYpbnPUqSlsy1a6UkQ3CGae6CA8Nswvcn3pby+tbCQKyfvcYKPjCnvz3xWffKssyGOZyCNjEMWc8ZztHauX1GKZTKJnRnO0HDDcB74J7CiU+XSKFTo+0fvM3brxT9nDx28aHGQjc8Zz0weK5DUNfvLjEWWeeTsSclcdufSs+eR7m8is9OijkmkcIzu/ygngAmt3wj4fWS5DSwKJmJDGQ7gvA6Enp1rHmctD0VRpYePNJEnhbw691dR3mqRv5agbFbkHjgdPxNet6RYC2jRFjjUxtmTYOrDHf1H9ai0S1ijaMOi4i+7t5UY+n1zW1JZ+W5ML7RINxwcZBrpo07K54mLxbrSs9B0sqxxuUYBGBwrLyx+vb/69YxlW4kCyKoVAecclvc+tPmcTSLC7qrAgEnoo/wAaS6uIrTasQiCRpt6Z59a2buc8IW06konWJQh+WQjAHr6YrFvL+KBf9Iwp6MGbr9ao6lrMNqry3EgB7HqT9K888Ra9JNcFp9ypk7I+uPc4rKdXoj0cNgpVHrsdPfao06T3ShfKi253cBeuPr0/SuUvdXe+1OLT4WO+d0SNl+UEs2MY9MnrWR/wkhtbe7eRke3aIwXMW0kGN/4z3G1gpz24ry+/8QX0usmKI+V5EoZSh53owYH/AMdpU6cp6nZUcMNo9X0NjxJ41bTLma2sVSW58wpMJPmjO04Kn1PGM9R61htcQ6m/mxGa3V2LfZpZC/lMeSY2OTgn+Fs1mC2a71W9nIy8k7tk4xyxP9a6bStIkVkwAcnBYdj257eldsaaieNVxM6kryZipa/vpBK6O/QSJwTz+VbVlDbwhTcDBOSO+a9BtPDtstuGvoY2lLAl5ADnPtVPVNDs7QjZaxL/ABFgvAHt6dKvnRCTnqcw+0oRZRsdhyCe47Vy3jK7mS3SKUAOxJDjiu1uo08kqrjYBgDONvpiuB8cReU1uquSASCrevFN2IlBxVzlATjAJ561atHEcwbBwOo/rVdmUrwCp+uQaUEbeW5BH0xUrRnOdVY63IoVQGYcjpwMc/1NSajr0kqNHkHacZ6be/Q/55rk2YgEMG4P4U6Nixwoyfc1t7URLeXLTyncxYjufrVMkZPpT3BVs9PoajJyR+lYybb1GORirArwQeor07w7drc6ZCVcltpyenNeYZ64Fdr4DmX7PcISMq27Geoog9TSk9bHWS7mGEXLuRnPNaum288ce1if3hOxUXPvVGNsAyKw3E4wa2NGmaRXBchg3APT6U2y50m72HiSRcb0kYEcNj7vt7Vm3tuTMDvY7s46961LryY87SwAGSC3HQ8VnmFZJGJ3BgBjnjpWkXpocFrMpRxTKQ6sAFO0/wC0M06Z0dmeJY1GcHsQe4/D2rQW3EyOQ2QpCnAxj3PqapTWkUcMqxDeM43dc4Na9A5itJsiPGCuzoB1NZt+wCFkYbT0A5Iz1/nWhd2yrcZRguF5z39aydQEkeFB25xjLetJotSv1MiyLDUI9mVzxz1+leyaRKW0lIVUgkjHrn/P8q8bskP9qxK/OBzhu/pXqOmORCseT5pIwB68YPrWFZ2iejgleZ6TpsjfYEXyN7ZPIOckD+dZfiK0S80598IVsElOgFbHh2LytMjDMXfk9cn6UtxILgeQzndzjA/L/wDXW0G3FJs9LRSukeMLi2uDC4Bb7xB+6BUwaKQFgio2R97qo74q94vtRFfyMNx28N83X61iQliHdckcAEcYNedNOLaO5aotGOOQ7izDPTaMCiqwBYcuqkcciilcVj6DsrxJLWWGzt9sij55iT8gz6envWZcTTWkz+Zc/wBo3bkrvPzH2wTzk1aNlcSZIZkhADOFIBA7ZPAA57mqF/LbWcCCCQGX/lq6gseuSR6/hXI5OxxQiuay1KYvktFukunaJXg2ukYGSc/dJJ4PA5rnLHTb7XpTFGwtrRs7JZSwWRiCVRSBznB56V1el+FE1a1knv5fsse4CCDPzSg8hz1A+h611MBkAUzyTHySCsSRhVBGMAdj0OfY9KSg5K8jZ4mNG6p/EcvoOkh7GO3ZoWvBCqiSFQojUnDoePmOAMMe3pXV6dYR2sK26MgIbK7+gGOg/KiCz+zhjKF8+T95hPurnseeDXRaTAGjaSUAsvB9TWsIa2PPr1m7ss2cIt48MNxA4Kjk/Qd6guZY/JdpgS23gbsc9B+Aqe5KoFIbcByARyP8Kxr+dJJFkL/IuMk9fp71u3yqyOWnFzd2P+1fZbNkDqTKd77Rk59CfpXE+K/EK2UBZmBkJIRFPLHHp+PJqt4k8WQ6RuAYPPuO1AfvfUdq8xa/l1bWoEvLlY1lkUysCBsi3ZY47KBmsJS5tEe5g8D/AMvKmxa1LXZpGMrSjzsZXDYVO4xnk1ymq6vmWQhnklkJbOSc56nJ61r3Wuy62dVv97pJJZx2kUe35mLsN4/75D/mKy10ppYgJLObkgB2XFaU6cYvU7as58j5FYw4J5opWuYp5d7Iw46H046Y46dxVJ7YS6kbiRACyB9o/vY6VtT2Qid4kIO3jOc5wa0dK0xQEMgCgnqQP8iu+yWqPmqtZ7MraLop8nznQtznc3QGu2s7eOA2zqm1mPAJA/SmxxJApVGbaRzF3Y56/wAq0EjjnbykEUar+JGMZ+lRJnDJNmkUMkaSQx72PGccYrmtV80FvnII7LkV0UczzqsURYKpB3ZwCKwNcKyMfLcCMDoOc1jJnpYFPVHPXbBkACMxPbP61w3jqCR7aKQpzGcnbzgHHU/hXcXKBCd5ZO+Bnk+9ZGtWf2q1khYbVdSMnByfX6VtHY2xELxaPJz75FJnr3qW6haCZomySpwajPbHakeQ1bRiZ9ant5hGzHPGMc1B3NA60J21ETTybyC33upqIYyN3I9jSdaO/FDdwDv6V0vglit5KFLAlcZ7Dn+dc2Oc84x+tdZ4Qs5DazT4O1jgYHPWnHc1oR5p2OphuWCsN2OPlwMDNael3W3nvyevQYrEkXem4YAzxzjBq7ZRMVYqhxwc/wCfrTkj1oQV9Torq4Plq8WDjJ6j2zWbb3RkkKsAuRgD39qbI7eWflwAOGA9R+tVyh83eoyAcHDZ9aqL0PMr0LTdjVjbbGXDryME9Of8iogXEaeTuUkn5iePf+dEUuVxGFAQYGMk5phmaBXy247iOeOQTmtYz0OGdJxZFJKwVSqhypycEc+v4Vj3skYkCsFDEdfyrUZdqMQ4XAORnBye31rmNZVI1LbipGSG9fT+VO4Ri2x1grHVjk5JB59a9HsyI1VMhN2AWHXPv+dedeFlBmDu3y5zn05zXpVsHaYLCikN2AzzXLXlZWPZy+m+a52umXYiSBOZGHBdeM8DJzV2aVZeVcFVO4MO3tmq2kW7wW6I8eGbPA6Lkd/es1SbaS6gByQdw5xxVxnZI9NQUm7dClqumLPbSTTENM2Q2ehHqK87u0axuHiBIQsCpJzkY/z+VenX0sQsWOGy4yuOP/196891lTNIpVcv6DrWNRo2UXZtmetyY8quwjP8aBjRUO+VeCF/HrRWIWifR+rooQqCI5XPliAhid2PvY5H5n8Kj0/SDqjedeIsUcJEavj5UVeSQP4jzyTx0rprLSopi0t4GMZKsyyDmQnnv91R69/atK6WRyq2arvJ2sNmEIUZ47duKxjSvqzx3X5VyxKkkMUMiRqTNM670dV2svHVl6EkdfSkfzNkck7fOqFm3YPXk/Q8j3p7lY4gEQCU8ZI5B7859B+VOijkd4cMZI92VBHJ989+taPUxvZXJktBLKrPEC5GF7cY7j9fxrV3RW8IQ4IJyfUelIlrs3Ou4gc4Hb8Kz9TuQkKs2Mj5ueCB9apLl1MNajsilrV4EU5cZbq3oPrXmHjnxgmlWv2aBzLfyD5U/hUHuf8ACmfELxpHZJNFBiXUTnyYxxxjBZvYfrXkN2/nNFN5081/JGHnkkQDY5Jyq4J4Axzx9BWLvPU+hwWCUbSkhL++mnupneVpJC2Xlfrnvj0HatWLS7mzsoYipN9qsSsIlBMgtycqWHQb8bh/sgHjNO0PSre3tv7Q1WMOhGbS0b/l5b++/cQg9T/F90dyNq2F5HqgkaaWS8ukIluHJVmVhgj2Bzj6cDAptpLQ9Ntzemy/q3y6jfCljbJfKtw6eUOQ2OGPqD0rvb+PTbnRflmtW2/KrMwBQ+vTmobe0tf7NXdbIAo+ZSAAMD1punywzXEEESWwSH5i5GAn+ea3oy5NO5y1mqmq6Hm2r2PlzghDyxGMYyPeprGINAhkfyiM7uB7iup8Raf9sn3R7plbJQr8oI9vXrXNonkzuJwxCcEMMEjPSuq+ljwcVS97mJjk3LSqSEDAIX6ngCrdv5rX6tFH3IHQBj/Wq7KJ2yHGFOR3wMcfrxUlvMYoHQSYkydxYc/QelSziatqx0k1yZZBNLiNiUODgU6dopI1UqS2NvGBj2HvVU/vgozllbPIzipLdIlUs2flGC57H2Hce9Q1fc3o1HDRGVqCASPgEJk9T096y5oxnLAkfdHc9K2b0glipG3I/wD1VnXAWNAeM56t0xUxbTseq1zQucL4r0fen2iIbpOBgdceuK4x0ZTjBBB6GvZWiV9xHCnuB9f0rl9b0CO5dni3JLu5G3AP1rb4jzK2Gd7o8/5xSkc9s1vXfhy+iyyx5jOdp5yazpNPuY2O6NvrjilZnG6cl0KJHQml+mauDT7pwcQk49Bip7XSLmZ1BjbaTgnFKzBU5PoUrO3a5uUiTOWOK9P0y0FtaxwRlRtXOSOc1l6RpUNnhlXMmOWI6GtpAQDvwA46jv8A55qrWPQw9L2auxr+Ufk2/NgDB4GamEbREDYMHBI6Ypu4NcBh8ysBt4Hf2qzOAgzgDd8hqXvY7FqmyPGVJAPJweMcYo+442tkccjpUiFeQuCB1x1H4VExCriT5NpIA/8Ar1SbWhz1FzakkUqggvuZc8gHBxTZW6hmAGeCenrUasM72Yk/3ev4cH61DLOgGXPBGRz+lUnqc0qaI7kkkNnGRyTzXK6lPI0mzgjOfr71t395uQoSMZJwB1H1rMgj8ybLr82Rhj65qr6BCglqbvh21HkLyF28jg816J4UsmZxJICYxyCOPpXK6XbEeXGn1zjgn1r03QIRa6ewkARmweFwMVyy9+dj1qFPkhfubEbhYsyk4ALEBcZ4/WuA1XV5JL2SWGFkRTgHFdok4MsnmyKERc9DjGOa5uG1WWCWRlLbnOPl4+lOo20oxOzDKMLuSM64uTdJb+S5ZhyRjIz/AE71m3oWS4dkTAGc8Ywcc1s2qWttHKSrb3zz6fhVNUE0c8hZcZyCRgkjrXPq9zpaOau7fdLlTIMgZAwP6UVoG2LEsPkyTkE+9FVzI5nDU+ppJBuRmABBCnYv+tPYfT6cVOjZm25REBGSM/J2IxzyenFJHaI8wknXD8sF5YenQ9vWpLgy2cqLuRixJGUzz6/rxQfL3T0Rl30izzRp5eBFwD/E3J61saPZq5ViCqonPqT6VTigZpg0qLy2Txzj3x9Kv2jcNvLJHz09e+KUd7sc3pZDrx/sy8TDg5IAx0/pXkXxN8aLoVt9lttkmpTqXiiYHai9N7e2e3eu28T61Hp9lc3MrM8aKeAw3MegUZ7k8V8v6zqE+rarLe6hGkd7JkPHlvlAJwpB+6QOOODj165zfMz1sswnM+aRV81p5Zbi4lEk8jfMSCXYnrj24HetOxtXkG2KEOxJyZOnTv6+tZ8MbfJIw+TuorpbAhY1dU+UfLnOOfWolI+k5LIeLd5pvOv5Jp5X4aZzknAwvPp0GOgA4rYt4HSYMXZmcBSzOdx547dKdLGxs/MASQZDDac96ZDPtBlIRc5A4OV96V1uyPiVomprAji00KhYkED5mOGNYFnc+RqUasizA5XYOg96S4u5ZI3jlLSbflBPXmqlpGwmBJORxwP61Mp3eg6dLli1I9Bazkns4GbH7kfdAx9OnX8K5bW9NSK2klJLknlsZAPpx71vWN7KtvH58sUaEfJIzHOR7Va1uBH2TW6TTK+BMw44x6Ec9/SvSozUkeNWpa2Z5E+rvakIo3AgEkjn9KsNr8UiIrhVwOB1x9e9O8RaOsEkklqhMR9WztHb8a5SaMxE7yuQfzzVtHDOhF6M7ODUI5HjCzFs4PPTPStCNopI3x9zPBHf1/lXnf2hx93g9/Sr1rrEkO5WPyZzkd+aVnbQx9glqjqr912ZQhVHtxmqGwtk8nPXjPHvVaLV4ZSPOfvg8cGrAkRgSG9MYbOahp9Dqoy5VqwMe1GXjAGM+h/z/Kqi24Z+TyhHbg1d3IItpIJznIPPvUKyAllyqA8gk80K6LqTixCgZSh2nGcd8cVRmsFfbtRcDpkdfrWohQfKVznnHXt3zTnG4lSF254B9TT52CpRktTFFsh+VVAIbBPrTYbZE+TBIIxycgY9K05diKQdo+XBAzzz3qILiVTtUPjIGcVSmzKVOxUEa7D5IP59+9OkWWRuA3OOvGO1WcjBIGOM5Heo2Qb2IClh1z1zRzMOWyIrWMRhW8wEZ9OetWpvmX94qkleo+tQQuv8QCk8LgZJH09ad5sR2kMMr6nmk97l8yUbDlRYyQRwRlec4AqrJLuG7PztycjGagubxUKkvyMgEHH9frWNd6qN2xMDA/yatJmGjNaW5RUwCFOSDg1l3d5nO1gcYx/+uqEl+Zl5zu7HPXmoZHbP3doU4Oexq0rB7qLhO6b5jjdyV64rS0i3Uy+aRwGzzWRDunyqqevJ9fau10TTjKViVSwzxjAz/k1FWXIjahD2srdDp/ClmjXCvccQDAU465/wrtbgMlu0sJ8yNT684xzxWXaKlm0NnJH87rge5x71PfXTxTgMBmRgQfQjHWsoWim2en7O7SRnX1+Y7WdEzn+HHOe+PYVW0zUdlvFGDtUD5gD3/l61bu2t2YjAD4IIHNY08SQFBbqNuAxyKwnKSd0zrhBNWsO1FkjlCBWYyc5BHTP0+tUZLjYHEfJyR1wetJqF1tY7MggdV6471mq7s42nex5PoBWLlqacjsWGl34KAYx6kUVds9DkuYBI+0E9qKr3+iMG9T6sll8kmSOTP3hnOMLngD6+lVo2L3KOpfceecce9Sh90nmyjLbgcD078d6fbBHmLA7MHJJPQ+3pWrdz4te6i1aQ+e0hYYZvuj0/wqlrFybaMRF8gfK5Dc478GtYtFGheRwVAJz3ry74oeIP7B0Ce8j/AHl9OwgtlIzmQ9Tj2GT+Aok7LQ0wtJ1qiSPLvjdrD32qJosLH7LbgTTJ/ec52g/Qc/jXEFXuiJZ28ybADSHktjpk+vrUdrFunclmkZyTl+WJz1Jq/bRnc24MF3Y56VzSelj7qhh40oqKHhFWI5jVsrgc4/Gp7C8aIMEYyIMkDoQB71Wk3bCgYFWOMA5qqdwbaSOOD6VGj0Ovl01Ny2vHCrsk2gEkbanN2HwhLbQDlutYUc4j2qDwc4AqfzXJG0tkH8PpSsLlXQ1TPsIKMWJJxnBz9a07O1E0DvJI6nO488fTFYVtLsjy23DDHTqa07WRZ4mPmhSv8LDpz/8AXotqY1YtLQ6Xwvb2/wBpLMAJQcgk5IHpXT3V2pjNvbjzbsg4Jb5EyOpPr7VxGk5mu1jSXywMt5oHzH2HoK6K31JNPaG1s4otrHDynlV9y3c110J2Wh5WIg3O+5yep6VdQGd23NvYYdm+8MdQPeuK1i0DSyEKCVJ4HNek+L7/AASsE4lI+9JnOB7HoB9K4WSeO4aRJE2nquMfNzWntIqVkE8PKrDnscfJEwcjJGe5xzVVm25ZwWOPuiug1KwYEgE7ieAFxzWPdRBACVBBGcf/AKq6ou60PHqRcXZlSSfnKkg9cdMdqjN5Mm8RSsvHTPpVlrmAWTRfZlaQsP3pHIHcD/PatDT9K8M3V1NNeaxfQwKm6O2jtC88j8fIG6DnvV2uc8puO6MD+27tW27/AJT+OasW/iWZF5RSCMBiMbf84o17w8lnHYvpmo22ofaEy8YISaCQAbkdewz0Oecdq564t7mIYlhkQE5DFc5/xqWiPas6qPxM4Lb0GT3Q4p0fidQT5icEdM8iuJE5TIC57EHvTRORyrcnPeo0H9ZaO3k8SqQMRNg85YjHsahXxIpIaRGLZ3fK/wB6uObc43ZJz171IIiCoZWOcYAHJot5C9vJnWQ+IUL5WPgfwknGPaj+133hgGD54AP+FczGrLhyflX+9kE1O+/I2BTwG3Dpz6+9WrFqo3ubD6rMqAxbc5ySe1UZdTYs2XYgcZU8GqnlyyOAcA/3j6+1Ri2Z3y7MFHU/h60CcpdCVrlnJYY9Rnkikjbd0LEj15zU0VvCFHDsw9Tx0/8A1VdiRccKobAzz6U7FcrZXt434Q/d7Htn1q3FaOSQCSxJOPX3qWAB2RcFwOMDmt/RtPL3CAqctjB6DH0pSairm9Ok5y5UGjaPIRiJPMJG4YXJHtXV6fF9jt1lbIdSCCO/qMVueGtJMIm8wsAi5YEdc9KS+j2RyBt20jeCo71xVHJrmZ7FCnGn7qNyB7a5sxOrBGC43HG4fTvWRrEqxQB0y4Qg5/iz64qFtQT+ymWAMiQtlvc/yxWXNqH9o33yh9iABUHT/wCtUyq3jY7KFJq7exqxyxL5M21tzAks5NY95dYWVUYqCfpmqmqXUousswDAY2jge9R6ZYXWq3ccUSkgjJLDoPWsnJy0RuqaguaRXjjmu3URIzknkdfxFdvoPh9YbcSXK7nb5sE9v8irui6BFp6BpG3so5OMjj61NqEhfEcblMclfX/IFaQo21kcVXEc75YbCC6WElEtxtz7UVUKt/A2V7ZPNFbe0kY8x9ABSF3NksDnJHFXbE/NuKD5jkkjrVNN7yZ+Zjn+72Hp6itF3aK23beSuDxjFSj46XYy9eumCFFwDnAXA6Zr5k+KWurr/jRLdppE06wYW4cDdht372QL39B/uivZviD4hOk6FfXAYpc7fLt2bnMh4H1x1/CvBdM0h+HdDITgl2GdxPU1zVKivY+oybDRhF1Z+iOq8QeGvC1lpME3hjxFfateTPhbdo8YXHJPAK9uvWsq90HUdPgimu9NnjhnjBjZhkHj7wOeRxXQaPbCxQPsbaAQDjqfY1vXDy38UUGoNdywRZKw7jhPz/lSvzavQ7liJ0bK/Mu73/Ap+EvC3hv/AIRSefxhFLaanKzS2ksdzvZ48fLtjUkA54+YZNeaXOkXzZZbSRwOeMdPpmvaYLa0WIKsJUKPkO3IH+FWE0q2lAUIrdyzLyavk0RhTx7pylKV3d/Jeh8/XEbQDbMGi7jcuAfpxUgnBGAAcL3Fe4Xnh22a3Jkb5CeQoyo5/Sue1DwBZXKNJArwSdvL6Z+nTFHs2dtPMqUnroeawz7QMZPYe1aVvdEL0zJj5T1Bq3qXgzU7POxEuEB4x8rfkeP1rBdZ7eQLPFJA/YOMZHt61Di0d0KkKq913OhivN8rCQLGGwMqOQKL+/nZViEp8n+FQABj6CsQq5KoWYqq9BU1pulYDABA439CKn0D2Ub3LquPs7+eCBghTjOKxzATJhFJU9WArqbeyMtoDsLpnaABnmui8OaFFMX+0RoygAbT61UIyk9DnniYU02zgYbeSSUIELKAOD2/pWbfaW7Ryy4JCseDk/8A1q95TSLSCPb9kGMfNkDOPX6Vzl34aW4e5uCgjg/5d4oxktjvj3ruhTlBaM8upUpV7ng97ZbVP8OW681nFQrOtw8irjIZQDlscDkjv1P869O1zw/LbKJLqJRuXOwDO3PT+lcvqOjzfdKqcjPT+ZreM09GedVw0o6x1RyKnC5kJAGeB605mAXgfMfXrVq7sJYgcAqE7EYrOeCSPnovzHOe/p/OtLdjkvYjcKVJTAOMHI+9681EUhBUCNMnk8YPI9acVfkONuOOKjl4GBkjp1pE6biosXl5wq4GRnnJ/ChR8xUFlXqOeajRiw3fLjj8aPNJ+VDnH8BPJxQK6W5IEwxGRuBz3zSRkKpAUBgM5x/KoGfGAAQeB6U8xuSzYUbV5oQNonICj5lyehIxwaliHz554ptvbtty3y8HBq7b2pBYLjB4Pb06UzaCvuRiIAD1znjpVq3t5JGygIxjk+tX7XT3k2gKcE+nX8K2YNPaKNXaJdp5yDyazlUUTrp4eVTZFGwszHtBGCcEknAzXfaTpkOnwpNdYZxhl2j72eapaZpglt1UpubcCABnA+tdBrkR2QWaFWRVUg88VySnzJyZ6dKjGFoosadriLC3nlUL56H34HFZWtaqLhE8ra3GCxHWsm9UpLMoGSrYFZ7GVFBmJ3MMjPGBWEqsmrNnZSw8U+YuNMXSSBF+dxgY4ApBNDZQiOOLfcs33hxzUNilxcThbcZ3cA12mgeFMDzpAGkOCdwOD/nNTGLk7I2q1YUlqYGheHLrU50muMhCc84P9etejW1rb2VtDFHCmRkE4BJ/GrKRR28LMMEpwCO2Risy6mDL8vy4bnJPOehrrhTVPXqePVryrvXYoXlxKxICL5Y5xt469cfnUEzABM/dxnAOec/yFLIyIW8tlEmOc5681Hc2s8cCTSxSRpMm6NmT7/v71m5NivayK8lw8TbIxhR/s0VhgTsSTOgOT3A/Q0VCa7FaH1VZnajkkgjjOOvtmo9Su0iiQ/KSM47g+/H1qw7slqFyNoGMHvXJ65dxRpK7MQqZ3N7fT8K0lLlR8rQh7SR5r8Rb5tQ163sLa4gQWiNcyebIEy+Dgc9TjoO+aztIkSa6a5vCJjI2WLDBz6jGPSsNjJqmo3FxK2ZZnLjjlRnA/LitnTysAjkuVMaA43Ic5b6V5/Nd3PsHTVKkqa7HWWMFhbgG+dlVgW3KeU/A1Y0u3kukZ3BCnO1m/iPYCqFlF9tu5Qtw5sQy5Jw7SnOQMcgYx611d/Da2VnGIH/dxuTMWkGEznufpXRFX2PLqz5Xy9WZckAiSNM/vXbrnGfWpFj2sM5UYCgjPP8AhVYXMF7eLbWDyStyS4UopA7AsOTweRxW/b+HCl29sVeI+UJAUmIAYE5HIwenpVRTb0MpzUV7xmyfKGJ3LHj1x3qSIRshTBQtjDHOMZ/OpdQTypBskQIp25IyDjt+dVboeTEsilljPJcDg+9WtCU00h8qo5w21htO3dyR9TWfqPh6Ca1VmEcm4Zw3I/I1YZTc2sUqt5jE4J42+nNTOJP3MXmE5yBu/pVcze5cZyh8LOG1fwFHIyvYq8ZORmP7p9B1rCvPDNzZkRsgIGf3q89v7vfFexMypGnyBiozkcEn0pLiKG6tz5sBLKRyvf6U/ZRlqdVPNK0LKWqPKtCe8tL2GKJY5LcjkDIOfx5FdXLJeCLzIkaCRegxx9a1bvw7Z3YzJtUAgZ6Ef41Wn0PUbOLbp91NJGf4Ww+PwNEabgrdCqmLp1nfRMq2V/falcrHcpGsERzNtY5c9h7DPWulKuYDLPgYyFB/n+XauZ0++uNJLrd6Z565Jk8ltrkg8nDcH861n8T6LMg8+4Nqw523aMgHtn7ufxropz01ZzVlJv3I6eRl+J7izhILnzGX7kRB+eTsox+vpXJv4bLJI8ilpmVTuzn5ycDAre0ezm1m9fVJY4mjDvFBDE3GCeXz6kVsToVbyozghwcMcAMP6UlLnd5HT7VUl7Nb9TzLV/B7QiMRr5hY7Tk9D6kVy+oeF5IJivlsp9QM/QivoC4TBheVdwYEdeKx9Q02OTTbmQYD4JX174rdKPTQ5vdqfEj52vNFdXZSvQ4wvX2zVKXQ2UswGBkdF6V7ZZ+Hbe606OdVUOrYdjnGRwc96yb7w5IhRt+VJ+XB/OlzvluS8Im7RPHpdJl5wc44AHbtiok0mTONxUt1zzXph0qWS9a02jeihiyrzUM2hzpOkMq5zz2PGan2iF9Rlex51HpR3cgjPXNW4NKG7iPgdya7m40XE1ukfPmHjt25NaUOiJbzmNztULllLcdaTqrojWGBfU4uDSWcjamAp5IHHPeuh0rw00meOjDJYZz+Nat9Zqbi3t7XOZPmyTjpXW+HoUijbfGCEYbiTWXO5PlOtYaNKPM9Wc9H4cFrd7CvmOQMKFPBP+FXbzSJFspJBGHVQdq579811Et1DG82WEWRuy2MkVjR6xHIL0EqsaLw3PzUpRgvmb05TdmkYVi0axeUs5ExIDYGTitSVZYQ7vEHVQG+9gkf5/lXO2F3KdQa58oNk8/4V1kP9qarF+7g8hMYB2j5h+NYQaOipHklq9DF1PVo5UEdnb7ZyepzgfnUOm6BfasxcxkrnGe1dvo3heG2kjkkVpGUdCQcnFbBWO3iPklkRBkL2J9xVKjKTvJnPPGxguWkZWhaBDZR/fBmZcsM5Gf6VsXc/lDMLHPQj6+9Q7g7EgkdANp49cVi6lO0EnIO3kY64/zwK2XLBWRxe9VleTH3sxLhRyOnfnNUbkSeUi4XO77uCKjlvQspLNhsfKx6fSnXLg7fKHmqcMwU8/l7Vk5XNVGwxVEdtIrHae+euKqazq9zcR2yLc+atsgSON2HC88f0qPVbqZ4k8kLjH3T1fHUVGNMsr2ylu49Us49vKQtuD4OO47DmsnLoi3FR96Rd0CW1n01XbzVbcwIz0OenaiuButWvdHvbm2Wfepk3h0Bw2QMkY9waKrlmto3MnKm3qz7C1CcJCVkdfkGSoOSB7+9ebeM7yaSwe0tYBO9wfL2bsDaOWOeMccZ967HVriIriWQYJyAOo9ia4OGb+0vE01mVWa2wpMm0l4cZJK9iD0Ofas6sr6HkYKnyrna21MGPTLbdbNZSiSYP5ZiQ7gqlSfvcbjnHatGw05JZsFQ0kakNj7zY6kt1HWugsbaXTrm3W0G52cgEBQEyNu/p8pwRS6tpCrIsmwSRbgGjGcnBBBLgjOe+Mdanksd0sU5O1yqsUM96Bp6qssRCeYJDHHH6K5AOSeeACad4v0tVm0++uLovlQwicYRMEZZFAxnk/eOeOtbml6XbTrD9g8vz8lDI4G2I7crtXP4Z7EVF8U/Kh8FWj3Evlzu3lIAuWkcg9OMk4BNacnuu5zRqv2sYr0NKGK3uZZJrC4+0BHKrJGuAzAb+v4nntgVc0/UodWmne0dPllYtn5gAygY45Bzk15XaXE3iPVYEvZHsNLRY1eygfACoAgLMD85PHA6A98VseKNTtdCktIdBMbMYlPkkgLCAchmAx74Gcnn6041NL9EE8G3NQ+0/wAPUnfWIDqtu2oKJAJSqW6Eb5F3HnHp35rV8ZavDeRLBpEqyShiJJjjZGhwcKv8R/l39K4/SIbea8lmSSbfIokuLqRRuVcnACg8JyowCce9P1SQSq+CQ6/MpjbCr2IxzgdRz27Cp53r5m/sI868j06zhtHtIo7KBohOpdSqd8ZOc9MkdPelv9NW4hkeIRZXLBwoVcgHn+Y/CuC0vxHGuiTwXMrm5TLovmHLLlcdeDgg5x7VY8N+IjcWdvK11IjTA71AwuCOwPA5PrW0asdEcksLVi3JdGbumWMt+02JNvkAFzkEjP8AI96fJpN9G3nAxyKzYyCefQ896yE102Il+zMwSRgZhtCk4PbPqAeldHo/jC0vvLeKFltHQFXmYZB54I+tVFxelzOqq0feS0Mu5SaCQR3aHfwSjdAOw9qvQsU81mDlRydvQfU11UF5aXM5MSK2P3bt0IOM4P6VYeCJ4GgRAImOWUg4I61olbY53iejRxM9urxzNOqmIdG28Aem716Vnf2dauEKAIsalsAhu3XB4rtxocR82OR3aNyTtDZA5984OPSqg8KxRXcbJNIbbGGjP3sDp83/ANanc0hiYrqecz+HbC/XzjaWdyGYtuRDbSZPPJQjP5VQj0e90tALCe6gO7IE0wnjHP8AdZcg9uGFeh6vo+pQ5W1jM0RO1SmMr6dTyf0rNNlfLZ+bfW8sAz5ZLlRgkcHGanlSe2p2wxba1d12OSkuteiQNdWtlOp3DILxMO3IwR78VQl1+TyfLn06dXA48ohx9RnFdnAqBUh+0pLHIC4kPJwOAPzNRx2e1bh4I45nChduRnHfmmr9Gbxr01vE85h1a2tbKSKE3vncna0fG73OfWkfWIrqGBZZFUKclmUnnH6V3ctlp80ZDQrE7sQoyDuHHt9aotodgqSIORuHRfuj+LIxzUWmtmdMcRSerTucFa3xfUruRWj/AHkg8sk7PlAxz7Vb1O5s5Lonz4l8uPavlsG3FvT6dK6yXw1pzFWjZ1WRcA469skVUh8M2QG2VvudQQAcjv7g1NqljdYijfm1ODeXy/Km+1LNNEPliCcAE88iiO433TNLIWR+XKrnJ9K9Fh8OWO25SKNX2FQVz83PoOpp9v4fskGGRn4AJ244z/8AWqfZT7lfW6VnZHmN0802pNcxxN5eMITwQPWr9reagsMkUFuzl8fMxPA+n5V6TbaZaeVN5lnJuUYBXGAc9+OnWrBiggaJLZ4CB97KgjHoDVexlvzGcsdF6cp59Hp2talGkchCg5XLLgj860bbwV8qG5nJk7gZx/8AXro7pNtzmNW2ZzwD07/Xr2qYX8MMkHnxCYJy0e/aWGOOecU1Sj9rUiWKqNe5oRWekWMUQSC2SMNy3fJq61wLdTHGq8AbQMZxWZNq6u7FVMfGVHfr61k3GqmO6kd2ODjg1pzxiYqnOp8R0kN2XgIjUsuNxY9cd+PxqiJZZMI0qiFSxAGM/wAsmsa6vHWP5PmwByWA4/xpPtYiiY4PmcDH/wBY1nKr0NFR6l64YwMkNqz/ADA7iO3+RXPXtyrXotpNqh8hS5xvJ6DJ71Y1TUnsoBcA4Xo7Fc+WO5xVW8KXNu6jy5lbPD8benI/WspSvpc3hBor3SPBKsiyKYvu7J+x9iP61BJ5N1aSB3ORlWYcFM+h/wA5rOYy2cEAvLkT28pwjZyyH0b29DUDFYL6GUSbYy2x+MjHY9fXIrP0N0tBY7uNbf7LIZF1JZvlmYgxyJ2+hzRYTGS6uFlQ24lGfvADd3I9j1xVq9hjkys7eQXwYmKZWUZ5KnsRVCUQlfJnDXMKyfLKF2n6+1Jdhb7FG9t7sTYW42gDABxRVl3uYGMYlDIPuk9SPfpz2/CirVSMdHY5Z4eEpOTS/E+jvEAEREgduAGJxXJ+EhH9tln3lrwvxKvABPIz/L/GtzX7kTCRDHKzNwB5TEfj6VV0rTo7a0K2+fKEWBkc7gC2M9/QVk9ZHmU3y0WnuzfVYZy73DYymxN3UfNnP8+3tWhHZRSaeY32iMElQq457jnsT+VVLeIzLGXyI2gXAYj5XwPl9u/vWneLHaWjSvxLkJ5Y+Ys3oD7966InHJ2sjnxeJocUTBZHupX2QQx4zIxOSuTwApwSe2ee1YeoWbeINenuNTuWa5trNg+1jshlYgeXEuMbdoJLH5iW7DArpp9GS5mm1G8jTcyHcAAFRf4gO6jgZI69awpJXSaa4hSONbss87AsCq7dqBTz8xUI3p61MnbR7HTSavzR3OWtbv7Fcz2FiI43VcvM3zrHx1HqxB6Gm6vo66ddIII3K7BMyrls8DJY889D+NRtbLFfgRxEWyjLnBbAzyT6k+tdF4sdIPCn2h4GhkVUWIBuJEP3Vx+XX0rGNndM9FycZR5epxz380GobIABMuGU4yY+OPoe9SRKWQ7mcs2CzLwSe/saqaWs9ujTS8NMCrtgZOeCP6Vo2Z2WwjWPMic4DcDPrxmiOrudUoqOiMrVYZra6SMyAZiZSFwdoIDfTtWzopDaTboIXkCgH5eCDj8M1j6tseKQou6YLuyqkn8PXvV2w1BtNtLnfv8A3tsEQbM4JYZI/AMKEkpDqRcoJLctS6hPdw78M4RmTJ5GAcVsaakUFlbLE21/L3Auvck5GBwRx/jXG2l4I9KLsTt3M7D15OB+Jq/pGo3DwiOTdvxnAPygdcUoy1VzOpQdrLZHY2HiA2t3MtrM0c06gzA4w23oR+GK1bfXsKJLmbynVwwcSsAynqD2x+GfevNtWuW8yCcgZjZQ2Dk7ScEfXkVoa6z21xc2O7ZsJBJPTBrT2sldHNLBQk15nqFv43iht5WnRjGjkAnGQuOB1yeanl8WRiIyQxhg4G35sDJzgHJBz/WvEbK5NyGLblXhDu7uOGYAds8VajvN13cQZG9AhLHBwSM1SxEuplPKaaZ7tp+rHVZI0KGJvvLu5XOMjB/Prmrpv7RkaIvFMv3pPmVhj3r511LWLuyt1kWeVVjljMoR8gqOME+wOePStCTWpoAjSTtJIrBBtfBAY45ODkDg49uorRV11MJZQ73TPRvFD2EMSnTY0iMqFlXBznqWH1AwBVLU59Pt9NsIbY3yFPlknIyoLDJHX19+3eua0GX55Bdupt3hb5pFzgAFvlPYnHUVJFqP2zTpY2ujbyRjcqqpJl5IxkYwADzn1oVS+posM42je9jcnaN7ee4jkjF0rH90epwM7wSeevGORTZrIaZBJLdOXBVWiLSYaTeNwyoyQAAe9csdTWKNZDEWnIKMU4yP8K29OuY7KTOpiQyOcGB49zhdg+fcQdvX17dBT576FOjKCLV7dKojjML+ZIqOEjkKkqewBB69qzppIZL1GRTHzkq4J288Lg8/WqWqzxrq0kgjha2jkIDB9xYrwQe/Xv8ApWje6rFqMYjlt4EkYb9+35mb6jgdfQUKd3ZlqDik0tyT+2VzkFUP3RuXPt1FRf2sVVz5e452bSemOuPWuUup5fthiifK/eZl7VB9uDy/x4jUnKICWbPuR+dHtWtDoWGjY6y01aSNSkckhifMgjGOuP8A9VVzNFboZJZo5G++G5GM9QRxkjpXPz6jJBNH5cqyFiFUxOGXPTgiql+8kswikKo6HnKkqPqKTq9Co0Fe6N7+0JZF3Rv8p5JPPHt6VDDOZSVxGSBgYYcfWsK11UXM5t2jS3uI1+dVJ24yBuUnqtaJntYZmhVgsjANuKjnPYfjU+07l+zS0SJppHW2YqpeVjtC7c4PriqEl0sTRyXUe5iQQvXJxjioLu4iguYykwbIJJI5Bz6f1qlc3aXVz5V5GhRflwqhOv06dOveocjWNM01nWa48tWUJ90krztyBnB9Kg025YebDOw823cxFlP3lz8uPwrDSdra4WKeVzEWASZhkj/ZYev86ktp9upGZ8bZPkcEZIweDms7tGqp6Gpqd1eRqlwsRltyhRztGR/tHHU1jWUgWNrVXMjRfOjqeSp/nitO7vLg2bxKhNpuyRk9c9R7/WqUty92LaWCyiU24VJJIZfnm35AOz6KM49MnrQ9RawtdEUzOv8ArCzxlgNuajvHtC8BdWkiL4kjJCHAIxyOnXHA7VYkQo+SQy9c4qjcgPOIGXbnA56+1NGklzK6Nh75Rp91pNwITGrlonGSYHXj5G7q2MHPoDVXUv7Mfw1p95bEQ33zWt5bLJne6jckyjrggYb3qnpNyQsglXnDxswHB681W1OJ7e1mjlUpiPepQjBwP5GrT1sctSN48y339e5Nq0f9nXz21zlZUAJAGQQRkH8iKKmsne+sre4ncSO8SfM4JONowOnYYFFZuUb6od29WezeIGkZ4YsEBn8v5QSce316Vp6RG/2GCDyVRyo+TuoUHJIyQOvOPQ+9ZerFVZ8wlmJ2qwbaBnvjviussI0n/s2SGWOOPy1QEPuZDz1x3/8Ar0QV5M8SrLlgkaMwiilVnJeNwE243BmPO4HtwDnHoKILaOS4mcbyScKZM7cdwPQf/WqrISks0OZDb5AkiAG8jByV5/A47U1tTllAhJ3LhFSDbjd6H9K6eY4uWTWha1WRBELSLcWlA3MGPyjHzjP5fnWTLpqrCY9iYzwqptIHufzH5VqXEayTOB+8yh3tgfe7/wBBnrTJVKI3mqSzd+wGABwO/H60mru7Lg+VKxxl5pji++y+csaSN5TEjkDP51zd7ps9x4gisncSWtqgnlAOcyEHA9uMnB5GRXZa3cxW1hNPdMdkSlt2BknsB9eBVHwwiGKU3QZ76ZzLcMxZdzuA3Xp/s4+hrGybselTqyhFz/q5x4tBbyvC6nO7IU8bR6c07EtvNJHL/rVONwPPB9RxXRa1YC3vBcxyEoM9eCffn1rN1GD7UFlU4xnoTjr6Gmly6HXCsp2ZhW9v9svbWxYtEJnCeYhOSGIGcE9s1kMLmaaRNxeSEfNubkYbbx+P866eCPErXsPlqLBBcKCCfmWRAP51gmaG91WzaNDbmSAQ3LMwCmQthmzngfd/Ks5aHXTlq2jKEc8iwQyqSoJZjg9iMA++TW3H5sN3JFu2yRsVOR90jjHtzVy9+yQ6882mBTZW8iiHcCVk2nO7k9Cf0xVfLPO8ztu83LSM3HzHk/rmi2uhr7RzSbWljNvZZGgkG4rwSHPXrUc2pS3UKyvLvnlGZCeSSTyfzzT76BCVQEpGAAWY/LyeafqEsUDJZw26RC0JDSFMSTMxBJbr06AdMD60nG9zSLV0rFPSnbypQ24RhsjJ7H/6+av6DND/AGi7zI5inutpZhg7QQp6fQ1Hp9usuh6pegEyWrjchbA2szY4xnO7HeoVi8nR7Jst5iStEzAHqV3DJ6ZPPHtT5GKTU7r5ElzILiJxg+U/BU9MH3pYZg2gwEoXuRKkb4OejDr6niqsjuEHzsACSRnOKrwS/vJFB3IH8wqTxlgOP0pIp07WNe91C4FlGluWjkVwofJAAY4x7AniooLxZhZvKzDe4Rw2SOTg/rVa7bMMiq23I2g546VlJM32Yssh8xHDn0U7s/zFUtSfZpHYW168K78JLAh5jccHPH6Vfspp9TmwjhrmQtgFvv4Gcc+wJrl0uV+ygdD1HPc1LpOqPaX9rcoVQW9wr4j6gZGc/gaXMzOdDRtbluK5JurhpN32dnWQheNwI5/ka0Gu4gWS1YTqW2KfuD2xWJdysl9OFOQJGXjjjJxVaznnMU+Sxh891VsZGRg456dRTu07j9le3macjSwsJo0hacZUpKhZXyMFWHGPYjBFY1pqEbXTQ3CfZ7xCHRweGAPIXPXFWpbgl1yF5wcnPbtVXVdPM+nW9zO6tFNK8aOrfNFIuMjjkcEEU077j9nbbcsTlftUiyHEFwPmyM5JBwQPf+eKs6aLh1WG4fE8R8p93y9AMH8Rg1i297IXNvfMrSKuGKjHmoeNw/rWrol7AttqFjexqwZlnhuEUBg+3GxzjlGA/A89M0W11JlorxQXmY42RwI5QcLKUyydDkemcDPqKgvZM2dvqET7nVykw3Z8sjqD/skEEfQ+laupCO3iiuJ5BqFrcw/6NcLKcwSDho2yDkr02n2Irn7m0udMInuIW+xyuFaI5G8Lg9cY4yRkdjTSI5klzL/hy1qELsI5VYNKRlWJ4J7CqDtLqNpHJAwjukyoUnGSOqn9a34kh1Ge50zTpVmikdpbCRWbDMuTtGQCdy5645UVkJFD9oluN7IZHG6IRkgDHLk445HOfUU0rGnPzb/1fZ/oXrC2g1AG2nj8q6kUC3EhxG+R9w8cM3BU5weB3zSeFIYLjULu1u5JRcLFIYkKktIArAj2dDtbHorU28uvtaLEYwWt7ZF3RjbhdzBSfcZAz7CrFwbm8tl1ZoQsxJikuFk+Z5lUEs3cFlOD68+tGiViG5Nb2v8An/wSxplvb6vbT24dLXWFXdEvSK7A/hH92T9D9azY7hW8PXWnTwMNRtJhc2MxAUo2f3kTHHRgOAe+fWlP72VjDkNH8uzH3R1z+uaqXUsk12Z5/l8wBWbOcnGMmiMuV3KnT9omr6b+jFiaCYiaCSSa0J2+YmQcDp2HI+lWdVt3WSNJDGWiAUvGRtkXqG+pFUPDI2W9/asMtBK6AA49x/OtC42JZMJkZmlhMduVOCrk4/Hg/pTsk7Ec+ikilDZbNMsL7axV1KOM4B56/gTTdWikFtICoyEI+gA7j8q606c9wZraZwFijRCznCqT94frWFqUITSZI5sG7jLRccnqQc+tOz0ZHtL6I5qC+j0e3it7rfhkEkWAfuEfX1yPwordXRpdXt4JYVMMESeTGMn5gCcnr6k/lRVKNGSvJu/ock6tWMnFbI9fvbiBNRKuiOjjaFZuhz1xnitnQbma1s5zZgXB4+VAS3PABA56nrXDSzXNrd3fkyNIk7YEcsYLEZ5x+Peul8PRSXN9G8CGLZG0jDaVwceo/lXLCTbOWvR5YXex1STmRVMYJCgbsrkhsAZHXHIqOWR7Sdo4mHmAhiTywO3B/GrMUMhmS2mcsmdxkB3ckHaDj3qk9uYZyjsqvyG2HPzev511NOx58bbFm2KQW0vmM2ch48ngZ7VIzuyJ5W8HJXK9BnmqrOTtyArplCM9v85pJZhCxuPOWNVwxXaWHA6YovYdr6mNqkK3JjtTIqxxusrR5yJeOOvTnP5CptLEXkvLGzMbeRWCbQ3Dcc++cVfm+yR6gMwECSEiUswBJ6jH0rL0b9zezF1V7WVVTaDjOCCSf5Vna0rnQm3CxrarZrPaG6MjsoJURsMY54+Uj14/xriZbaeNHVA/lZLbpMgZyeMjpyMV2cF0zWSWzTDYDxE4+6CM5B+tc/ds8N66LkxJncQwBwT6Hg9j+FXUd9SsO5RvE5a+kaHTbi3yTJIqRyKoDD5SWAPscL0rnIIh9kvn8nzkjCuzBziNSSvb/aZfyrtvFECx3HnWyStDPiRxkcnOAxx1/Sub0uKOa21ZZ4TNIlo6W/yn5GEisxAHsGHNZSjZ2PWpVFycw2K2mvm7M7hm2BABnrwKjewlW3IQIVOTgtjkdvrXSaDatcny/KDhsYXIHI9z9abq9vcW0xcxI/lsCUkP38dic9OKcYaXH7f3+U5jS7NdVvWtS7x/Z7aa5kwf7iFgPpnGaua7JZTTXyG2RbgX7SGRQSDERgr6YBH61FpMgs5NWuJon3z2UkIZQoUF3TJGTx3Hy5PNJ4otGi1W6dXaRPObczE5OT+dJJcrNb81azen/DXMdBM73EAWFTcP5r4KFQu4OACfu9hgc8Yondnv1tUJwq+bsPPPIz+Wa2db0xLOztZIwzTC0WWfYgUI7fw+pIULk+pNV7HT3uL67leLyi4Uou7+HaOnsck/jTsy41YtcyMu8twgZtvyk8ZOKNNs0k043UZ3SGRVkwRhcgkfLjn7p5zW1JZxx6lbLqzH7C0yCZs4JTI3DP0zVCBgCFtYHIml+SNcdf4R+tFrbmntebboUxjdiVpjEOHK4yAfr744oe4tJtMitZjCrWkFzGHGX8ws+6PI/h+82DzWpq1sRdSrtXIOP/11i6WIYPE1vJd+cLVWSaV4pNhCBuSp7HinFWbt/WoVGpQ5v62ZIyPGkYYYUxJIoB4IZQc5PrRFCLiwvN84RoCsiJJJgsCdrBR652n6fSrd3J9qt7NtpUwW6ws24kkKTg8+xH5VTjmW1jmef7QsbQyINhxluMA/KcjIHHH1qbaluT5L9SaZxPJKjOJGZgwkLbiWI5GR65qrpjlYbqHau1JxOQy4bccIQPUfdPFamvxRtq9yYJoJocr5ckBBRvkXOCPQ5H4U/UdMjtoYdQheK5gnjUXH2dChinESyOrcnceQSe/PTFUla5j7RWg+5npEpmEQZPnbPJwCevOaWBmks7+waUhCBdxAsQDIgIIx6lS34inyoXVnjQlcZX1FWpGivGgupYz/AGtDKrvG67or0Zzlj2c9GHQ9RzxSSNpPT+tzBkhM1qN5II4Qkcj6VFbKZGkTyiZFAyVIYBcHP4c/h0rX1mNY7vfawNBZzr5tupYM3ltyASO45GPak8OwxXd99muJPL87csM3AjWQjCh89VPT2zmlt7oSl7vtULoesR6XLPBq6Nc6HeBY5wT80DDhJUzwCuce44q1qFzPo8R0vVFSa3t23wtgMrRHB+Vh1XADKQcjkd+MvUbP7JdS2UrLKoO07SCsg6Z/nWa11JbPbWN00rpEpW3kd8gR5yEA7YJP51aemm6OepSi5X+zL8+hryW9xoUtq8M8TzW85kikhkBCurbhg9cbWQ8+tHim9jme/vLVZVhdvOZFLLvDfMy9eQrZ9jtqGzmaTTb/AE5IbmV7e5W588HcsUbIFIIHTJ8sA/7PvTbeH/SCsm4xyIwyT6Yzx9CKG+WVyYR56er95XX6ot+HNT/srWLa+dBLBdx/Z3XJ2shI3ZH8Xys30PNSSGK1S+g8wyQ+YUhKsRk7toYDocg96xNGiYjT7Lfh4L02wZyFzgMoJ9OMH8a0tcSW3EzlQsqTKeOeFOSfwCmiSa0/rqNWk3Lv/wABlm5tpI1hlGT5gWBiT3Gcf4VHfWhidoZQUATG5SCQT6nvXZppiahpMyQM0UDxhd8uMxzBcjP1YdayLore2KTLEyysMOrDJVu+T2wf5UOGiZEMQm+U5/QYPs/id/lWRtkF2yEfK+0sGH4hf1rfu54LrxHbvMClnbSGZYgQChbIRF+h/SoNNkW18b26iGMCbSxFLIVyfllJLL/tYJFWJraOKYyGTejzK8Zx25IH12iny2uvT8jFO718/wA2achkmWMyqnDE5b+LnPJrl9XeR0lAVN73D4J55PI574ya7CWwC2tu8k4YT/MoUdM+vrWfcaV5rRPE5f5jGRjgue/scYq6ibWhnCrFMpwW3k20EY+6kaqDuPPFFbmp2e27ZPIkYoAp2gYGBjFFHLJaIlVObU0fEcTK9oyZkcEKAXwqg84HpzW/4NuoJ7gfZn8w4I8tztI46nscUUVyQ0mc9XXDXfQ294YIyBlmlyz7jhc9voMGoNqjyJYGAAZsAnkEfSiiuy1zz9iw0gumaNjm5PPpuUDof89qpyMIoCH8vzGJAVlB5/GiioequWlZ2K6ETGaSTzEfBJZcYqCyl8u+gyU5TGTyFyMbj6df0ooqGtTeK0aNTTT9rmkWX5ZYl8yLAx8hzlWI/H3/ACrD8Q6d50VxJLlTHkOi5y2DtyPrRRWy1jqZwk41LI5p7yZrG5xIs8dvEY0B/wBZLnAUDtwduOKgiin03w9GWKZWcwTRsrbj2bnp3bHPWiisZHqPR8vmb0VkbK4lQSKTw8aAMSV468Y4yK2JrSJlgaWLaAxOUXJHy7sEfWiit4LU8+c20mcxFp/2i7tLRGaLmW4JRdxUllVc5P3ee3cGs7xXDLbm5N2A1zOA6sqkKxPOe1FFZP4WztpSbqpDIpVu7K6Ek37tEw7sM5XHOO+fapdFt5Lg2sl1NK00u3zWlTaUIG05A7DH6UUUo62ubVPdTsVfGDeZcQwwI372fgEfNtGSd3p2BqG+tGt5LZrF5A8bMRIF5U4ByPQ0UVcleTLpyaghmqiQWirsyFI+fuT71zV3AFN66gki2AYLwOTxn/61FFQ9zog/dsa7WzRwR528qMFBwR71m3dvNcW94iqpeOF3IYhTgY5Gep9qKKTWxUpvlbLWkRifTILjy1jVwXxHk7T+JJ/WrPgee1jgaLVZXSwuVFxOdpYqQSc45/hZh070UVSVrPzMpLni0+w9LcpGpU+azIDsweVI+8KjjtGku/LYjcxwB7+mfXiiiq5U0ma8zKd5EyQLGARb4chsEmPJ4HpgnP4mobWxWeEQrkxuM5b19PyoorOS1sXGTUXY1JbV7iCe0uABcW8CTWzBTiVFXaycDJbbg+nyH1rmL20+1xNbzjnojjkqQOD+FFFOXuvQyovmvB7FDTL26sbm7WVkS5kX7DMhLDcuFZW468pxnjkV0Tox+yOQFCyBSTwQGyD+oFFFVV/T9DKk9H6iT2sB12WPBijmntblcZ6MrIx/NP1rQe3aRryPCyRiCRPUjcrc/Xp+tFFU9Zr5GfM+WS9TpNDJh0+J4nz58Cb1wSGOAefpnrUdxbfZdS1EMrIJys8YwDnOQ4/76H60UURS5F8jnbaqNHOXokl8ZW67IgPsJBOSQoMh/I8VrLakXkIZSYVGe5JLY/QDP50UU1FSu35fkjW7SSXn+bOqjWJbpY48GIDCBieOev5U5Il+ynEHzpMGBXgEYzmiitbXOCejQ2/jtryYTOwDMvO5TnNFFFO7EtFY/9k=);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    A layer of blood at the bottom of the anterior chamber.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Reproduced with permission from: Trobe JD, Hackel RE. Field Guide to the Eyes. Lippincott Williams &amp; Wilkins, Philadelphia 2002. Copyright &copy; 2002 Lippincott Williams &amp; Wilkins.",
"    </div>",
"    <div class=\"contractual\">",
"     <br/>",
"     <a href=\"file://www.lww.com\">",
"      file://www.lww.com",
"     </a>",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f3_24_3458=[""].join("\n");
var outline_f3_24_3458=null;
var title_f3_24_3459="Tinea corporis on leg";
var content_f3_24_3459=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=PC%2F53271&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=PC%2F53271&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Tinea corporis",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 319px; height: 396px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    This annular lesion with central clearing and a scaly border was consistent with tinea corporis.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Reproduced with permission from: Goodheart, HP. Goodheart's Photoguide of Common Skin Disorders, 2nd ed, Lippincott Williams &amp; Wilkins, Philadelphia 2003. Copyright &copy; 2003 Lippincott Williams &amp; Wilkins.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f3_24_3459=[""].join("\n");
var outline_f3_24_3459=null;
var title_f3_24_3460="Iopromide: Patient drug information";
var content_f3_24_3460=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"1\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"disclaimer\">",
"   The content on the UpToDate website is not intended nor recommended as a substitute",
"for medical advice, diagnosis, or treatment.  Always seek the advice of your own physician or",
"other qualified health care professional regarding any medical questions or conditions.  The",
"use of this website is governed by the",
"   <a href=\"/home/terms-use\" target=\"_blank\">",
"    UpToDate Terms of Use",
"   </a>",
"   &copy;2013 UpToDate, Inc.",
"  </div>",
"  <div id=\"drugTitle\">",
"   Iopromide: Patient drug information",
"  </div>",
"  <div id=\"lexiTitleImg\">",
"   <img height=\"17\" src=\"./../images/lexiComp/Lexicomp_2012_71x17.myextg\" width=\"71\"/>",
"  </div>",
"  <div class=\"clear\">",
"  </div>",
"  <div id=\"drugCopy\">",
"   Copyright 1978-2013 Lexicomp, Inc. All rights reserved.",
"  </div>",
"  <div id=\"topicText\">",
"   <p>",
"    (For additional information",
"    <a class=\"drug drug_general\" href=\"UTD.htm?16/46/17126?source=see_link\">",
"     see \"Iopromide: Drug information\"",
"    </a>",
"    )",
"   </p>",
"   <div class=\"list ubnlist drugH1Div drugBrandNames\" id=\"F183947\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Brand Names: U.S.",
"    </span>",
"    <ul>",
"     <li>",
"      Ultravist&reg;",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"list cbnlist drugH1Div drugBrandNames\" id=\"F14457201\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Brand Names: Canada",
"    </span>",
"    <ul>",
"     <li>",
"      Ultravist&reg;",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt war-os drugH1Div\" id=\"F10025487\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Warning",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2700621",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       This drug is given as a shot into a vein or artery only.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yya-os drugH1Div\" id=\"F10025489\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What is this drug used for?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2691287",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       It is used before an x-ray or an alike test.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt coi-os drugH1Div\" id=\"F10025488\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What do I need to tell my doctor before I take this drug?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2705259",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have an allergy to iopromide or any other part of this drug.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697128",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have a contrast dye allergy, talk with your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2703164",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have an iodine allergy, talk with your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2705171",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you are allergic to any drugs, foods, or other substances. Tell your doctor about the allergy and what signs you had, like rash; hives; itching; shortness of breath; wheezing; cough; swelling of face, lips, tongue, or throat; or any other signs.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yye-os drugH1Div\" id=\"F10025492\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What are some things I need to know or do while I take this drug?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699677",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Keep a list of all your drugs (prescription, natural products, vitamins, OTC) with you. Give this list to your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697197",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have high blood sugar (diabetes), talk with your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697258",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have heart disease, talk with your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697282",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have kidney disease, talk with your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697341",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have sickle cell disease, talk with your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697343",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have thyroid disease, talk with your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696717",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Check all drugs you are taking with your doctor. This drug may not mix well with some other drugs.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697641",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Tell your doctor if you are pregnant or plan on getting pregnant. You will need to talk about the benefits and risks of using this drug while you are pregnant.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697636",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Tell your doctor if you are breast-feeding. You will need to talk about any risks to your baby.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyf-os drugH1Div\" id=\"F10025493\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What are some side effects of this drug?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698119",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Headache.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697883",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Back pain.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698261",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Upset stomach or throwing up.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698189",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Irritation where the shot is given.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698328",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Unsafe allergic effects may rarely happen.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyh-os drugH1Div\" id=\"F10025495\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What are some side effects that I need to call my doctor about right away?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698721",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you think there has been an overdose, call 1-800-222-1222 (the American Association of Poison Control Centers), your local poison control center (file://www.aapcc.org), or emergency room (ER) right away.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699066",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Signs of an allergic reaction, like rash; hives; itching; red, swollen, blistered, or peeling skin with or without fever; wheezing; tightness in the chest or throat; trouble breathing or talking; unusual hoarseness; or swelling of the mouth, face, lips, tongue, or throat.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698655",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       A fast heartbeat.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699023",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Very bad dizziness or passing out.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698640",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Trouble breathing.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698619",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Change in strength on 1 side is greater than the other, trouble speaking or thinking, change in balance, or blurred eyesight.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699104",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Not able to pass urine.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698603",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Any rash.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698977",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Side effect or health problem is not better or you are feeling worse.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyi-os drugH1Div\" id=\"F10025496\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     How do I store and/or throw out this drug?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699596",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       This drug will be given to you in a hospital or doctor's office. You will not store it at home.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyj-os drugH1Div\" id=\"F10025497\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     General drug facts",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699675",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If your symptoms or health problems do not get better or if they become worse, call your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699673",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Do not share your drugs with others and do not take anyone else's drugs.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699678",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Keep all drugs out of the reach of children and pets.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699709",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have any questions about this drug, please talk with your doctor, pharmacist, or other health care provider.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s3302581",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       In Canada, take any unused drugs to the pharmacy. Also, visit file://www.hc-sc.gc.ca/hl-vs/iyh-vsv/med/disposal-defaire-eng.php#th to learn about the right way to get rid of unused drugs.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699677",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Keep a list of all your drugs (prescription, natural products, vitamins, OTC) with you. Give this list to your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699671",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       These are not all of the side effects that may occur. If you have questions about side effects, call your doctor. Call your doctor for medical advice about side effects.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699683",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Talk with the doctor before starting any new drug, including prescription or OTC, natural products, or vitamins.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 12025 Version 35.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.6- C21.56",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     AsanBook Dig. Med. Lib.",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [0505-83.177.194.223-2AD339225F-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f3_24_3460=[""].join("\n");
var outline_f3_24_3460=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F183947\">",
"      Brand Names: U.S.",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F14457201\">",
"      Brand Names: Canada",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10025487\">",
"      Warning",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10025489\">",
"      What is this drug used for?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10025488\">",
"      What do I need to tell my doctor before I take this drug?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10025492\">",
"      What are some things I need to know or do while I take this drug?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10025493\">",
"      What are some side effects of this drug?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10025495\">",
"      What are some side effects that I need to call my doctor about right away?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10025496\">",
"      How do I store and/or throw out this drug?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10025497\">",
"      General drug facts",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"drug drug_general\" href=\"UTD.htm?16/46/17126?source=related_link\">",
"      Iopromide: Drug information",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f3_24_3461="Normal anal ultrasound";
var content_f3_24_3461=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=GAST%2F54502&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=GAST%2F54502&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Normal anal ultrasound",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 358px; height: 342px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Anal ultrasound showing the anal sphincter muscles in cross section through the mid anal canal. The darker homogenous ring is the internal anal sphincter smooth muscle (i). The white heterogeneous ring surrounding this is the external anal sphincter (arrows; E). The top of the figure is anterior.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f3_24_3461=[""].join("\n");
var outline_f3_24_3461=null;
var title_f3_24_3462="Pityriasis rubra pilaris keratoderma 2";
var content_f3_24_3462=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=DERM%2F87825&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=DERM%2F87825&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 596px\">",
"   <div class=\"ttl\">",
"    Keratoderma associated with pityriasis rubra pilaris",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 576px; height: 427px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    A waxy keratoderma with an orange hue is characteristic of pityriasis rubra pilaris.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Reproduced with permission from: www.visualdx.com. Copyright Logical Images, Inc.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f3_24_3462=[""].join("\n");
var outline_f3_24_3462=null;
var title_f3_24_3463="Idiopathic LS plexopathy";
var content_f3_24_3463=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=NEURO%2F80779&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=NEURO%2F80779&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 517px\">",
"   <div class=\"ttl\">",
"    Idiopathic lumbosacral plexopathy",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 497px; height: 396px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    A) Coronal view of fat suppressed, gadolinium enhanced T1 weighted MRI image shows increased signal in the left lumbar plexus. B) Six months after treatment, the enhancement of the left lumbar plexus disappeared.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Reproduced with permission from: Ishii K, Tamaoka A, Shoji S. MRI of idiopathic lumbosacral plexopathy. Neurology 2004; 63:E6. Copyright &copy; 2004 Lippincott Williams &amp; Wilkins.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f3_24_3463=[""].join("\n");
var outline_f3_24_3463=null;
var title_f3_24_3464="Pulmonary artery sarcoma";
var content_f3_24_3464=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=PULM%2F76230&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=PULM%2F76230&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 676px\">",
"   <div class=\"ttl\">",
"    Osteogenic sarcoma of the pulmonary artery",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 656px; height: 526px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Chest radiograph (above left) shows a left hilar mass and multiple bilateral calcified pulmonary nodules. The pulmonary arteriogram (above right) shows obstruction of the left pulmonary artery and a filling defect in the right pulmonary artery. The CT scan (bottom) demonstrates ossified tumor in the left pulmonary artery (arrow), and in the periphery of the left lung.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Courtesy of Paul Stark, MD",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f3_24_3464=[""].join("\n");
var outline_f3_24_3464=null;
var title_f3_24_3465="Outcomes associated with nocturnal hemodialysis";
var content_f3_24_3465=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/wk_utd-rgb.myextg\" width=\"220px\">",
"   </img>",
"  </div>",
"  <div id=\"printHeaderText\">",
"   Official reprint from  UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"   <a href=\"file://www.uptodate.com\">",
"    www.uptodate.com",
"   </a>",
"   <br>",
"    &copy;2013 UpToDate",
"    <sup>",
"     &reg;",
"    </sup>",
"   </br>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"3\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"topicTitle\">",
"   Outcomes associated with nocturnal hemodialysis",
"  </div>",
"  <div id=\"topicContributors\">",
"   <div>",
"    <a id=\"authors\">",
"    </a>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?3/24/3465/contributors\">",
"     Author",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?3/24/3465/contributors\">",
"     Andreas Pierratos, MD, FRCPC",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?3/24/3465/contributors\">",
"     Section Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?3/24/3465/contributors\">",
"     Steve J Schwab, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?3/24/3465/contributors\">",
"     Deputy Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?3/24/3465/contributors\">",
"     Alice M Sheridan, MD",
"    </a>",
"    <br/>",
"   </div>",
"  </div>",
"  <div id=\"disclosures\">",
"   <a href=\"UTD.htm?3/24/3465/contributor-disclosure\" target=\"_blank\">",
"    Disclosures",
"   </a>",
"  </div>",
"  <div id=\"reviewProcess\">",
"   <span>",
"    All topics are updated as new evidence becomes available and our",
"   </span>",
"   <a href=\"/home/editorial-policy\" target=\"_blank\">",
"    peer review process",
"   </a>",
"   <span>",
"    is complete.",
"   </span>",
"  </div>",
"  <div id=\"literatureReviewDate\">",
"   <span class=\"emphasis\">",
"    Literature review current through:",
"   </span>",
"   Oct 2013.",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <span class=\"emphasis\">",
"    This topic last updated:",
"   </span>",
"   Jul 2, 2012.",
"  </div>",
"  <div id=\"topicText\">",
"   <p class=\"headingAnchor\" id=\"H1\">",
"    <span class=\"h1\">",
"     INTRODUCTION AND OVERVIEW",
"    </span>",
"    &nbsp;&mdash;&nbsp;The mortality rate of patients undergoing maintenance hemodialysis is unacceptably high [",
"    <a class=\"abstract\" href=\"UTD.htm?3/24/3465/abstract/1\">",
"     1",
"    </a>",
"    ]. An extremely high morbidity, relatively low quality of life (due in part to a high level of dependence and unemployment), and high cost have also been observed [",
"    <a class=\"abstract\" href=\"UTD.htm?3/24/3465/abstract/2\">",
"     2",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    The institution of more intensive dialysis regimens appears to improve morbidity and possible mortality in this patient population. Compared to conventional three times per week regimens, for example, dialysis associated with longer duration",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    higher frequency correlates with enhanced outcomes [",
"    <a class=\"abstract\" href=\"UTD.htm?3/24/3465/abstract/3-7\">",
"     3-7",
"    </a>",
"    ]. However, the HEMO study found that increasing the dialysis dose within the general restrictions of a thrice weekly regimen failed to decrease patient mortality [",
"    <a class=\"abstract\" href=\"UTD.htm?3/24/3465/abstract/8-10\">",
"     8-10",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?36/13/37082?source=see_link\">",
"     \"Patient survival and maintenance dialysis\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?6/14/6378?source=see_link\">",
"     \"Kt/V and the adequacy of hemodialysis\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Given these findings, nocturnal hemodialysis (eg, long nightly home hemodialysis) was introduced as a (possibly) more desirable alternative to conventional dialysis, since it provides superior dialysis based upon dose, duration, and frequency. This can be accomplished because it is performed during nightly sleep [",
"    <a class=\"abstract\" href=\"UTD.htm?3/24/3465/abstract/11\">",
"     11",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Although Sheldon is credited for overnight dialysis at home [",
"    <a class=\"abstract\" href=\"UTD.htm?3/24/3465/abstract/12\">",
"     12",
"    </a>",
"    ], the late Robert Uldall established the first quotidian (daily) nocturnal hemodialysis program in 1994 at the Wellesley Hospital in Toronto [",
"    <a class=\"abstract\" href=\"UTD.htm?3/24/3465/abstract/11,13\">",
"     11,13",
"    </a>",
"    ]. Since then, its use has been extended to more centers in Canada, the United States, Australia, and several European countries [",
"    <a class=\"abstract\" href=\"UTD.htm?3/24/3465/abstract/14-17\">",
"     14-17",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    A description of nocturnal hemodialysis, particularly the outcomes associated with the procedure, will be presented here. Technical aspects of nocturnal hemodialysis and an overview of short daily hemodialysis are presented separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?0/16/264?source=see_link\">",
"     \"Technical aspects of nocturnal hemodialysis\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?17/45/18137?source=see_link\">",
"     \"Short daily hemodialysis\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H2\">",
"    <span class=\"h1\">",
"     OUTCOMES",
"    </span>",
"    &nbsp;&mdash;&nbsp;Nocturnal hemodialysis is associated with marked benefits compared with conventional hemodialysis regimens. These include improved solute clearance and quality of life, better blood pressure control, and reduced medication requirements. Some of the benefits with the technique have been clearly shown, such as markedly increased clearances of urea and phosphate, while others, such as enhanced survival, require further analysis. Some of the benefits demonstrated by the observational studies may have been influenced by patient selection biases with younger and healthier patients choosing home modalities.",
"   </p>",
"   <p>",
"    Multiple observational studies and one randomized trial have shown that more frequent dialysis improves selected outcomes. A benefit on survival has not been shown. These data are discussed elsewhere. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?17/45/18137?source=see_link&amp;anchor=H15#H15\">",
"     \"Short daily hemodialysis\", section on 'Outcomes'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H3\">",
"    <span class=\"h2\">",
"     Clearances",
"    </span>",
"    &nbsp;&mdash;&nbsp;Clearance of different solutes are markedly enhanced with nocturnal hemodialysis:",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H4\">",
"    <span class=\"h3\">",
"     Urea",
"    </span>",
"    &nbsp;&mdash;&nbsp;Even at low dialysate flow rates (100",
"    <span class=\"nowrap\">",
"     mL/min),",
"    </span>",
"    nocturnal hemodialysis can provide a nightly equilibrated",
"    <span class=\"nowrap\">",
"     Kt/V",
"    </span>",
"    for urea of approximately 1 [",
"    <a class=\"abstract\" href=\"UTD.htm?3/24/3465/abstract/11,18\">",
"     11,18",
"    </a>",
"    ]. Higher dialysate flows in combination with large surface area dialyzers provide a",
"    <span class=\"nowrap\">",
"     spKt/V",
"    </span>",
"    of 1.7 to 2 and weekly",
"    <span class=\"nowrap\">",
"     Kt/V",
"    </span>",
"    of about 10 [",
"    <a class=\"abstract\" href=\"UTD.htm?3/24/3465/abstract/19,20\">",
"     19,20",
"    </a>",
"    ]. This compares favorably to the target weekly",
"    <span class=\"nowrap\">",
"     Kt/V",
"    </span>",
"    of only 3.6 that is recommended for patients undergoing conventional hemodialysis by the Dialysis Outcomes Quality Initiation working group for hemodialysis adequacy. The weekly standard",
"    <span class=\"nowrap\">",
"     Kt/V,",
"    </span>",
"    which has been proposed as a measure of dialysis dose across dissimilar regimens and residual renal function [",
"    <a class=\"abstract\" href=\"UTD.htm?3/24/3465/abstract/21\">",
"     21",
"    </a>",
"    ], is approximately 5, thereby making this technique particularly suitable for large patients [",
"    <a class=\"abstract\" href=\"UTD.htm?3/24/3465/abstract/20,22\">",
"     20,22",
"    </a>",
"    ]. The",
"    <span class=\"nowrap\">",
"     K/DOQI",
"    </span>",
"    clinical practice guidelines for hemodialysis adequacy, as well as other",
"    <span class=\"nowrap\">",
"     K/DOQI",
"    </span>",
"    guidelines, can be accessed through the National Kidney Foundation's web site at",
"    <a class=\"external\" href=\"file://www.kidney.org/professionals/kdoqi/guidelines.cfm\">",
"     www.kidney.org/professionals/kdoqi/guidelines.cfm",
"    </a>",
"    .",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H5\">",
"    <span class=\"h3\">",
"     Phosphate",
"    </span>",
"    &nbsp;&mdash;&nbsp;Phosphate removal per nocturnal hemodialysis session is similar to that removed during a conventional hemodialysis session. Thus, weekly removal of phosphate with nocturnal hemodialysis is twice as high, thereby obviating the need for phosphate binders in virtually all patients [",
"    <a class=\"abstract\" href=\"UTD.htm?3/24/3465/abstract/11,23-28\">",
"     11,23-28",
"    </a>",
"    ]. As examples:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      In the Frequent Hemodialysis Network (FHN) Nocturnal trial, 87 patients were randomly assigned to either three times weekly conventional hemodialysis or six times weekly nocturnal hemodialysis [",
"      <a class=\"abstract\" href=\"UTD.htm?3/24/3465/abstract/29\">",
"       29",
"      </a>",
"      ]. At 12 months of follow-up, compared with those receiving conventional hemodialysis, patients receiving frequent nocturnal hemodialysis had a lower serum phosphorus (5.91 versus 4.72",
"      <span class=\"nowrap\">",
"       mg/dl,",
"      </span>",
"      respectively), and many more patients did not require phosphate binders (73 percent versus 8 percent in the conventional hemodialysis group) [",
"      <a class=\"abstract\" href=\"UTD.htm?3/24/3465/abstract/28\">",
"       28",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      In a cross-over study, the serum phosphorous levels of eight chronic dialysis patients were measured during five months of conventional hemodialysis and then after the switch to five months of therapy with nocturnal hemodialysis [",
"      <a class=\"abstract\" href=\"UTD.htm?3/24/3465/abstract/23\">",
"       23",
"      </a>",
"      ]. Serum phosphate levels were significantly lower with nocturnal hemodialysis (4.0 versus 6.5",
"      <span class=\"nowrap\">",
"       mg/dL",
"      </span>",
"      [1.3 versus 2.1",
"      <span class=\"nowrap\">",
"       mmol/L])",
"      </span>",
"      than those with conventional hemodialysis. In addition, patients undergoing nightly dialysis increased their dietary phosphorous intake by 50 percent and did not require phosphate binders after the fourth month. Furthermore, to maintain normal serum phosphate concentrations, more than 50 percent of all patients required the addition of phosphate to the dialysate.",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H6\">",
"    <span class=\"h3\">",
"     Beta2-microglobulin",
"    </span>",
"    &nbsp;&mdash;&nbsp;Since large molecule removal by hemodialysis is time dependent, the removal of beta2-microglobulin is markedly higher with nocturnal hemodialysis than with conventional hemodialysis. In one study, nocturnal hemodialysis was associated with a four-times higher solute removal of beta2-microglobulin (585 versus 127",
"    <span class=\"nowrap\">",
"     mg/week)",
"    </span>",
"    and a greater reduction in plasma beta2-microglobulin concentrations (39 versus 21 percent) compared with conventional hemodialysis (performed for four hours, three times per week) [",
"    <a class=\"abstract\" href=\"UTD.htm?3/24/3465/abstract/30\">",
"     30",
"    </a>",
"    ]. Although unproven, this finding may be associated with a delay in the development of dialysis-related amyloidosis.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H7\">",
"    <span class=\"h2\">",
"     Quality of life",
"    </span>",
"    &nbsp;&mdash;&nbsp;Among those treated with",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    switched to nocturnal hemodialysis, measurements of quality of life (such as the SF- 36, Sickness Impact Profile (SIP), and Beck depression index) reveal improvement in some, but not all, parameters [",
"    <a class=\"abstract\" href=\"UTD.htm?3/24/3465/abstract/29,31-34\">",
"     29,31-34",
"    </a>",
"    ]. The improvement in the quality of life was not confirmed in two prospective randomized controlled studies [",
"    <a class=\"abstract\" href=\"UTD.htm?3/24/3465/abstract/34,35\">",
"     34,35",
"    </a>",
"    ] although some of the kidney disease-specific quality of life domain parameters improved in one study [",
"    <a class=\"abstract\" href=\"UTD.htm?3/24/3465/abstract/34\">",
"     34",
"    </a>",
"    ]. Both trials may have been underpowered to show a possible benefit [",
"    <a class=\"abstract\" href=\"UTD.htm?3/24/3465/abstract/36\">",
"     36",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Using different methodologies to determine patient preference, patients appear to prefer nocturnal hemodialysis to conventional in-center hemodialysis [",
"    <a class=\"abstract\" href=\"UTD.htm?3/24/3465/abstract/37\">",
"     37",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H8\">",
"    <span class=\"h2\">",
"     Cognition",
"    </span>",
"    &nbsp;&mdash;&nbsp;Nocturnal hemodialysis may be associated with improved general cognitive efficiency as measured by psychomotor efficiency and increased attention and working memory [",
"    <a class=\"abstract\" href=\"UTD.htm?3/24/3465/abstract/38\">",
"     38",
"    </a>",
"    ], although this has not been shown in all studies [",
"    <a class=\"abstract\" href=\"UTD.htm?3/24/3465/abstract/29\">",
"     29",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H9\">",
"    <span class=\"h2\">",
"     Cardiovascular effects",
"    </span>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H10\">",
"    <span class=\"h3\">",
"     Blood pressure",
"    </span>",
"    &nbsp;&mdash;&nbsp;Excellent blood pressure control is achieved by nocturnal hemodialysis, with almost all patients no longer requiring antihypertensive medications. As an example, in the FHN Nocturnal trial cited above, systolic blood pressure was lower at 12 months among patients who received frequent nocturnal dialysis compared with patients who received conventional three times weekly hemodialysis (137 versus 151 mmHg, respectively) [",
"    <a class=\"abstract\" href=\"UTD.htm?3/24/3465/abstract/29\">",
"     29",
"    </a>",
"    ]. To achieve normotension without medications, the target weight is progressively decreased until all antihypertensive agents are discontinued [",
"    <a class=\"abstract\" href=\"UTD.htm?3/24/3465/abstract/19,39\">",
"     19,39",
"    </a>",
"    ]. Nevertheless, a small number of patients (approximately 10 percent) may require a small dose of a beta blocker to prevent tachycardia because of the presence of a large fistula or extracellular volume contraction (resulting from the attempt to lower blood pressure).",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H11\">",
"    <span class=\"h3\">",
"     LV hypertrophy",
"    </span>",
"    &nbsp;&mdash;&nbsp;Some, but not all studies suggest that nocturnal hemodialysis is associated with regression of left ventricular hypertrophy [",
"    <a class=\"abstract\" href=\"UTD.htm?3/24/3465/abstract/19,25,29\">",
"     19,25,29",
"    </a>",
"    ]. As an example, in a study of 44 patients undergoing maintenance hemodialysis who were randomly assigned to nocturnal hemodialysis (six",
"    <span class=\"nowrap\">",
"     times/week)",
"    </span>",
"    or continued conventional hemodialysis (three",
"    <span class=\"nowrap\">",
"     times/week)",
"    </span>",
"    [",
"    <a class=\"abstract\" href=\"UTD.htm?3/24/3465/abstract/25\">",
"     25",
"    </a>",
"    ]. At six months, left ventricular mass had significantly decreased with nocturnal hemodialysis (177 to 164 g) compared with no change in the conventional hemodialysis group (182 to 183 g). The effect was related, in part, to a decrease in blood pressure; however, the effect of improved volume control was unclear since volume status was not assessed.",
"   </p>",
"   <p>",
"    However, in the FHN Nocturnal trial, there was no difference at 12 months in one of the primary composite endpoint which included death or change in left ventricular mass among 87 patients were randomly assigned to either three times weekly conventional hemodialysis or six times weekly nocturnal hemodialysis [",
"    <a class=\"abstract\" href=\"UTD.htm?3/24/3465/abstract/29\">",
"     29",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    The interpretation of this trial is limited since change in left ventricular mass was not a primary outcome, only part of a composite outcome. In addition, because of difficulty in recruiting patients, the trial may have been underpowered to detect small differences in the composite outcomes.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H12\">",
"    <span class=\"h3\">",
"     Cardiac function",
"    </span>",
"    &nbsp;&mdash;&nbsp;Limited evidence suggests that the switch to nocturnal hemodialysis may improve myocardial function as assessed by ejection fraction. In one small study, for example, cardiac function improved upon conversion to nocturnal hemodialysis in a group of six patients with end-stage renal disease and diminished left ventricular ejection fraction [",
"    <a class=\"abstract\" href=\"UTD.htm?3/24/3465/abstract/40\">",
"     40",
"    </a>",
"    ]. Ejection fraction increased from 28 to 41 percent. In another study, intradialytic left ventricular regional wall motion abnormalities (myocardial stunning) decreased with increasing dialysis intensity, favoring daily and nocturnal hemodialysis [",
"    <a class=\"abstract\" href=\"UTD.htm?3/24/3465/abstract/41\">",
"     41",
"    </a>",
"    ]. Myocardial stunning is associated with high ultrafiltration requirements, intradialytic hypotension, long-term loss of systolic function, increased likelihood of cardiovascular events, and death [",
"    <a class=\"abstract\" href=\"UTD.htm?3/24/3465/abstract/41\">",
"     41",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H13\">",
"    <span class=\"h3\">",
"     Vascular function",
"    </span>",
"    &nbsp;&mdash;&nbsp;There are improvements in vascular responsiveness with nocturnal hemodialysis. In a prospective cohort study of 18 end-stage renal disease patients before and after conversion to nocturnal hemodialysis, an improvement in blood pressure control was associated with significant decreases in the total peripheral resistance (TPR) [",
"    <a class=\"abstract\" href=\"UTD.htm?3/24/3465/abstract/42\">",
"     42",
"    </a>",
"    ]. This suggests that the hypotensive effect of nocturnal hemodialysis is mediated through a reduction in an elevated TPR, rather than exclusively by a fall in the intravascular volume [",
"    <a class=\"abstract\" href=\"UTD.htm?3/24/3465/abstract/42\">",
"     42",
"    </a>",
"    ]. Other studies have shown increased vascular compliance, improved endothelium dependent vasodilatation, increased number and function of endothelial progenitor cells, improved angiogenesis, and restoration of perfusion associated with nocturnal hemodialysis [",
"    <a class=\"abstract\" href=\"UTD.htm?3/24/3465/abstract/43-45\">",
"     43-45",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H14\">",
"    <span class=\"h3\">",
"     Heart rate variability",
"    </span>",
"    &nbsp;&mdash;&nbsp;Conversion from conventional to quotidian nocturnal hemodialysis is associated with increased heart rate variability during sleep [",
"    <a class=\"abstract\" href=\"UTD.htm?3/24/3465/abstract/46\">",
"     46",
"    </a>",
"    ]. A decrease in heart rate variability, a characteristic common in patients with end-stage renal disease, correlates with increased cardiovascular mortality in the general population [",
"    <a class=\"abstract\" href=\"UTD.htm?3/24/3465/abstract/47\">",
"     47",
"    </a>",
"    ]. How this affects clinical outcomes needs to be determined. Nocturnal hemodialysis has also been associated with improved baroreflex sensitivity and the baroreflex effectiveness index [",
"    <a class=\"abstract\" href=\"UTD.htm?3/24/3465/abstract/48\">",
"     48",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H15\">",
"    <span class=\"h3\">",
"     Coronary calcification",
"    </span>",
"    &nbsp;&mdash;&nbsp;The natural history of coronary calcification and factors underlying progression were evaluated in an observational cohort study of 38 patients who converted to nocturnal dialysis [",
"    <a class=\"abstract\" href=\"UTD.htm?3/24/3465/abstract/49\">",
"     49",
"    </a>",
"    ]. At follow-up at a mean period of 16 months, there was no change in coronary calcification (as assessed by multi-slice CT) in 24 patients with minimal coronary calcification (initial score of 0.7 to follow-up score of 6.0), while there was a nonsignificant increase in the remaining individuals with higher initial calcification (1874 to 2038). The calcium-phosphate product and use of oral calcium-based phosphate binders also significantly decreased after conversion.",
"   </p>",
"   <p>",
"    This rate of coronary calcification progression is significantly lower than that observed in studies of patients undergoing conventional hemodialysis and peritoneal dialysis. Although further study with a randomized controlled trial is required, these findings suggest that conversion to nocturnal hemodialysis may lower rates of progression of coronary calcification, perhaps due in part to favorable effects upon",
"    <span class=\"nowrap\">",
"     calcium/phosphate",
"    </span>",
"    metabolism. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?17/20/17738?source=see_link\">",
"     \"Vascular calcification in chronic kidney disease\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H16\">",
"    <span class=\"h2\">",
"     Erythropoietin and iron administration",
"    </span>",
"    &nbsp;&mdash;&nbsp;Several reports claiming improved anemia control on daily or nocturnal hemodialysis have been published [",
"    <a class=\"abstract\" href=\"UTD.htm?3/24/3465/abstract/6,50\">",
"     6,50",
"    </a>",
"    ]. However, negative results have also been reported [",
"    <a class=\"abstract\" href=\"UTD.htm?3/24/3465/abstract/11,29,51\">",
"     11,29,51",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    In our group, 63 nocturnal hemodialysis patients and 32 self-care dialysis patients were evaluated with respect to anemia control [",
"    <a class=\"abstract\" href=\"UTD.htm?3/24/3465/abstract/52\">",
"     52",
"    </a>",
"    ]. After conversion to nocturnal hemodialysis, there was a substantial increase in hemoglobin concentrations with a fall in",
"    <a class=\"drug drug_general\" href=\"UTD.htm?2/48/2825?source=see_link\">",
"     recombinant human erythropoietin",
"    </a>",
"    (rHuEPO) requirements, while the control cohort did not reflect such changes [",
"    <a class=\"abstract\" href=\"UTD.htm?3/24/3465/abstract/52\">",
"     52",
"    </a>",
"    ]. There were no differences in baseline iron indices between the two groups. In addition to these decreased requirements, approximately 24 percent of nocturnal hemodialysis patients versus 9 percent of controls no longer required the administration of rHuEPO [",
"    <a class=\"abstract\" href=\"UTD.htm?3/24/3465/abstract/22,52\">",
"     22,52",
"    </a>",
"    ]. The effect of nocturnal hemodialysis on erythropoiesis needs further investigation.",
"   </p>",
"   <p>",
"    Intravenous",
"    <a class=\"drug drug_general\" href=\"UTD.htm?40/31/41461?source=see_link\">",
"     iron sucrose",
"    </a>",
"    (Venofer&reg;) is self-administered by patients at home. Iron sucrose is well tolerated, without any reported immediate or delayed allergic reactions. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?36/55/37752?source=see_link\">",
"     \"Iron balance in non-dialysis, peritoneal dialysis, and home hemodialysis patients\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?37/39/38521?source=see_link\">",
"     \"Use of iron preparations in hemodialysis patients\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H17\">",
"    <span class=\"h2\">",
"     Dyslipidemia",
"    </span>",
"    &nbsp;&mdash;&nbsp;Chronic kidney disease, including end-stage renal disease, is associated with significant dyslipidemia. This commonly consists of increased levels of triglycerides, total cholesterol, low density lipoproteins (LDL), non-high-density lipoproteins (HDL), and reduced high density lipoproteins. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?32/41/33430?source=see_link\">",
"     \"Lipid abnormalities in nephrotic syndrome\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Nocturnal hemodialysis may improve the lipid profile of patients with end-stage renal disease. This was reported in a study of 11 patients undergoing conventional hemodialysis in whom decreases in triglyceride levels (186 to 89",
"    <span class=\"nowrap\">",
"     mg/dL",
"    </span>",
"    [2.1 to 1.0",
"    <span class=\"nowrap\">",
"     mmol/L])",
"    </span>",
"    and increases in HDL levels (45 to 64",
"    <span class=\"nowrap\">",
"     mg/dL",
"    </span>",
"    [1.17 to 1.65",
"    <span class=\"nowrap\">",
"     mmol/L])",
"    </span>",
"    occurred after three months of nocturnal hemodialysis [",
"    <a class=\"abstract\" href=\"UTD.htm?3/24/3465/abstract/53\">",
"     53",
"    </a>",
"    ]. Total cholesterol and LDL levels were unchanged.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H18\">",
"    <span class=\"h2\">",
"     Sleep",
"    </span>",
"    &nbsp;&mdash;&nbsp;Sleep disturbance is minimal during nocturnal hemodialysis, and sleep architecture appears to improve [",
"    <a class=\"abstract\" href=\"UTD.htm?3/24/3465/abstract/54\">",
"     54",
"    </a>",
"    ]. In one study, for example, assessment of sleep performed before and after the conversion to nocturnal hemodialysis found that the new regimen significantly improved preexisting sleep apnea [",
"    <a class=\"abstract\" href=\"UTD.htm?3/24/3465/abstract/55\">",
"     55",
"    </a>",
"    ]. In seven patients, conversion was associated with a markedly decreased number of apnea and hypopnea episodes (46 to 9 per hour) and increased oxygen saturation (89.2 to 94.1 percent). However, periodic limb movements and daytime sleepiness do not improve on nocturnal hemodialysis [",
"    <a class=\"abstract\" href=\"UTD.htm?3/24/3465/abstract/56\">",
"     56",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H19\">",
"    <span class=\"h2\">",
"     Nutrition",
"    </span>",
"    &nbsp;&mdash;&nbsp;Nocturnal hemodialysis significantly liberates dietary intake of dialysis patients. All patients are maintained on a free diet including the unrestricted intake of salt, water, potassium, phosphate, and protein.",
"   </p>",
"   <p>",
"    Although potassium intake is not restricted, the amount ingested needs to be relatively consistent. The potassium dialysate concentration is adjusted as necessary.",
"   </p>",
"   <p>",
"    A high protein intake is encouraged, as patients on nocturnal hemodialysis lose 10 to 15 g of amino acids daily in the dialysate [",
"    <a class=\"abstract\" href=\"UTD.htm?3/24/3465/abstract/57\">",
"     57",
"    </a>",
"    ]. Using in vivo neutron activation analysis, preliminary results of measurements of total body nitrogen did not reveal evidence of negative nitrogen balance [",
"    <a class=\"abstract\" href=\"UTD.htm?3/24/3465/abstract/58\">",
"     58",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Serum albumin did not change after a year on nocturnal hemodialysis [",
"    <a class=\"abstract\" href=\"UTD.htm?3/24/3465/abstract/11\">",
"     11",
"    </a>",
"    ]. Conversely, Spanner detected a decrease in serum albumin on nocturnal hemodialysis not observed on short daily hemodialysis [",
"    <a class=\"abstract\" href=\"UTD.htm?3/24/3465/abstract/59\">",
"     59",
"    </a>",
"    ]. A secondary analysis of data from the FHN trial cited above showed no difference between patients undergoing frequent nocturnal versus conventional hemodialysis in serum albumin, protein catabolic rate, or total body weight at 12 months [",
"    <a class=\"abstract\" href=\"UTD.htm?3/24/3465/abstract/60\">",
"     60",
"    </a>",
"    ]. Further studies are needed to delineate the effect of nocturnal hemodialysis on nutrition.",
"   </p>",
"   <p>",
"    The dose of daily multivitamin preparation is increased to two tablets daily. However, there has been no definite evidence of vitamin deficiency.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H20\">",
"    <span class=\"h2\">",
"     Bone disease",
"    </span>",
"    &nbsp;&mdash;&nbsp;The excellent phosphate control on nocturnal hemodialysis is useful in the prevention and treatment of secondary hyperparathyroidism. High dialysate calcium levels suppresses PTH levels successfully and normalize alkaline phosphatase levels in most patients [",
"    <a class=\"abstract\" href=\"UTD.htm?3/24/3465/abstract/61\">",
"     61",
"    </a>",
"    ]. This is achieved by adjusting the dialysate calcium. Inadequate dialysate calcium can lead to negative calcium balance associated with increased PTH and alkaline phosphatase [",
"    <a class=\"abstract\" href=\"UTD.htm?3/24/3465/abstract/62,63\">",
"     62,63",
"    </a>",
"    ]. Conversely, an overzealous increase in dialysate calcium can lead to low bone turnover [",
"    <a class=\"abstract\" href=\"UTD.htm?3/24/3465/abstract/61\">",
"     61",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Bone density studies performed yearly and occasionally more often are very useful in adjusting dialysate calcium concentrations and ensuring that negative calcium balance is avoided. The role of vitamin D analogues is currently unknown. In one patient, extensive preexisting extraosseous tumoral calcifications dissolved upon conversion to nocturnal hemodialysis [",
"    <a class=\"abstract\" href=\"UTD.htm?3/24/3465/abstract/64\">",
"     64",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    There is also an increase in both 25-hydroxy and 1,25-dihydroxy vitamin D levels, which directly correlates with the enhanced dialysis dose in nocturnal hemodialysis [",
"    <a class=\"abstract\" href=\"UTD.htm?3/24/3465/abstract/65\">",
"     65",
"    </a>",
"    ]. The clinical significance of increased vitamin D levels is unclear.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H21\">",
"    <span class=\"h2\">",
"     Fertility",
"    </span>",
"    &nbsp;&mdash;&nbsp;Women undergoing conventional hemodialysis have markedly decreased fertility. When pregnancy does occur, intrauterine growth retardation and miscarriage occur unless dialysis frequency is increased to five to six times per week. A paucity of data exists concerning the effect of nocturnal hemodialysis on fertility and pregnancy. In a small cohort study, five women undergoing nocturnal hemodialysis had seven pregnancies, resulting in six live infants [",
"    <a class=\"abstract\" href=\"UTD.htm?3/24/3465/abstract/66\">",
"     66",
"    </a>",
"    ]. Although less common or severe than historic controls, complications included intrauterine growth restriction or small for gestational age (two infants), delivery before 32 weeks (one), and shortened cervix threatening labor (one). Thus, nocturnal hemodialysis may be associated with improved fertility. However, given its small size and observational design, this study is limited. Whether it is the increased frequency, greater dose, or better timed-average concentration of Urea that produces a greater success rate requires further prospective studies.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H22\">",
"    <span class=\"h2\">",
"     Survival",
"    </span>",
"    &nbsp;&mdash;&nbsp;Data on patient survival on nocturnal hemodialysis have been published, with some evidence of increased survival with the technique [",
"    <a class=\"abstract\" href=\"UTD.htm?3/24/3465/abstract/67,68\">",
"     67,68",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Among 746 patients initiated for the first time on in-center three times weekly nocturnal hemodialysis performed at 77 outpatient centers in the United States, the two year adjusted mortality risk was lower compared with 2062 matched control patients on conventional hemodialysis (19 versus 27 percent, respectively, hazard ratio 0.75, 95% CI 0.61-0.91) [",
"      <a class=\"abstract\" href=\"UTD.htm?3/24/3465/abstract/69\">",
"       69",
"      </a>",
"      ]. The mortality of the matched cohort was lower than the reported mortality rate for hemodialysis patients in the Unites States however, suggesting that patients selected for in-center nocturnal hemodialysis may be healthier than the average hemodialysis patient in the United States [",
"      <a class=\"abstract\" href=\"UTD.htm?3/24/3465/abstract/70\">",
"       70",
"      </a>",
"      ].",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      In one retrospective study, 338 patients who were receiving intensive home hemodialysis (either day or overnight with a mean of 4.8 sessions per week and a mean treatment time of 7.4 hours per session) were compared with 1338 propensity-matched patients on conventional hemodialysis (mean of 3 sessions per week with a mean treatment time of 7.4 hours per session) [",
"      <a class=\"abstract\" href=\"UTD.htm?3/24/3465/abstract/71\">",
"       71",
"      </a>",
"      ]. Mortality was lower among patients on intensive hemodialysis (13 percent versus 21 percent for control patients on conventional hemodialysis).",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      A matched cohort study reported that mortality was significantly lower among 94 patients undergoing nocturnal hemodialysis compared with 43 patients undergoing thrice-weekly conventional hemodialysis (hazard ratio 0.38, 95% CI 0.22-0.61) [",
"      <a class=\"abstract\" href=\"UTD.htm?3/24/3465/abstract/68\">",
"       68",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      A retrospective matched cohort study found similar survival rates with nocturnal hemodialysis and deceased donor transplantation [",
"      <a class=\"abstract\" href=\"UTD.htm?3/24/3465/abstract/67\">",
"       67",
"      </a>",
"      ].",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    However, in the FHN Nocturnal trial cited above, there was no difference at 12 months in the two primary composite endpoints which included death or change in left ventricular mass and death or change quality of life as assessed by the RAND-36 survey among 87 patients were randomly assigned to either three times weekly conventional hemodialysis or six times weekly nocturnal hemodialysis [",
"    <a class=\"abstract\" href=\"UTD.htm?3/24/3465/abstract/29\">",
"     29",
"    </a>",
"    ]. However the interpretation of this trial is limited since death was not evaluated as a primary outcome, and only two patients died. In addition, because of difficulty in recruiting patients, the trial may have been underpowered to detect small differences even in the composite outcomes.",
"   </p>",
"   <p>",
"    Additional information on patient survival with nocturnal hemodialysis will hopefully be provided by an already established international daily hemodialysis registry [",
"    <a class=\"abstract\" href=\"UTD.htm?3/24/3465/abstract/72,73\">",
"     72,73",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H23\">",
"    <span class=\"h2\">",
"     Cost",
"    </span>",
"    &nbsp;&mdash;&nbsp;Due to the nightly schedule with nocturnal hemodialysis, the cost of consumables is higher than on conventional hemodialysis and is similar to the cost of short daily hemodialysis. On the other hand, the personnel cost of nocturnal hemodialysis is lower than that with in-center hemodialysis regimens [",
"    <a class=\"abstract\" href=\"UTD.htm?3/24/3465/abstract/74\">",
"     74",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Depending upon the",
"    <span class=\"nowrap\">",
"     consumable/personnel",
"    </span>",
"    cost ratio in different countries, nocturnal hemodialysis can be less or more expensive than in-center conventional hemodialysis. In addition, the cost of medications, including EPO, antihypertensive agents, and phosphate binders, is lower with nocturnal hemodialysis. It also appears that hospitalization expenses may be lower [",
"    <a class=\"abstract\" href=\"UTD.htm?3/24/3465/abstract/31,75\">",
"     31,75",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Two prospective non-randomized controlled studies evaluated the costs associated with home nocturnal versus conventional in-center hemodialysis in Canada [",
"    <a class=\"abstract\" href=\"UTD.htm?3/24/3465/abstract/75,76\">",
"     75,76",
"    </a>",
"    ]. The overall treatment cost of patients on nocturnal hemodialysis was 20 percent lower than those on conventional hemodialysis, similar to the observations in a study in the US [",
"    <a class=\"abstract\" href=\"UTD.htm?3/24/3465/abstract/31\">",
"     31",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    The combination of improved quality of life and lower cost lead to higher cost-utility for nocturnal hemodialysis when compared to conventional hemodialysis [",
"    <a class=\"abstract\" href=\"UTD.htm?3/24/3465/abstract/77\">",
"     77",
"    </a>",
"    ]. A decision analysis that compared nocturnal with conventional hemodialysis based upon a Markov state transition model reported similar findings [",
"    <a class=\"abstract\" href=\"UTD.htm?3/24/3465/abstract/78\">",
"     78",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H25\">",
"    <span class=\"h1\">",
"     ROLE FOR NOCTURNAL HEMODIALYSIS",
"    </span>",
"    &nbsp;&mdash;&nbsp;In view of the excellent clinical results, enthusiastic acceptance by patients, and favorable financial profile, nocturnal hemodialysis should be considered for patients who are willing and capable of performing home hemodialysis. Nocturnal home hemodialysis along with short daily hemodialysis will hopefully increase the use of home hemodialysis, which has already been known to provide improved outcomes, even in its conventional form [",
"    <a class=\"abstract\" href=\"UTD.htm?3/24/3465/abstract/79\">",
"     79",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?18/44/19144?source=see_link\">",
"     \"Home hemodialysis\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Current obstacles to adoption of nocturnal hemodialysis are unfamiliarity with home hemodialysis and the financial impact of the high frequency of dialysis. With most current reimbursement schemes, the dialysis provider does NOT benefit from the savings realized from the decreased cost of medications (including EPO), hospitalization, and transportation but is burdened by the increased cost of providing dialysis at increased frequency [",
"    <a class=\"abstract\" href=\"UTD.htm?3/24/3465/abstract/22\">",
"     22",
"    </a>",
"    ]. Therefore, changes in the reimbursement schemes are needed.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H26\">",
"    <span class=\"h1\">",
"     SUMMARY AND RECOMMENDATIONS",
"    </span>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Nocturnal hemodialysis is associated with marked benefits compared with conventional hemodialysis regimens. Some of the benefits with the technique have been clearly shown, while others require further analysis. Some of the benefits demonstrated by the observational studies may have been influenced by patient selection biases with younger and healthier patients choosing home modalities. (See",
"      <a class=\"local\" href=\"#H2\">",
"       'Outcomes'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Clearance of urea, phosphate, and beta2-microglobulin are markedly enhanced with nocturnal hemodialysis. Limited data suggest that quality of life also may be improved. (See",
"      <a class=\"local\" href=\"#H3\">",
"       'Clearances'",
"      </a>",
"      above and",
"      <a class=\"local\" href=\"#H7\">",
"       'Quality of life'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Excellent blood pressure control is achieved by nocturnal hemodialysis, with almost all patients no longer requiring antihypertensive medications. Increasing evidence also suggests that nocturnal hemodialysis is associated with regression of left ventricular hypertrophy. (See",
"      <a class=\"local\" href=\"#H9\">",
"       'Cardiovascular effects'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Sleep disturbance is minimal during nocturnal hemodialysis, and sleep architecture appears to improve. Nocturnal hemodialysis also significantly liberates dietary intake of dialysis patients. Patients are kept on a free diet including the unrestricted intake of salt, water, potassium, phosphate, and protein. (See",
"      <a class=\"local\" href=\"#H18\">",
"       'Sleep'",
"      </a>",
"      above and",
"      <a class=\"local\" href=\"#H19\">",
"       'Nutrition'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      No significant conclusions can be drawn concerning the effect of nocturnal hemodialysis on survival. In addition, depending upon the",
"      <span class=\"nowrap\">",
"       consumable/personnel",
"      </span>",
"      cost ratio in different countries, nocturnal hemodialysis can be less or more expensive than in-center conventional hemodialysis. (See",
"      <a class=\"local\" href=\"#H22\">",
"       'Survival'",
"      </a>",
"      above and",
"      <a class=\"local\" href=\"#H23\">",
"       'Cost'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      In view of the clinical results, enthusiastic acceptance by patients, and favorable financial profile in some jurisdictions, nocturnal hemodialysis should be considered as an attractive option for patients who are willing and capable of performing home hemodialysis. Current obstacles to adoption of nocturnal hemodialysis are unfamiliarity with home hemodialysis and the financial impact of the high frequency of dialysis. (See",
"      <a class=\"local\" href=\"#H25\">",
"       'Role for nocturnal hemodialysis'",
"      </a>",
"      above.)",
"     </li>",
"    </ul>",
"   </p>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <h1>",
"    REFERENCES",
"   </h1>",
"   <ol id=\"reference\">",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/24/3465/abstract/1\">",
"      USRDS: The United States Renal Data System: Overall hospitalization and mortality. Am J Kidney Dis 2010; 55(Suppl 1): S1.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/24/3465/abstract/2\">",
"      Bell CM, Chapman RH, Stone PW, et al. An off-the-shelf help list: a comprehensive catalog of preference scores from published cost-utility analyses. Med Decis Making 2001; 21:288.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/24/3465/abstract/3\">",
"      Saran R, Bragg-Gresham JL, Levin NW, et al. Longer treatment time and slower ultrafiltration in hemodialysis: associations with reduced mortality in the DOPPS. Kidney Int 2006; 69:1222.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/24/3465/abstract/4\">",
"      Charra B, Calemard E, Ruffet M, et al. Survival as an index of adequacy of dialysis. Kidney Int 1992; 41:1286.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/24/3465/abstract/5\">",
"      Buoncristiani U. Fifteen years of clinical experience with daily haemodialysis. Nephrol Dial Transplant 1998; 13 Suppl 6:148.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/24/3465/abstract/6\">",
"      Woods JD, Port FK, Orzol S, et al. Clinical and biochemical correlates of starting \"daily\" hemodialysis. Kidney Int 1999; 55:2467.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/24/3465/abstract/7\">",
"      Locatelli F, Buoncristiani U, Canaud B, et al. Dialysis dose and frequency. Nephrol Dial Transplant 2005; 20:285.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/24/3465/abstract/8\">",
"      Lowrie EG, Laird NM, Parker TF, Sargent JA. Effect of the hemodialysis prescription of patient morbidity: report from the National Cooperative Dialysis Study. N Engl J Med 1981; 305:1176.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/24/3465/abstract/9\">",
"      Hakim RM, Breyer J, Ismail N, Schulman G. Effects of dose of dialysis on morbidity and mortality. Am J Kidney Dis 1994; 23:661.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/24/3465/abstract/10\">",
"      Eknoyan G, Beck GJ, Cheung AK, et al. Effect of dialysis dose and membrane flux in maintenance hemodialysis. N Engl J Med 2002; 347:2010.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/24/3465/abstract/11\">",
"      Pierratos A, Ouwendyk M, Francoeur R, et al. Nocturnal hemodialysis: three-year experience. J Am Soc Nephrol 1998; 9:859.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/24/3465/abstract/12\">",
"      Shaldon S. Independence in maintenance haemodialysis. Lancet 1968; 1:520.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/24/3465/abstract/13\">",
"      Udall, PR, Francoeur, R, Ouwendyk, M. Simplified nocturnal home hemodialysis (SNHHD). A new approach to renal replacement therapy. J Am Soc Nephrol 1994; 5:428.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/24/3465/abstract/14\">",
"      Lindsay RM, Daily/Nocturnal Dialysis Study Group. The London, Ontario, Daily/Nocturnal Hemodialysis Study. Semin Dial 2004; 17:85.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/24/3465/abstract/15\">",
"      Lockridge RS Jr, Spencer M, Craft V, et al. Nocturnal home hemodialysis in North America. Adv Ren Replace Ther 2001; 8:250.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/24/3465/abstract/16\">",
"      Agar JW, Somerville CA, Dwyer KM, et al. Nocturnal hemodialysis in australia. Hemodial Int 2003; 7:278.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/24/3465/abstract/17\">",
"      Kooistra MP. Frequent prolonged home haemodialysis: three old concepts, one modern solution. Nephrol Dial Transplant 2003; 18:16.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/24/3465/abstract/18\">",
"      Powell JR, Oluwaseun O, Woo YM, et al. Ten years experience of in-center thrice weekly long overnight hemodialysis. Clin J Am Soc Nephrol 2009; 4:1097.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/24/3465/abstract/19\">",
"      Chan CT, Floras JS, Miller JA, et al. Regression of left ventricular hypertrophy after conversion to nocturnal hemodialysis. Kidney Int 2002; 61:2235.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/24/3465/abstract/20\">",
"      Suri R, Depner TA, Blake PG, et al. Adequacy of quotidian hemodialysis. Am J Kidney Dis 2003; 42:42.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/24/3465/abstract/21\">",
"      Gotch FA. The current place of urea kinetic modelling with respect to different dialysis modalities. Nephrol Dial Transplant 1998; 13 Suppl 6:10.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/24/3465/abstract/22\">",
"      Pierratos A. Daily nocturnal home hemodialysis. Kidney Int 2004; 65:1975.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/24/3465/abstract/23\">",
"      Mucsi I, Hercz G, Uldall R, et al. Control of serum phosphate without any phosphate binders in patients treated with nocturnal hemodialysis. Kidney Int 1998; 53:1399.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/24/3465/abstract/24\">",
"      Lockridge, RS, Albert, J, Andrerson, H, et al. Nightly Home Hemodialysis: Fifteen Months of Experience in Lynchburg, Virginia. Home Hemodial Int 1999; 3:23.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/24/3465/abstract/25\">",
"      Culleton BF, Walsh M, Klarenbach SW, et al. Effect of frequent nocturnal hemodialysis vs conventional hemodialysis on left ventricular mass and quality of life: a randomized controlled trial. JAMA 2007; 298:1291.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/24/3465/abstract/26\">",
"      Walsh M, Manns BJ, Klarenbach S, et al. The effects of nocturnal compared with conventional hemodialysis on mineral metabolism: A randomized-controlled trial. Hemodial Int 2010; 14:174.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/24/3465/abstract/27\">",
"      FHN Trial Group, Chertow GM, Levin NW, et al. In-center hemodialysis six times per week versus three times per week. N Engl J Med 2010; 363:2287.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/24/3465/abstract/28\">",
"      Daugirdas JT, Chertow GM, Larive B, et al. Effects of frequent hemodialysis on measures of CKD mineral and bone disorder. J Am Soc Nephrol 2012; 23:727.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/24/3465/abstract/29\">",
"      Rocco MV, Lockridge RS Jr, Beck GJ, et al. The effects of frequent nocturnal home hemodialysis: the Frequent Hemodialysis Network Nocturnal Trial. Kidney Int 2011; 80:1080.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/24/3465/abstract/30\">",
"      Raj DS, Ouwendyk M, Francoeur R, Pierratos A. beta(2)-microglobulin kinetics in nocturnal haemodialysis. Nephrol Dial Transplant 2000; 15:58.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/24/3465/abstract/31\">",
"      Mohr PE, Neumann PJ, Franco SJ, et al. The case for daily dialysis: its impact on costs and quality of life. Am J Kidney Dis 2001; 37:777.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/24/3465/abstract/32\">",
"      McPhatter LL, Lockridge RS Jr, Albert J, et al. Nightly home hemodialysis: improvement in nutrition and quality of life. Adv Ren Replace Ther 1999; 6:358.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/24/3465/abstract/33\">",
"      Brissenden, JE, Pierratos, A, Ouwendyk, M, Roscoe, JM. Improvements in quality of life with Nocturnal Hemodialysis. J Am Soc Nephrol 1998; 9:168A.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/24/3465/abstract/34\">",
"      Manns BJ, Walsh MW, Culleton BF, et al. Nocturnal hemodialysis does not improve overall measures of quality of life compared to conventional hemodialysis. Kidney Int 2009; 75:542.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/24/3465/abstract/35\">",
"      Hall YN, Larive B, Painter P, et al. Effects of six versus three times per week hemodialysis on physical performance, health, and functioning: Frequent Hemodialysis Network (FHN) randomized trials. Clin J Am Soc Nephrol 2012; 7:782.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/24/3465/abstract/36\">",
"      Jablonski KL, Chonchol M. Frequent hemodialysis: a way to improve physical function? Clin J Am Soc Nephrol 2012; 7:707.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/24/3465/abstract/37\">",
"      McFarlane PA, Pierratos A, Bayoumi AM, Redelmeier DA. Estimating preference scores in conventional and home nocturnal hemodialysis patients. Clin J Am Soc Nephrol 2007; 2:477.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/24/3465/abstract/38\">",
"      Jassal SV, Devins GM, Chan CT, et al. Improvements in cognition in patients converting from thrice weekly hemodialysis to nocturnal hemodialysis: a longitudinal pilot study. Kidney Int 2006; 70:956.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/24/3465/abstract/39\">",
"      Pierratos A. Nocturnal home haemodialysis: an update on a 5-year experience. Nephrol Dial Transplant 1999; 14:2835.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/24/3465/abstract/40\">",
"      Chan C, Floras JS, Miller JA, Pierratos A. Improvement in ejection fraction by nocturnal haemodialysis in end-stage renal failure patients with coexisting heart failure. Nephrol Dial Transplant 2002; 17:1518.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/24/3465/abstract/41\">",
"      Jefferies HJ, Virk B, Schiller B, et al. Frequent hemodialysis schedules are associated with reduced levels of dialysis-induced cardiac injury (myocardial stunning). Clin J Am Soc Nephrol 2011; 6:1326.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/24/3465/abstract/42\">",
"      Chan CT, Harvey PJ, Picton P, et al. Short-term blood pressure, noradrenergic, and vascular effects of nocturnal home hemodialysis. Hypertension 2003; 42:925.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/24/3465/abstract/43\">",
"      Chan CT, Li SH, Verma S. Nocturnal hemodialysis is associated with restoration of impaired endothelial progenitor cell biology in end-stage renal disease. Am J Physiol Renal Physiol 2005; 289:F679.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/24/3465/abstract/44\">",
"      Yuen DA, Kuliszewski MA, Liao C, et al. Nocturnal hemodialysis is associated with restoration of early-outgrowth endothelial progenitor-like cell function. Clin J Am Soc Nephrol 2011; 6:1345.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/24/3465/abstract/45\">",
"      Chan CT, Jain V, Picton P, et al. Nocturnal hemodialysis increases arterial baroreflex sensitivity and compliance and normalizes blood pressure of hypertensive patients with end-stage renal disease. Kidney Int 2005; 68:338.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/24/3465/abstract/46\">",
"      Chan CT, Hanly P, Gabor J, et al. Impact of nocturnal hemodialysis on the variability of heart rate and duration of hypoxemia during sleep. Kidney Int 2004; 65:661.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/24/3465/abstract/47\">",
"      Tsuji H, Larson MG, Venditti FJ Jr, et al. Impact of reduced heart rate variability on risk for cardiac events. The Framingham Heart Study. Circulation 1996; 94:2850.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/24/3465/abstract/48\">",
"      Chan CT, Shen XS, Picton P, Floras J. Nocturnal home hemodialysis improves baroreflex effectiveness index of end-stage renal disease patients. J Hypertens 2008; 26:1795.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/24/3465/abstract/49\">",
"      Yuen D, Pierratos A, Richardson RM, Chan CT. The natural history of coronary calcification progression in a cohort of nocturnal haemodialysis patients. Nephrol Dial Transplant 2006; 21:1407.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/24/3465/abstract/50\">",
"      Ting GO, Kjellstrand C, Freitas T, et al. Long-term study of high-comorbidity ESRD patients converted from conventional to short daily hemodialysis. Am J Kidney Dis 2003; 42:1020.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/24/3465/abstract/51\">",
"      Kooistra MP, Vos J, Koomans HA, Vos PF. Daily home haemodialysis in The Netherlands: effects on metabolic control, haemodynamics, and quality of life. Nephrol Dial Transplant 1998; 13:2853.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/24/3465/abstract/52\">",
"      Schwartz DI, Pierratos A, Richardson RM, et al. Impact of nocturnal home hemodialysis on anemia management in patients with end-stage renal disease. Clin Nephrol 2005; 63:202.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/24/3465/abstract/53\">",
"      Bugeja AL, Chan CT. Improvement in lipid profile by nocturnal hemodialysis in patients with end-stage renal disease. ASAIO J 2004; 50:328.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/24/3465/abstract/54\">",
"      Perl J, Unruh ML, Chan CT. Sleep disorders in end-stage renal disease: 'Markers of inadequate dialysis'? Kidney Int 2006; 70:1687.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/24/3465/abstract/55\">",
"      Hanly PJ, Pierratos A. Improvement of sleep apnea in patients with chronic renal failure who undergo nocturnal hemodialysis. N Engl J Med 2001; 344:102.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/24/3465/abstract/56\">",
"      Hanly PJ, Gabor JY, Chan C, Pierratos A. Daytime sleepiness in patients with CRF: impact of nocturnal hemodialysis. Am J Kidney Dis 2003; 41:403.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/24/3465/abstract/57\">",
"      Ikizler TA, Flakoll PJ, Parker RA, Hakim RM. Amino acid and albumin losses during hemodialysis. Kidney Int 1994; 46:830.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/24/3465/abstract/58\">",
"      Pierratos, A, Ouwendyk, M, Rassi, M. Total Body Nitrogen Increases on Nocturnal Hemodialysis (Abstract). J Am Soc Nephrol 1999; 10:299A.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/24/3465/abstract/59\">",
"      Spanner E, Suri R, Heidenheim AP, Lindsay RM. The impact of quotidian hemodialysis on nutrition. Am J Kidney Dis 2003; 42:30.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/24/3465/abstract/60\">",
"      Kaysen GA, Greene T, Larive B, et al. The effect of frequent hemodialysis on nutrition and body composition: frequent Hemodialysis Network Trial. Kidney Int 2012; 82:90.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/24/3465/abstract/61\">",
"      Pierratos, A, Hercz, G, Sherrard, DJ, et al. Calcium, Phosphorus Metabolism and Bone Pathology on Long Term Nocturnal Hemodialysis. J Am Soc Nephrol 2001; 12:274A.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/24/3465/abstract/62\">",
"      Al-Hejaili F, Kortas C, Leitch R, et al. Nocturnal but not short hours quotidian hemodialysis requires an elevated dialysate calcium concentration. J Am Soc Nephrol 2003; 14:2322.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/24/3465/abstract/63\">",
"      Toussaint N, Boddington J, Simmonds R, et al. Calcium phosphate metabolism and bone mineral density with nocturnal hemodialysis. Hemodial Int 2006; 10:280.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/24/3465/abstract/64\">",
"      Kim SJ, Goldstein M, Szabo T, Pierratos A. Resolution of massive uremic tumoral calcinosis with daily nocturnal home hemodialysis. Am J Kidney Dis 2003; 41:E12.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/24/3465/abstract/65\">",
"      Nessim SJ, Jassal SV, Fung SV, Chan CT. Conversion from conventional to nocturnal hemodialysis improves vitamin D levels. Kidney Int 2007; 71:1172.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/24/3465/abstract/66\">",
"      Barua M, Hladunewich M, Keunen J, et al. Successful pregnancies on nocturnal home hemodialysis. Clin J Am Soc Nephrol 2008; 3:392.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/24/3465/abstract/67\">",
"      Pauly RP, Gill JS, Rose CL, et al. Survival among nocturnal home haemodialysis patients compared to kidney transplant recipients. Nephrol Dial Transplant 2009; 24:2915.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/24/3465/abstract/68\">",
"      Johansen KL, Zhang R, Huang Y, et al. Survival and hospitalization among patients using nocturnal and short daily compared to conventional hemodialysis: a USRDS study. Kidney Int 2009; 76:984.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/24/3465/abstract/69\">",
"      Lacson E Jr, Xu J, Suri RS, et al. Survival with three-times weekly in-center nocturnal versus conventional hemodialysis. J Am Soc Nephrol 2012; 23:687.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/24/3465/abstract/70\">",
"      Kuhlmann MK. The eternal (nocturnal) quest for better dialysis outcomes. J Am Soc Nephrol 2012; 23:571.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/24/3465/abstract/71\">",
"      Nesrallah GE, Lindsay RM, Cuerden MS, et al. Intensive hemodialysis associates with improved survival compared with conventional hemodialysis. J Am Soc Nephrol 2012; 23:696.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/24/3465/abstract/72\">",
"      Nesrallah GE, Moist LM, Awaraji C, Lindsay RM. An international registry to compare quotidian dialysis regimens with conventional thrice-weekly hemodialysis: why, how, and potential pitfalls. Semin Dial 2004; 17:131.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/24/3465/abstract/73\">",
"      Nesrallah GE, Suri RS, Zoller R, et al. The International Quotidian Dialysis Registry: annual report 2006. Hemodial Int 2006; 10:219.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/24/3465/abstract/74\">",
"      McFarlane PA. Reducing hemodialysis costs: conventional and quotidian home hemodialysis in Canada. Semin Dial 2004; 17:118.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/24/3465/abstract/75\">",
"      McFarlane PA, Pierratos A, Redelmeier DA. Cost savings of home nocturnal versus conventional in-center hemodialysis. Kidney Int 2002; 62:2216.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/24/3465/abstract/76\">",
"      Kroeker A, Clark WF, Heidenheim AP, et al. An operating cost comparison between conventional and home quotidian hemodialysis. Am J Kidney Dis 2003; 42:49.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/24/3465/abstract/77\">",
"      McFarlane PA, Bayoumi AM, Pierratos A, Redelmeier DA. The quality of life and cost utility of home nocturnal and conventional in-center hemodialysis. Kidney Int 2003; 64:1004.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/24/3465/abstract/78\">",
"      McFarlane PA, Bayoumi AM, Pierratos A, Redelmeier DA. The impact of home nocturnal hemodialysis on end-stage renal disease therapies: a decision analysis. Kidney Int 2006; 69:798.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/24/3465/abstract/79\">",
"      Woods JD, Port FK, Stannard D, et al. Comparison of mortality with home hemodialysis and center hemodialysis: a national study. Kidney Int 1996; 49:1464.",
"     </a>",
"    </li>",
"   </ol>",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 1959 Version 9.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.3 - C21.34",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     Morehouse School of Medicine",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [1102-211.167.112.15-0980553D96-S473950.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f3_24_3465=[""].join("\n");
var outline_f3_24_3465=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li>",
"     <a class=\"sr_button\" href=\"#H26\" id=\"summRecButton\">",
"      <span>",
"       SUMMARY &amp; RECOMMENDATIONS",
"      </span>",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H1\">",
"      INTRODUCTION AND OVERVIEW",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H2\">",
"      OUTCOMES",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H3\">",
"      Clearances",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H4\">",
"      - Urea",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H5\">",
"      - Phosphate",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H6\">",
"      - Beta2-microglobulin",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H7\">",
"      Quality of life",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H8\">",
"      Cognition",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H9\">",
"      Cardiovascular effects",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H10\">",
"      - Blood pressure",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H11\">",
"      - LV hypertrophy",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H12\">",
"      - Cardiac function",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H13\">",
"      - Vascular function",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H14\">",
"      - Heart rate variability",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H15\">",
"      - Coronary calcification",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H16\">",
"      Erythropoietin and iron administration",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H17\">",
"      Dyslipidemia",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H18\">",
"      Sleep",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H19\">",
"      Nutrition",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H20\">",
"      Bone disease",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H21\">",
"      Fertility",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H22\">",
"      Survival",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H23\">",
"      Cost",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H25\">",
"      ROLE FOR NOCTURNAL HEMODIALYSIS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H26\">",
"      SUMMARY AND RECOMMENDATIONS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a href=\"#references\">",
"      REFERENCES",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?18/44/19144?source=related_link\">",
"      Home hemodialysis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?36/55/37752?source=related_link\">",
"      Iron balance in non-dialysis, peritoneal dialysis, and home hemodialysis patients",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?6/14/6378?source=related_link\">",
"      Kt/V and the adequacy of hemodialysis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?32/41/33430?source=related_link\">",
"      Lipid abnormalities in nephrotic syndrome",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?36/13/37082?source=related_link\">",
"      Patient survival and maintenance dialysis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?17/45/18137?source=related_link\">",
"      Short daily hemodialysis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?0/16/264?source=related_link\">",
"      Technical aspects of nocturnal hemodialysis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?37/39/38521?source=related_link\">",
"      Use of iron preparations in hemodialysis patients",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?17/20/17738?source=related_link\">",
"      Vascular calcification in chronic kidney disease",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f3_24_3466="Quality of life in head and neck cancer";
var content_f3_24_3466=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"4\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"topicTitle\">",
"   Quality of life in head and neck cancer",
"  </div>",
"  <div id=\"topicContributors\">",
"   <div>",
"    <a id=\"authors\">",
"    </a>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?3/24/3466/contributors\">",
"     Authors",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?3/24/3466/contributors\">",
"     Jonas A de Souza, MD",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?3/24/3466/contributors\">",
"     Marcy A List, PhD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?3/24/3466/contributors\">",
"     Section Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?3/24/3466/contributors\">",
"     Bruce E Brockstein, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?3/24/3466/contributors\">",
"     Deputy Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?3/24/3466/contributors\">",
"     Michael E Ross, MD",
"    </a>",
"    <br/>",
"   </div>",
"  </div>",
"  <div id=\"disclosures\">",
"   <a href=\"UTD.htm?3/24/3466/contributor-disclosure\" target=\"_blank\">",
"    Disclosures",
"   </a>",
"  </div>",
"  <div id=\"reviewProcess\">",
"   <span>",
"    All topics are updated as new evidence becomes available and our",
"   </span>",
"   <a href=\"/home/editorial-policy\" target=\"_blank\">",
"    peer review process",
"   </a>",
"   <span>",
"    is complete.",
"   </span>",
"  </div>",
"  <div id=\"literatureReviewDate\">",
"   <span class=\"emphasis\">",
"    Literature review current through:",
"   </span>",
"   Oct 2013.",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <span class=\"emphasis\">",
"    This topic last updated:",
"   </span>",
"   Feb 1, 2012.",
"  </div>",
"  <div id=\"topicText\">",
"   <p class=\"headingAnchor\" id=\"H1\">",
"    <span class=\"h1\">",
"     INTRODUCTION",
"    </span>",
"    &nbsp;&mdash;&nbsp;The results of treatment for patients with malignant disease historically have been measured by overall survival, disease-free survival, or objective tumor response rates. However, there is an increasing recognition of the importance of the psychosocial needs of patients in this assessment.",
"   </p>",
"   <p>",
"    The loss of health due to the disease",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    the consequences of treatment can result in physical or functional impairment, disruption of social and family interactions, psychological distress, and financial difficulties, all of which can negatively affect quality of life (QoL). Thus, health care interventions must be judged not only by their impact on survival, but also on QoL.",
"   </p>",
"   <p>",
"    In judging the efficacy of treatment, extending survival does not always correlate with improvements in QoL; furthermore, specific treatments may not necessarily prolong life but may enhance its quality. Understanding the patient's perception of",
"    <span class=\"nowrap\">",
"     his/her",
"    </span>",
"    disease and its treatment is critical to comprehensive cancer care. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?4/1/4120?source=see_link&amp;anchor=H3#H3\">",
"     \"Evaluation of health-related quality of life\", section on 'Measuring HRQL'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    For patients with head and neck cancer, appreciation of the full impact of the disease and its treatment is critical. The majority of patients are diagnosed with locoregionally advanced disease; thus treatment tends to be aggressive, with significant acute and long-term effects. A wide range of delayed effects, from both the disease and its therapy can interfere with basic human functions, including eating, speaking, and breathing. [",
"    <a class=\"abstract\" href=\"UTD.htm?3/24/3466/abstract/1,2\">",
"     1,2",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?29/44/30407?source=see_link\">",
"     \"Overview of head and neck cancer\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?22/1/22554?source=see_link\">",
"     \"Management and prevention of complications of head and neck cancer during initial treatment\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?29/42/30378?source=see_link\">",
"     \"Management of late complications of head and neck cancer and its treatment\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H2\">",
"    <span class=\"h1\">",
"     DEFINITION",
"    </span>",
"    &nbsp;&mdash;&nbsp;Health-related QoL focuses upon the patient's perception of the impact of illness before, during, and after treatment. There are two fundamental premises of health-related QL:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Multi-dimensionality - QoL encompasses a broad range of domains [",
"      <a class=\"abstract\" href=\"UTD.htm?3/24/3466/abstract/3-6\">",
"       3-6",
"      </a>",
"      ]. These include:",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    <ul class=\"hyphen-block\">",
"     <li>",
"      <span class=\"nowrap\">",
"       Physical/somatic",
"      </span>",
"      (eg, pain, nausea, and fatigue)",
"     </li>",
"     <li>",
"      Functional (eg, energy level and activities of daily living)",
"     </li>",
"     <li>",
"      Social (eg, maintenance of relationships with family and friends)",
"     </li>",
"     <li>",
"      <span class=\"nowrap\">",
"       Psychological/emotional",
"      </span>",
"      (eg, mood, anxiety, and depression)",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Subjectivity &ndash; different people may have substantially different reactions to a similar illness or disability",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    These factors distinguish assessment of QoL from standard toxicity ratings or global functional ratings (eg, Karnofsky scale of performance status). These are assessed by the health care provider rather than the patient and summarize only one area (ie, somatic symptoms or performance) rather than multiple domains.",
"   </p>",
"   <p>",
"    In addition, QoL differs from endpoints such as response rate or survival in that it changes over time. As a result, QoL evaluation should examine these changes over the course of the disease and its treatment.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H3\">",
"    <span class=\"h1\">",
"     AVAILABLE TOOLS FOR ASSESSMENT OF QOL",
"    </span>",
"    &nbsp;&mdash;&nbsp;QoL instruments can be categorized as generic (ie, applicable across a range of diseases) or specific, which are limited to a disease, site",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    treatment modality.",
"   </p>",
"   <p>",
"    The sections below briefly describe a number of the more frequently used tools in the evaluation of QoL in head and neck cancer patients. Many of these instruments have been analyzed in a systematic content review, with the international classification of functioning, disability and health serving as a reference [",
"    <a class=\"abstract\" href=\"UTD.htm?3/24/3466/abstract/7\">",
"     7",
"    </a>",
"    ]. In this review, differences in content among measures are presented in tables and can serve as a resource for clinicians and investigators in questionnaire interpretation or selection. A more detailed discussion of QoL measures can also be found in two comprehensive reviews [",
"    <a class=\"abstract\" href=\"UTD.htm?3/24/3466/abstract/8,9\">",
"     8,9",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H4\">",
"    <span class=\"h2\">",
"     Generic",
"    </span>",
"    &nbsp;&mdash;&nbsp;Many validated generic measures that can be used across a range of disease states are available. These include:",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      Medical Outcomes Study 36-Item Short-Form Survey (SF-36)",
"     </li>",
"     <li>",
"      General Health Questionnaire (GHQ)-20",
"     </li>",
"     <li>",
"      Rotterdam Symptom Checklist, Functional Living Index",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H5\">",
"    <span class=\"h2\">",
"     Cancer-specific",
"    </span>",
"    &nbsp;&mdash;&nbsp;Several QoL tools have been developed specifically for patients with cancer:",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      Functional Assessment of Cancer Therapy - General (FACT-G)",
"     </li>",
"     <li>",
"      European Organization for Research and Treatment of Cancer QoL Core Questionnaire 30 (EORTC QLQ-C30)",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    These instruments are not interchangeable; although each measures some aspect of QoL, they provide different information.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H6\">",
"    <span class=\"h2\">",
"     Head and neck cancer-specific",
"    </span>",
"    &nbsp;&mdash;&nbsp;A number of frequently employed head and neck cancer-specific instruments are reliable and validated. These include:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      The Functional Assessment of Cancer Therapy - Head and Neck (FACT-H&amp;N) consists of the FACT-G, to which an 11-item site-specific, head and neck cancer subscale is added. The H&amp;N subscale evaluates the unique concerns of patients with head and neck cancer such as swallowing, chewing [",
"      <a class=\"abstract\" href=\"UTD.htm?3/24/3466/abstract/10\">",
"       10",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      The FACT Head and Neck Symptom Index (FHNSI) is a 10-item symptom index with items extracted from the FACT-H&amp;N [",
"      <a class=\"abstract\" href=\"UTD.htm?3/24/3466/abstract/11\">",
"       11",
"      </a>",
"      ]. The FHNSI was designed to allow rapid assessment of the most relevant disease symptoms. The FHNSI is a reliable and valid symptom index, which can be administered alone or scored using items embedded within the FACT-H&amp;N [",
"      <a class=\"abstract\" href=\"UTD.htm?3/24/3466/abstract/12\">",
"       12",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      The European Organization for Research and Treatment of Cancer QoL Questionnaire - Head and Neck Specific Module (EORTC QLQ)-H&amp;N35 can be used in conjunction with the QLQ-C30 [",
"      <a class=\"abstract\" href=\"UTD.htm?3/24/3466/abstract/13,14\">",
"       13,14",
"      </a>",
"      ]. This scale includes items assessing symptoms and side effects relevant to patients with head and neck cancer and appears to be sensitive to temporal changes before, during, and after treatment with surgery, radiation therapy (RT), and chemotherapy [",
"      <a class=\"abstract\" href=\"UTD.htm?3/24/3466/abstract/15\">",
"       15",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      The University of Washington QoL (UW-QoL) questionnaire is a self-administered scale consisting of 15 questions assessing nine domains: pain, physical appearance, activity, recreation, employment, chewing, swallowing, speech, shoulder function, and overall QoL [",
"      <a class=\"abstract\" href=\"UTD.htm?3/24/3466/abstract/16\">",
"       16",
"      </a>",
"      ]. The UW-QoL is complementary to the EORTC QLQ H&amp;N35 rather than duplicative [",
"      <a class=\"abstract\" href=\"UTD.htm?3/24/3466/abstract/17\">",
"       17",
"      </a>",
"      ]. Although the UW-QoL provides less specific information than the EORTC QLQ H&amp;N35, it is shorter and easier to use.",
"     </li>",
"     <li>",
"      The Head and Neck Radiotherapy Questionnaire (HNRQ) is a patient-rated tool that measures early treatment-related effects in patients undergoing RT for HNC [",
"      <a class=\"abstract\" href=\"UTD.htm?3/24/3466/abstract/18\">",
"       18",
"      </a>",
"      ]. It consists of 22 questions that cover symptoms related to six domains: oral cavity, throat, skin, digestive function, energy and psychosocial function.",
"     </li>",
"     <li>",
"      The University of Michigan Head and Neck QoL Questionnaire (HNQOLQ) is a 20-item, five-point Likert questionnaire that covers four major domains: pain, communication, eating and emotion [",
"      <a class=\"abstract\" href=\"UTD.htm?3/24/3466/abstract/19\">",
"       19",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      The QoL - Radiation Therapy Instrument (QoL-RTI) specifically addresses issues related to RT in patients with head and neck cancer [",
"      <a class=\"abstract\" href=\"UTD.htm?3/24/3466/abstract/20\">",
"       20",
"      </a>",
"      ]. This instrument evaluates the impact of treatment on mucus production, saliva, taste, cough and local pain.",
"     </li>",
"     <li>",
"      The M. D. Anderson Dysphagia Inventory (MDADI) is a self-administered questionnaire that evaluates the impact of treatment-related dysphagia on QoL [",
"      <a class=\"abstract\" href=\"UTD.htm?3/24/3466/abstract/21\">",
"       21",
"      </a>",
"      ]. This instrument includes global, emotional, functional, and physical subscales.",
"     </li>",
"     <li>",
"      The Voice-Related QoL measure (V-RQOL) is a 10-item, self-administered voice outcome measure [",
"      <a class=\"abstract\" href=\"UTD.htm?3/24/3466/abstract/22\">",
"       22",
"      </a>",
"      ]. Scores are reported in two domains: social-emotional and physical functioning, and a total score, all ranging from 1 to 100. A higher score indicates better voice-related QoL.",
"     </li>",
"     <li>",
"      The Performance Status Scale for Head and Neck Cancer (PSS-HN) consists of three subscales: normalcy of diet, understandability of speech, and eating in public [",
"      <a class=\"abstract\" href=\"UTD.htm?3/24/3466/abstract/10,23,24\">",
"       10,23,24",
"      </a>",
"      ]. The interviewer rates the patient on each scale based on his or her response to targeted questions. Scores on each subscale range from 0 to 100, with higher scores indicating better performance. The PSS-HN has demonstrated good inter-rater reliability sensitivity to changes over time (eg, before, during, and after treatment), and differences related to broad functional categories [",
"      <a class=\"abstract\" href=\"UTD.htm?3/24/3466/abstract/10\">",
"       10",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      The Vanderbilt Head and Neck Symptom Survey (VHNSS) was developed specifically to assess the physical and functional problems relevant to patients with head and neck cancer treated with chemoradiotherapy [",
"      <a class=\"abstract\" href=\"UTD.htm?3/24/3466/abstract/25\">",
"       25",
"      </a>",
"      ]. This 28-question survey has an emphasis on oral health outcomes, such as mucous production. At the same time the VHNSS excludes general symptoms such as fatigue and",
"      <span class=\"nowrap\">",
"       nausea/vomiting.",
"      </span>",
"      A subsequent version that assesses other symptoms such as mucosal sensitivity, dental health, and trismus contains 50 questions and has been studied in the post radiotherapy setting [",
"      <a class=\"abstract\" href=\"UTD.htm?3/24/3466/abstract/26\">",
"       26",
"      </a>",
"      ].",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H454937277\">",
"    <span class=\"h2\">",
"     Limitations of QOL data",
"    </span>",
"    &nbsp;&mdash;&nbsp;The interpretation of studies of QoL in patients with head and neck cancer requires caution. Different instruments measure different symptoms and an instrument should be selected carefully for a defined clinical application [",
"    <a class=\"abstract\" href=\"UTD.htm?3/24/3466/abstract/7,27\">",
"     7,27",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Different studies often employ diverse methodologies, varying assessment instruments, and include patients with different sites and stages of head and neck cancer. These issues make comparisons of results between studies difficult or impossible.",
"     </li>",
"     <li>",
"      Baseline data are necessary to attribute a decline in the level of functioning to disease or treatment-related effects. Patients with head and neck cancer often have difficulties that are unrelated to their cancer or its treatment because of excessive alcohol consumption, tobacco or other substance abuse.",
"     </li>",
"     <li>",
"      Head and neck cancer is relatively uncommon, and many studies thus have analyzed a relatively heterogeneous patient population. These differences may influence different domains of QoL, independent of specific treatment effects. Many study samples are too small to provide adequate statistical power for comparisons or analysis by disease site.",
"     </li>",
"     <li>",
"      Historically, treatment approaches have varied considerably, with respect to both modality of treatment (surgery, RT,",
"      <span class=\"nowrap\">",
"       and/or",
"      </span>",
"      chemotherapy), and within modality (eg, type of resection or reconstruction, chemotherapy regimen, or RT technique). These differences must be taken into consideration when analyzing the impact of treatment on QoL.",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Despite these caveats, the use of well-validated QoL instruments has permitted a better understanding of the acute and long-term effects of head and neck cancer and its treatment.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H4095337\">",
"    <span class=\"h1\">",
"     FUNCTIONAL PERFORMANCE AND QOL",
"    </span>",
"    &nbsp;&mdash;&nbsp;Impairments in speech, swallowing and eating all can contribute to a poor QoL in patients with head and neck cancer, but the majority of data from longitudinal studies does not support a direct relationship with QoL. In spite of residual functional deficits, many patients adapt to their deficits and recover to pretreatment QoL levels. While there are subgroups of patients who continue to experience considerable emotional distress and depression, these symptoms are not clearly related to functional outcome.",
"   </p>",
"   <p>",
"    These observations are supported by a number of studies:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      In 47 patients with head and neck cancer who were relapse-free from 12 to 60 months following chemotherapy and RT, 50 percent were unable to eat a normal solid food diet [",
"      <a class=\"abstract\" href=\"UTD.htm?3/24/3466/abstract/28\">",
"       28",
"      </a>",
"      ]. There was little change in patients' social or emotional well-being from the pretreatment baseline, during treatment and recovery from adverse effects [",
"      <a class=\"abstract\" href=\"UTD.htm?3/24/3466/abstract/29\">",
"       29",
"      </a>",
"      ]. The QoL at 12 months was best predicted by pretreatment QoL, with little relationship to residual side effects or functional impairment. Others have also found that long-term QoL improved despite residual physical side effects [",
"      <a class=\"abstract\" href=\"UTD.htm?3/24/3466/abstract/30\">",
"       30",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      While speech handicap is an important problem among patients who have undergone a laryngectomy, no correlation has been observed with overall QoL [",
"      <a class=\"abstract\" href=\"UTD.htm?3/24/3466/abstract/31-34\">",
"       31-34",
"      </a>",
"      ]. In the VA larynx study [",
"      <a class=\"abstract\" href=\"UTD.htm?3/24/3466/abstract/35\">",
"       35",
"      </a>",
"      ], the better QoL scores in the group treated with chemotherapy and RT appeared to be more closely related to freedom from pain, better emotional well-being, and lower levels of depression compared with preservation of speech function [",
"      <a class=\"abstract\" href=\"UTD.htm?3/24/3466/abstract/36\">",
"       36",
"      </a>",
"      ]. The association appears to be between laryngectomy (ie, surgery) and QoL rather than speech intelligibility and QoL. The laryngectomized patients were able to communicate as well as the radiated patients. With long-term follow-up, differences between the laryngectomy and non-laryngectomy group are in the physical and emotional rather than functional domains.",
"     </li>",
"     <li>",
"      In a report exploring the relationship between QoL and depression in patients with head and neck cancer, performance parameters (eating in public, speech, normalcy of diet) showed little relationship to depression, global QoL or emotional well being [",
"      <a class=\"abstract\" href=\"UTD.htm?3/24/3466/abstract/37\">",
"       37",
"      </a>",
"      ].",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H26096818\">",
"    <span class=\"h1\">",
"     FINANCIAL DISTRESS",
"    </span>",
"    &nbsp;&mdash;&nbsp;Treatment for head and neck cancer may have a prolonged debilitating effect on a patient's functional status, thus limiting their ability to work during and after treatment. In a cross-sectional study examining work-related disability among patients with head and neck cancer, 52 percent of those who were employed at the time of diagnosis were unable to return to work after treatment was completed [",
"    <a class=\"abstract\" href=\"UTD.htm?3/24/3466/abstract/38\">",
"     38",
"    </a>",
"    ]. Even when patients with head and neck cancer are able to return to work, many change their jobs because of physical discomfort and poor health following their cancer treatment [",
"    <a class=\"abstract\" href=\"UTD.htm?3/24/3466/abstract/39\">",
"     39",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    In comparison to other types of cancer, survivors of head and neck cancer have the highest risk of disability or quitting work [",
"    <a class=\"abstract\" href=\"UTD.htm?3/24/3466/abstract/40\">",
"     40",
"    </a>",
"    ]. Patients with head and neck cancers who undergo chemotherapy are also 3.5 times more likely to report work-related disability, and patients who undergo a neck dissection are twice as likely to be disabled as a result of shoulder dysfunction [",
"    <a class=\"abstract\" href=\"UTD.htm?3/24/3466/abstract/38\">",
"     38",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H19\">",
"    <span class=\"h1\">",
"     QOL AND SURVIVAL",
"    </span>",
"    &nbsp;&mdash;&nbsp;QoL may be a predictor of long-term disease control",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    survival in patients with head and neck cancer [",
"    <a class=\"abstract\" href=\"UTD.htm?3/24/3466/abstract/41-47\">",
"     41-47",
"    </a>",
"    ]:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      The Radiation Therapy Oncology Group (RTOG) analyzed QoL using the FACT-H&amp;N in over 1000 patients with locally advanced head and neck cancer who were treated on two RTOG phase III trials [",
"      <a class=\"abstract\" href=\"UTD.htm?3/24/3466/abstract/48,49\">",
"       48,49",
"      </a>",
"      ]. Baseline FACT-H&amp;N scores independently predicted locoregional control but not overall survival. The functional well-being component was most associated with locoregional control. There was no association between emotional well-being and survival, suggesting that emotional functioning does not play a prognostic role in determining survival of cancer patients [",
"      <a class=\"abstract\" href=\"UTD.htm?3/24/3466/abstract/49\">",
"       49",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      A study of 540 patients suggested that the baseline EORTC-C30 physical functioning score was an independent predictor of overall survival [",
"      <a class=\"abstract\" href=\"UTD.htm?3/24/3466/abstract/50\">",
"       50",
"      </a>",
"      ]. Although changes in most dimensions of QoL were significantly associated with overall survival, change in physical functioning was the strongest predictor.",
"     </li>",
"     <li>",
"      QoL as reassessed during treatment or follow-up has also been associated with survival [",
"      <a class=\"abstract\" href=\"UTD.htm?3/24/3466/abstract/47\">",
"       47",
"      </a>",
"      ]. One possible explanation is that some QoL questionnaires identify symptoms (eg, pain, dysphagia, weight loss) that may reflect persistent or recurrent disease [",
"      <a class=\"abstract\" href=\"UTD.htm?3/24/3466/abstract/47\">",
"       47",
"      </a>",
"      ]. Thus, QoL questionnaires may provide an indication for physicians to initiate interventions, such as pain management, that can improve QoL, as well as to make an earlier diagnosis of recurrent or persistent disease.",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H4095503\">",
"    <span class=\"h1\">",
"     IMPACT OF TREATMENT",
"    </span>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H20\">",
"    <span class=\"h2\">",
"     Surgery",
"    </span>",
"    &nbsp;&mdash;&nbsp;Surgery for head and neck cancer can cause disfigurement, voice loss, and difficulty with chewing or swallowing. Other symptoms may include drooling, choking, respiratory problems, impaired vision, a decreased sense of smell, or other problems. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?22/1/22554?source=see_link\">",
"     \"Management and prevention of complications of head and neck cancer during initial treatment\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?29/42/30378?source=see_link\">",
"     \"Management of late complications of head and neck cancer and its treatment\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    These problems can be associated with moderate to severe distress, negative self image, and disturbed interpersonal relationships [",
"    <a class=\"abstract\" href=\"UTD.htm?3/24/3466/abstract/51-54\">",
"     51-54",
"    </a>",
"    ]. Feelings of shame while eating in the presence of others, a decrease in social and sexual activity, diminished social acceptance, and financial repercussions have also been reported [",
"    <a class=\"abstract\" href=\"UTD.htm?3/24/3466/abstract/51,52,55\">",
"     51,52,55",
"    </a>",
"    ]. Larger tumors and more extensive surgery, which generally go hand-in-hand, result in poorer QoL outcomes [",
"    <a class=\"abstract\" href=\"UTD.htm?3/24/3466/abstract/44,56-59\">",
"     44,56-59",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    In contrast, other studies, using well-validated measures, have suggested relatively good patient acceptance and outcomes in surgically treated patients [",
"    <a class=\"abstract\" href=\"UTD.htm?3/24/3466/abstract/60-62\">",
"     60-62",
"    </a>",
"    ]. For example, microvascular flap reconstruction in patients with oral and oropharyngeal cancer resulted in stable or improved QoL, emotional functioning, pain, and insomnia, at 12 months. Most head and neck specific functions deteriorated on treatment but returned to baseline by 12 months. However, sticky saliva, opening mouth, coughing, and impaired senses persisted as problems. Tumor site and stage, marital status, age, comorbidity, and extensive resections were associated with QoL scores. Since these patients also received postoperative RT, it is difficult to distinguish treatment-related effects [",
"    <a class=\"abstract\" href=\"UTD.htm?3/24/3466/abstract/60\">",
"     60",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Factors that influence QoL after surgery for head and neck cancer include the use of postoperative RT and the extent of neck dissection, especially with regard to shoulder function [",
"    <a class=\"abstract\" href=\"UTD.htm?3/24/3466/abstract/59,63\">",
"     59,63",
"    </a>",
"    ]. In a series of 84 patients studied with the UW-QoL instrument, shoulder function was worse in patients treated with radical neck dissection compared to those undergoing selective neck dissection, both at 6 and 12 months [",
"    <a class=\"abstract\" href=\"UTD.htm?3/24/3466/abstract/64\">",
"     64",
"    </a>",
"    ]. Patients undergoing a modified radical neck dissection reported greater shoulder disability at six months compared with patients with selective dissection but by 12 months, there was no difference between the two groups. Other studies have reported greater pain at one year in patients receiving neck dissection [",
"    <a class=\"abstract\" href=\"UTD.htm?3/24/3466/abstract/65\">",
"     65",
"    </a>",
"    ]. More limited neck dissection may mitigate some of these symptoms [",
"    <a class=\"abstract\" href=\"UTD.htm?3/24/3466/abstract/66-68\">",
"     66-68",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H21\">",
"    <span class=\"h2\">",
"     Radiation therapy",
"    </span>",
"    &nbsp;&mdash;&nbsp;RT is not generally associated with major physical disfigurement or loss of voice; however, it results in other significant and long-term sequelae especially affecting swallowing, chewing, and voice quality. The impact of these complications on QoL has yielded variable results in different studies [",
"    <a class=\"abstract\" href=\"UTD.htm?3/24/3466/abstract/69,70\">",
"     69,70",
"    </a>",
"    ]. The acute and long-term complications of RT are discussed separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?22/1/22554?source=see_link\">",
"     \"Management and prevention of complications of head and neck cancer during initial treatment\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?29/42/30378?source=see_link\">",
"     \"Management of late complications of head and neck cancer and its treatment\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Recognition of the importance of complications of radiation has contributed to the development of newer RT techniques such as intensity modulated RT (IMRT) and altered treatment schedules. The optimal use of these approaches can significantly decrease the incidence of treatment-related adverse events. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?17/7/17525?source=see_link\">",
"     \"General principles of radiation therapy for head and neck cancer\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?22/57/23446?source=see_link\">",
"     \"Definitive radiotherapy for advanced head and neck cancer: Dose and fractionation schedule\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    The Parotid-Sparing Intensity Modulated Versus Conventional Radiotherapy in Head and Neck Cancer trial (PARSPORT) randomly assigned 94 patients with locally advanced head and neck cancer to either conventional 3D radiotherapy or IMRT [",
"    <a class=\"abstract\" href=\"UTD.htm?3/24/3466/abstract/71\">",
"     71",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?22/1/22554?source=see_link&amp;anchor=H722454159#H722454159\">",
"     \"Management and prevention of complications of head and neck cancer during initial treatment\", section on 'Highly conformal RT technique'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    The trial was designed to assess the proportion of patients with grade 2 xerostomia or worse by the Late Effects of Normal Tissues Subjective-Objective Management Analytic (LENTSOMA) subjective side-effect scale one year after treatment [",
"    <a class=\"abstract\" href=\"UTD.htm?3/24/3466/abstract/72,73\">",
"     72,73",
"    </a>",
"    ] At both 12 and 24 months, significant benefits were seen in recovery of saliva secretion with IMRT compared with conventional radiotherapy, as were clinically significant improvements in dry-mouth-specific and global QoL scores.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H25\">",
"    <span class=\"h2\">",
"     RT versus surgery",
"    </span>",
"    &nbsp;&mdash;&nbsp;Various studies have compared QoL in patients treated with RT alone, surgery alone, or surgery and postoperative RT. In general, QoL and functional results have favored the RT group, although none of these was a randomized trial [",
"    <a class=\"abstract\" href=\"UTD.htm?3/24/3466/abstract/57,59,74-80\">",
"     57,59,74-80",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    As an example, in a cohort of 111 three-year disease-free survivors who underwent surgery, RT, or surgery followed by postoperative RT, the RT group had the fewest problems, followed by the surgery-only group, while the surgery plus RT group experienced the greatest impairment [",
"    <a class=\"abstract\" href=\"UTD.htm?3/24/3466/abstract/57\">",
"     57",
"    </a>",
"    ]. Patients undergoing RT alone had significantly less pain, disfigurement, chewing, and speech concerns than the surgery plus RT group. In contrast, survivors of surgery with or without RT experienced more functional deficits; they more often required repetition and face-to-face communication to be understood, restricted the types of foods they ate in public, and had problems eating solid, crunchy or dry foods. However, this was not a randomized trial; patients with earlier stage disease were generally treated with RT or surgery alone, but those with more advanced disease were managed with surgery combined with RT.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H26\">",
"    <span class=\"h2\">",
"     Systemic therapy",
"    </span>",
"    &nbsp;&mdash;&nbsp;Functional organ preservation approaches that incorporate both chemotherapy and RT are being increasingly used in place of radical surgery. However, these regimens also have short-term and long-term toxicities that affect QoL. Both cytotoxic chemotherapy and",
"    <a class=\"drug drug_general\" href=\"UTD.htm?9/58/10151?source=see_link\">",
"     cetuximab",
"    </a>",
"    , a monoclonal antibody targeting the EGFR receptor, have been used in these approaches. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?29/15/29946?source=see_link\">",
"     \"Locally advanced squamous cell carcinoma of the head and neck: Approaches combining chemotherapy and radiation therapy\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      In one study of 64 patients with advanced head and neck cancer who were treated with curative-intent concomitant chemoradiotherapy (",
"      <a class=\"drug drug_general\" href=\"UTD.htm?20/51/21305?source=see_link\">",
"       cisplatin",
"      </a>",
"      , 5",
"      <a class=\"drug drug_general\" href=\"UTD.htm?32/32/33280?source=see_link\">",
"       fluorouracil",
"      </a>",
"      ,",
"      <a class=\"drug drug_general\" href=\"UTD.htm?16/16/16648?source=see_link\">",
"       hydroxyurea",
"      </a>",
"      and twice daily RT), acute treatment toxicities were severe, with significant declines in virtually all QoL domains [",
"      <a class=\"abstract\" href=\"UTD.htm?3/24/3466/abstract/29\">",
"       29",
"      </a>",
"      ]. However, by 12 months, general functional and physical measures had returned to baseline levels (good to excellent). Although up to one-third of patients continued to report swallowing problems, hoarseness, and mouth pain at one year, these conditions were present at a similar frequency pretreatment. Adverse effects that were more prevalent 12 months following treatment than at baseline included dry mouth (58 versus 17 percent), difficulty with taste (32 versus 8 percent), and dietary restriction to soft foods (82 versus 42 percent) [",
"      <a class=\"abstract\" href=\"UTD.htm?3/24/3466/abstract/29\">",
"       29",
"      </a>",
"      ]. Subsequent studies using",
"      <a class=\"drug drug_general\" href=\"UTD.htm?16/58/17320?source=see_link\">",
"       paclitaxel",
"      </a>",
"      as well as a lower dose of 5-FU as an alternative to cisplatin suggest fewer long-term problems with eating [",
"      <a class=\"abstract\" href=\"UTD.htm?3/24/3466/abstract/81\">",
"       81",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      While pain, swallowing dysfunction, and lack of taste improve over time, xerostomia and sticky saliva persist in many cases [",
"      <a class=\"abstract\" href=\"UTD.htm?3/24/3466/abstract/30,82-84\">",
"       30,82-84",
"      </a>",
"      ]. Other persistent dysfunctions involve aspiration, which was present in 68 percent of patients following treatment versus 14 percent pretreatment in one report [",
"      <a class=\"abstract\" href=\"UTD.htm?3/24/3466/abstract/85\">",
"       85",
"      </a>",
"      ], and the need for a feeding tube [",
"      <a class=\"abstract\" href=\"UTD.htm?3/24/3466/abstract/83,86\">",
"       83,86",
"      </a>",
"      ]. In one comparative study, 51 percent of patients undergoing chemoradiotherapy using hyperfractionated RT still required a feeding tube at two years compared to 25 percent of irradiated patients [",
"      <a class=\"abstract\" href=\"UTD.htm?3/24/3466/abstract/86\">",
"       86",
"      </a>",
"      ]. In other reports, between 8 and 20 percent of patients undergoing chemoradiotherapy are still using feeding tubes at 12 months [",
"      <a class=\"abstract\" href=\"UTD.htm?3/24/3466/abstract/81,87,88\">",
"       81,87,88",
"      </a>",
"      ].",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H26096910\">",
"    <span class=\"h2\">",
"     Quality of life in head and neck cancer trials",
"    </span>",
"    &nbsp;&mdash;&nbsp;The impact of treatment on outcome in patients with head and neck cancer and the utilization of QoL instruments to assess outcomes is illustrated by the following examples:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      In patients with locally advanced head and neck cancer, a phase III trial found that the combination of",
"      <a class=\"drug drug_general\" href=\"UTD.htm?9/58/10151?source=see_link\">",
"       cetuximab",
"      </a>",
"      plus radiation therapy (RT) was significantly more effective than RT alone [",
"      <a class=\"abstract\" href=\"UTD.htm?3/24/3466/abstract/89\">",
"       89",
"      </a>",
"      ]. QoL was assessed by the European Organisation for Research and Treatment of Cancer (EORTC) QoL Questionnaire C30 (QLQ-C30) and the EORTC QLQ Head and Neck Cancer&ndash;Specific Module (H&amp;N35) [",
"      <a class=\"abstract\" href=\"UTD.htm?3/24/3466/abstract/43\">",
"       43",
"      </a>",
"      ]. QoLCompliance with completion of QoL questionnaires was high in both arms, with 419 of 424 patients assessable. QoL worsened during treatment and improved after cessation of treatment, reaching baseline levels at 12 months, with no significant differences in QoL scores between the treatment arms. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?29/15/29946?source=see_link&amp;anchor=H168427307#H168427307\">",
"       \"Locally advanced squamous cell carcinoma of the head and neck: Approaches combining chemotherapy and radiation therapy\", section on 'Cetuximab alone plus RT'",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      The EORTC",
"      <span class=\"nowrap\">",
"       24971/TAX",
"      </span>",
"      323 trial compared two induction chemotherapy regimens followed by RT [",
"      <a class=\"abstract\" href=\"UTD.htm?3/24/3466/abstract/90\">",
"       90",
"      </a>",
"      ]. The EORTC QoL Questionnaire C30 (EORTC QLQ-C30), the EORTC QLQ Head and Neck Cancer-Specific Module (EORTC QLQ-H&amp;N35), and the clinician-assessed Performance Status Scale for Head and Neck Cancer Patients (PSS-HN) were used to assess QoL in both groups. Overall compliance to the QLQ-C30 questionnaire was 97 percent at baseline, 86 percent at the end of cycle 2, and 76 percent at the end of cycle 4, dropping to 54 percent by six months. No difference in global health-related QoL was seen between the treatment groups during the treatment period. The PSS-HN instrument showed high compliance (75 percent at six months after radiotherapy). There were no significant differences in with the addition of a taxane QoL to the",
"      <a class=\"drug drug_general\" href=\"UTD.htm?20/51/21305?source=see_link\">",
"       cisplatin",
"      </a>",
"      plus 5-",
"      <a class=\"drug drug_general\" href=\"UTD.htm?32/32/33280?source=see_link\">",
"       fluorouracil",
"      </a>",
"      regimen. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?29/15/29946?source=see_link&amp;anchor=H281026593#H281026593\">",
"       \"Locally advanced squamous cell carcinoma of the head and neck: Approaches combining chemotherapy and radiation therapy\", section on 'Induction chemotherapy'",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      In patients with metastatic head and neck cancer, the addition of",
"      <a class=\"drug drug_general\" href=\"UTD.htm?9/58/10151?source=see_link\">",
"       cetuximab",
"      </a>",
"      to",
"      <a class=\"drug drug_general\" href=\"UTD.htm?20/51/21305?source=see_link\">",
"       cisplatin",
"      </a>",
"      or",
"      <a class=\"drug drug_general\" href=\"UTD.htm?37/61/38873?source=see_link\">",
"       carboplatin",
"      </a>",
"      plus 5-",
"      <a class=\"drug drug_general\" href=\"UTD.htm?32/32/33280?source=see_link\">",
"       fluorouracil",
"      </a>",
"      significantly improved survival compared with platinum based chemotherapy alone [",
"      <a class=\"abstract\" href=\"UTD.htm?3/24/3466/abstract/91\">",
"       91",
"      </a>",
"      ] . The European Organisation for Research and Treatment of Cancer (EORTC) QoL Questionnaire C30 (QLQ-C30) and the EORTC QLQ Head and Neck Cancer&ndash;Specific Module (H&amp;N35) were used to assess the impact of the treatment on QoL. The compliance rates for both questionnaires were low (&lt;55 percent in both treatment arms) at all scheduled post-baseline assessments. No adverse effect on the QoL was detected. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?39/25/40345?source=see_link&amp;anchor=H14#H14\">",
"       \"Treatment of metastatic and recurrent head and neck cancer\", section on 'Anti-EGFR monoclonal antibodies plus platinum-based chemotherapy'",
"      </a>",
"      .)",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Despite the adverse impact of treatment-related side effects, long-term QoL appears to be better in patients who successfully achieve organ preservation by nonsurgical treatment in most but not all series [",
"    <a class=\"abstract\" href=\"UTD.htm?3/24/3466/abstract/35,78,92-95\">",
"     35,78,92-95",
"    </a>",
"    ]. The only randomized trial to address this issue is the VA larynx study, which randomly assigned patients with laryngeal cancer to induction chemotherapy followed by RT or to surgery plus RT [",
"    <a class=\"abstract\" href=\"UTD.htm?3/24/3466/abstract/35\">",
"     35",
"    </a>",
"    ]. A long-term follow-up report of 46 long-term survivors (25 assigned to surgery plus RT and 21 to chemotherapy plus RT) found significantly better QoL scores and less head and neck pain in the chemotherapy plus RT group [",
"    <a class=\"abstract\" href=\"UTD.htm?3/24/3466/abstract/36\">",
"     36",
"    </a>",
"    ]. Although there was no difference in speech or communication scores, compared to patients undergoing laryngectomy, those who maintained an intact larynx had less body pain, better mental health, better emotional scores and less depression.",
"   </p>",
"   <p>",
"    Other data suggest that voice-related QoL is better in patients after chemoradiation as compared to laryngectomy. Speech and swallowing function was prospectively studied using the voice-related QoL measure (V-RQOL) and the head and neck cancer -specific performance status scale (PSS-HN) in a phase II trial of 97 patients with advanced laryngeal cancer who were given one cycle of chemotherapy with 5-FU and",
"    <a class=\"drug drug_general\" href=\"UTD.htm?20/51/21305?source=see_link\">",
"     cisplatin",
"    </a>",
"    [",
"    <a class=\"abstract\" href=\"UTD.htm?3/24/3466/abstract/93\">",
"     93",
"    </a>",
"    ]. Patients with a &gt;50 percent response underwent concurrent chemoradiotherapy while those with a lesser response were referred for early \"salvage\" laryngectomy. Of the 56 patients who were alive and disease-free with a minimum of eight months follow-up, those with an intact larynx (n = 37) had significantly higher V-RQOL scores than laryngectomized individuals (n = 19), although their scores were worse than those of normal subjects. Overall swallowing function was comparable between the groups.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H27\">",
"    <span class=\"h2\">",
"     Feeding tubes",
"    </span>",
"    &nbsp;&mdash;&nbsp;The majority of patients receiving chemoradiotherapy for locoregional disease experience significant weight loss due to treatment-related side effects such as mucositis and dysphagia. Feeding tubes may limit malnutrition, which is associated with poorer scores on QoL instruments [",
"    <a class=\"abstract\" href=\"UTD.htm?3/24/3466/abstract/96\">",
"     96",
"    </a>",
"    ]. However, whether the prophylactic placement of feeding tubes is of benefit is controversial. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?29/4/29770?source=see_link&amp;anchor=H14#H14\">",
"     \"The role of parenteral and enteral/oral nutritional support in patients with cancer\", section on 'Head and neck cancer'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    On the one hand, a randomized study showed significantly higher QoL scores (EORTC) in the group receiving systematic prophylactic gastrostomy [",
"    <a class=\"abstract\" href=\"UTD.htm?3/24/3466/abstract/97\">",
"     97",
"    </a>",
"    ]. Some argue that prophylactic feeding tube placement leads to increased disuse of swallowing muscles and ultimately higher rates of feeding tube dependence. The importance of these issues led to the development of a specific instrument that measures the impact of enteral feeding tubes on the QoL of these patients [",
"    <a class=\"abstract\" href=\"UTD.htm?3/24/3466/abstract/98\">",
"     98",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H616616552\">",
"    <span class=\"h2\">",
"     Rehabilitation",
"    </span>",
"    &nbsp;&mdash;&nbsp;Functional rehabilitation following treatment is also an important component of overall patient management:",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?15/54/16231?source=see_link\">",
"       \"Alaryngeal speech rehabilitation\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?30/51/31545?source=see_link\">",
"       \"Speech and swallowing rehabilitation of the patient with head and neck cancer\"",
"      </a>",
"      .)",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H29\">",
"    <span class=\"h1\">",
"     PREDICTORS OF LONG-TERM QOL",
"    </span>",
"    &nbsp;&mdash;&nbsp;The sections above described the effects of various treatment modalities or regimens on both short and long term QoL. Other studies have explored the factors that might predict long term QoL.",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      In a study of 173 head and neck cancer patients assessed pretreatment and at one year posttreatment, multivariate regression models showed that pretreatment QoL (University of Washington QoL scale), comorbidity, and tumor stage were the strongest predictors of 12 month QoL [",
"      <a class=\"abstract\" href=\"UTD.htm?3/24/3466/abstract/99\">",
"       99",
"      </a>",
"      ]. Other studies using other QoL instruments also observed a strong association between baseline and 12 month QoL [",
"      <a class=\"abstract\" href=\"UTD.htm?3/24/3466/abstract/87,100\">",
"       87,100",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      Others found that the major predictors of change in QoL through one year were treatment factors, smoking and depressive symptoms [",
"      <a class=\"abstract\" href=\"UTD.htm?3/24/3466/abstract/100\">",
"       100",
"      </a>",
"      ].",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H4095083\">",
"    <span class=\"h1\">",
"     TREATMENT TARGETING QOL",
"    </span>",
"    &nbsp;&mdash;&nbsp;The nature and severity of problems in patients with head and neck cancer depend upon both the anatomic sites involved and treatment. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?22/1/22554?source=see_link\">",
"     \"Management and prevention of complications of head and neck cancer during initial treatment\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?29/42/30378?source=see_link\">",
"     \"Management of late complications of head and neck cancer and its treatment\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Pilot studies using longitudinal measurements of QoL suggest that psychosocial interventions may produce significant QoL benefits for patients with head and neck cancer [",
"    <a class=\"abstract\" href=\"UTD.htm?3/24/3466/abstract/101\">",
"     101",
"    </a>",
"    ]. In this section, representative studies demonstrating the need for or impact of such interventions are presented.",
"   </p>",
"   <p>",
"    Psychosocial morbidity (worry, anxiety, mood disorder, fatigue, depression) is common in patients with head and neck cancer [",
"    <a class=\"abstract\" href=\"UTD.htm?3/24/3466/abstract/102,103\">",
"     102,103",
"    </a>",
"    ]. Treatment-related morbidity is usually highest in the first year following therapy, although there is significant variability:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      In a study of patients treated with RT for head and neck cancer, assessment by the UW-QoL questionnaire and the Hospital Anxiety Depression (HAD) scale documented significant deterioration in QoL and worsening depressive symptoms during treatment [",
"      <a class=\"abstract\" href=\"UTD.htm?3/24/3466/abstract/104\">",
"       104",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      In another study of 55 newly diagnosed head and neck cancer patients, assessment using the HAD scale found that 18 percent of patients had high levels of distress at diagnosis compared with 25 percent at follow-up. Despite such high levels of distress, few patients were referred for psychosocial intervention [",
"      <a class=\"abstract\" href=\"UTD.htm?3/24/3466/abstract/105\">",
"       105",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      In another study, approximately one-third of patients had a possible or probable major mood disorder at six different assessment points during the first year following diagnosis [",
"      <a class=\"abstract\" href=\"UTD.htm?3/24/3466/abstract/106\">",
"       106",
"      </a>",
"      ]. The anxiety level was highest at diagnosis, while depression was most common during treatment. Females were more anxious than males at diagnosis and patients under 65 years of age were more depressed than those over 65.",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Despite an initially high level of depressive symptomatology, there appears to be gradual improvement of psychological functioning and global QoL over a longer period of time [",
"    <a class=\"abstract\" href=\"UTD.htm?3/24/3466/abstract/107,108\">",
"     107,108",
"    </a>",
"    ]. However, depressive symptoms do not improve and either remain elevated or worsen over time [",
"    <a class=\"abstract\" href=\"UTD.htm?3/24/3466/abstract/105,106\">",
"     105,106",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    These results suggest that psychosocial",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    medical intervention is frequently needed in these patients to maintain or improve QoL. As an example, 36 patients were randomly assigned to treatment with 40 mg",
"    <a class=\"drug drug_general\" href=\"UTD.htm?12/56/13193?source=see_link\">",
"     citalopram",
"    </a>",
"    or placebo for 12 weeks [",
"    <a class=\"abstract\" href=\"UTD.htm?3/24/3466/abstract/109\">",
"     109",
"    </a>",
"    ]. This pilot trial suggested that treatment with prophylactic antidepressants could prevent the development of major depressive disorder, reduce depressive symptoms, and preserve QoL and psychological health.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H31\">",
"    <span class=\"h1\">",
"     SUMMARY",
"    </span>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Health-related QoL is focused upon the patient&rsquo;s perception of his illness. QoL incorporates several dimensions (physical, functional, social, psychological) and is subjective, based upon the patient&rsquo;s perception of",
"      <span class=\"nowrap\">",
"       his/her",
"      </span>",
"      illness and disability. QoL requires multiple assessments over time to judge the impact of interventions. (See",
"      <a class=\"local\" href=\"#H2\">",
"       'Definition'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Various instruments are available to assess QoL. These include some that are available for cancer patients in general, as well as a number of validated tools that were specifically designed for use in patients with head and neck cancer. (See",
"      <a class=\"local\" href=\"#H3\">",
"       'Available tools for assessment of qol'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      In addition to the cancer itself, the modalities used to treat disease (surgery, radiation therapy, systemic therapy) all are associated with significant complications",
"      <span class=\"nowrap\">",
"       and/or",
"      </span>",
"      toxicities that can have an important impact on QoL. A full consideration of these issues is necessary in managing patients with head and neck cancer. (See",
"      <a class=\"local\" href=\"#H4095503\">",
"       'Impact of treatment'",
"      </a>",
"      above.)",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    While the past five years have shown many advances in the field of head and neck cancer QoL research, there are still a number of continued challenges that command attention. Mean QoL scores, that is, group averages, are adequate and sufficient for between-treatment comparisons. The extent to which, and how, the same data might be useful clinically for an individual patient, for example, to assist in decision making, is a relatively uncharted area of investigation. From a methodologic perspective, efforts are underway to calculate instrument specific standardized scores that would in turn provide for easier comparison across measures and studies. Continued and expanded application of QoL data to the design of psychosocial or other interventions is now necessary and warranted.",
"   </p>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <h1>",
"    REFERENCES",
"   </h1>",
"   <ol id=\"reference\">",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/24/3466/abstract/1\">",
"      Mittal BB, Pauloski BR, Haraf DJ, et al. Swallowing dysfunction--preventative and rehabilitation strategies in patients with head-and-neck cancers treated with surgery, radiotherapy, and chemotherapy: a critical review. Int J Radiat Oncol Biol Phys 2003; 57:1219.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/24/3466/abstract/2\">",
"      Sciubba JJ, Goldenberg D. Oral complications of radiotherapy. Lancet Oncol 2006; 7:175.",
"     </a>",
"    </li>",
"    <li>",
"     Cella D. Instruments and assessments methods in psycho-oncology quality of life. In: Textbook of Psycho-Oncology, Holland JC (Ed), Oxford University Press, New York 1998.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/24/3466/abstract/4\">",
"      Schipper H, Levitt M. Measuring quality of life: risks and benefits. Cancer Treat Rep 1985; 69:1115.",
"     </a>",
"    </li>",
"    <li>",
"     Specific Scales, Tests and Measures. In: In: Quality of Life and Pharmacoeconomics in Clinical Trials, 2nd, Lippincott-Raven, Philadelphia 1996. p.161.",
"    </li>",
"    <li>",
"     F.A.C.I.T. Manual: Manual of the Functional Assessment of Chronic Illness Therapy (FACIT) Scales - Version 4. In: Center on Outcomes, Research and Education, 1997.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/24/3466/abstract/7\">",
"      Tschiesner U, Rogers SN, Harr&eacute;us U, et al. Content comparison of quality of life questionnaires used in head and neck cancer based on the international classification of functioning, disability and health: a systematic review. Eur Arch Otorhinolaryngol 2008; 265:627.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/24/3466/abstract/8\">",
"      Pusic A, Liu JC, Chen CM, et al. A systematic review of patient-reported outcome measures in head and neck cancer surgery. Otolaryngol Head Neck Surg 2007; 136:525.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/24/3466/abstract/9\">",
"      Murphy BA, Ridner S, Wells N, Dietrich M. Quality of life research in head and neck cancer: a review of the current state of the science. Crit Rev Oncol Hematol 2007; 62:251.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/24/3466/abstract/10\">",
"      List MA, D'Antonio LL, Cella DF, et al. The Performance Status Scale for Head and Neck Cancer Patients and the Functional Assessment of Cancer Therapy-Head and Neck Scale. A study of utility and validity. Cancer 1996; 77:2294.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/24/3466/abstract/11\">",
"      Cella D, Paul D, Yount S, et al. What are the most important symptom targets when treating advanced cancer? A survey of providers in the National Comprehensive Cancer Network (NCCN). Cancer Invest 2003; 21:526.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/24/3466/abstract/12\">",
"      Yount S, List M, Du H, et al. A randomized validation study comparing embedded versus extracted FACT Head and Neck Symptom Index scores. Qual Life Res 2007; 16:1615.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/24/3466/abstract/13\">",
"      Bjordal K, Kaasa S. Psychometric validation of the EORTC Core Quality of Life Questionnaire, 30-item version and a diagnosis-specific module for head and neck cancer patients. Acta Oncol 1992; 31:311.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/24/3466/abstract/14\">",
"      Bjordal K, Ahlner-Elmqvist M, Tollesson E, et al. Development of a European Organization for Research and Treatment of Cancer (EORTC) questionnaire module to be used in quality of life assessments in head and neck cancer patients. EORTC Quality of Life Study Group. Acta Oncol 1994; 33:879.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/24/3466/abstract/15\">",
"      Bjordal K, Hammerlid E, Ahlner-Elmqvist M, et al. Quality of life in head and neck cancer patients: validation of the European Organization for Research and Treatment of Cancer Quality of Life Questionnaire-H&amp;N35. J Clin Oncol 1999; 17:1008.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/24/3466/abstract/16\">",
"      Hassan SJ, Weymuller EA Jr. Assessment of quality of life in head and neck cancer patients. Head Neck 1993; 15:485.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/24/3466/abstract/17\">",
"      Rogers SN, Lowe D, Brown JS, Vaughan ED. A comparison between the University of Washington Head and Neck Disease-Specific measure and the Medical Short Form 36, EORTC QOQ-C33 and EORTC Head and Neck 35. Oral Oncol 1998; 34:361.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/24/3466/abstract/18\">",
"      Browman GP, Levine MN, Hodson DI, et al. The Head and Neck Radiotherapy Questionnaire: a morbidity/quality-of-life instrument for clinical trials of radiation therapy in locally advanced head and neck cancer. J Clin Oncol 1993; 11:863.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/24/3466/abstract/19\">",
"      Terrell JE, Nanavati KA, Esclamado RM, et al. Head and neck cancer-specific quality of life: instrument validation. Arch Otolaryngol Head Neck Surg 1997; 123:1125.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/24/3466/abstract/20\">",
"      Trotti A, Johnson DJ, Gwede C, et al. Development of a head and neck companion module for the quality of life-radiation therapy instrument (QOL-RTI). Int J Radiat Oncol Biol Phys 1998; 42:257.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/24/3466/abstract/21\">",
"      Chen AY, Frankowski R, Bishop-Leone J, et al. The development and validation of a dysphagia-specific quality-of-life questionnaire for patients with head and neck cancer: the M. D. Anderson dysphagia inventory. Arch Otolaryngol Head Neck Surg 2001; 127:870.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/24/3466/abstract/22\">",
"      Hogikyan ND, Sethuraman G. Validation of an instrument to measure voice-related quality of life (V-RQOL). J Voice 1999; 13:557.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/24/3466/abstract/23\">",
"      List MA, Ritter-Sterr C, Lansky SB. A performance status scale for head and neck cancer patients. Cancer 1990; 66:564.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/24/3466/abstract/24\">",
"      List MA, Ritter-Sterr CA, Baker TM, et al. Longitudinal assessment of quality of life in laryngeal cancer patients. Head Neck 1996; 18:1.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/24/3466/abstract/25\">",
"      Murphy BA, Dietrich MS, Wells N, et al. Reliability and validity of the Vanderbilt Head and Neck Symptom Survey: a tool to assess symptom burden in patients treated with chemoradiation. Head Neck 2010; 32:26.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/24/3466/abstract/26\">",
"      Cooperstein E, Gilbert J, Epstein JB, et al. Vanderbilt head and neck symptom survey version 2.0: Report of the development and initial testing of a subscale for assessment of oral health. Head Neck 2011.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/24/3466/abstract/27\">",
"      Silveira AP, Gon&ccedil;alves J, Sequeira T, et al. Patient reported outcomes in head and neck cancer: selecting instruments for quality of life integration in clinical protocols. Head Neck Oncol 2010; 2:32.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/24/3466/abstract/28\">",
"      List MA, Mumby P, Haraf D, et al. Performance and quality of life outcome in patients completing concomitant chemoradiotherapy protocols for head and neck cancer. Qual Life Res 1997; 6:274.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/24/3466/abstract/29\">",
"      List MA, Siston A, Haraf D, et al. Quality of life and performance in advanced head and neck cancer patients on concomitant chemoradiotherapy: a prospective examination. J Clin Oncol 1999; 17:1020.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/24/3466/abstract/30\">",
"      Magn&eacute; N, Marcy PY, Chamorey E, et al. Concomitant twice-a-day radiotherapy and chemotherapy in unresectable head and neck cancer patients: A long-term quality of life analysis. Head Neck 2001; 23:678.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/24/3466/abstract/31\">",
"      Finizia C, Hammerlid E, Westin T, Lindstr&ouml;m J. Quality of life and voice in patients with laryngeal carcinoma: a posttreatment comparison of laryngectomy (salvage surgery) versus radiotherapy. Laryngoscope 1998; 108:1566.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/24/3466/abstract/32\">",
"      Herranz J, Gavil&aacute;n J. Psychosocial adjustment after laryngeal cancer surgery. Ann Otol Rhinol Laryngol 1999; 108:990.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/24/3466/abstract/33\">",
"      Deleyiannis FW, Weymuller EA Jr, Coltrera MD, Futran N. Quality of life after laryngectomy: are functional disabilities important? Head Neck 1999; 21:319.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/24/3466/abstract/34\">",
"      Vilaseca I, Chen AY, Backscheider AG. Long-term quality of life after total laryngectomy. Head Neck 2006; 28:313.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/24/3466/abstract/35\">",
"      Induction chemotherapy plus radiation compared with surgery plus radiation in patients with advanced laryngeal cancer. The Department of Veterans Affairs Laryngeal Cancer Study Group. N Engl J Med 1991; 324:1685.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/24/3466/abstract/36\">",
"      Terrell JE, Fisher SG, Wolf GT. Long-term quality of life after treatment of laryngeal cancer. The Veterans Affairs Laryngeal Cancer Study Group. Arch Otolaryngol Head Neck Surg 1998; 124:964.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/24/3466/abstract/37\">",
"      D'Antonio LL, Long SA, Zimmerman GJ, et al. Relationship between quality of life and depression in patients with head and neck cancer. Laryngoscope 1998; 108:806.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/24/3466/abstract/38\">",
"      Taylor JC, Terrell JE, Ronis DL, et al. Disability in patients with head and neck cancer. Arch Otolaryngol Head Neck Surg 2004; 130:764.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/24/3466/abstract/39\">",
"      Liu HE. Changes of satisfaction with appearance and working status for head and neck tumour patients. J Clin Nurs 2008; 17:1930.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/24/3466/abstract/40\">",
"      Short PF, Vasey JJ, Tunceli K. Employment pathways in a large cohort of adult cancer survivors. Cancer 2005; 103:1292.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/24/3466/abstract/41\">",
"      Fang FM, Liu YT, Tang Y, et al. Quality of life as a survival predictor for patients with advanced head and neck carcinoma treated with radiotherapy. Cancer 2004; 100:425.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/24/3466/abstract/42\">",
"      Nordgren M, Hammerlid E, Bjordal K, et al. Quality of life in oral carcinoma: a 5-year prospective study. Head Neck 2008; 30:461.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/24/3466/abstract/43\">",
"      Curran D, Giralt J, Harari PM, et al. Quality of life in head and neck cancer patients after treatment with high-dose radiotherapy alone or in combination with cetuximab. J Clin Oncol 2007; 25:2191.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/24/3466/abstract/44\">",
"      Ward EC, Bishop B, Frisby J, Stevens M. Swallowing outcomes following laryngectomy and pharyngolaryngectomy. Arch Otolaryngol Head Neck Surg 2002; 128:181.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/24/3466/abstract/45\">",
"      Goldstein DP, Hynds Karnell L, Christensen AJ, Funk GF. Health-related quality of life profiles based on survivorship status for head and neck cancer patients. Head Neck 2007; 29:221.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/24/3466/abstract/46\">",
"      Grignon LM, Jameson MJ, Karnell LH, et al. General health measures and long-term survival in patients with head and neck cancer. Arch Otolaryngol Head Neck Surg 2007; 133:471.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/24/3466/abstract/47\">",
"      Karvonen-Gutierrez CA, Ronis DL, Fowler KE, et al. Quality of life scores predict survival among patients with head and neck cancer. J Clin Oncol 2008; 26:2754.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/24/3466/abstract/48\">",
"      Siddiqui F, Pajak TF, Watkins-Bruner D, et al. Pretreatment quality of life predicts for locoregional control in head and neck cancer patients: a radiation therapy oncology group analysis. Int J Radiat Oncol Biol Phys 2008; 70:353.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/24/3466/abstract/49\">",
"      Coyne JC, Pajak TF, Harris J, et al. Emotional well-being does not predict survival in head and neck cancer patients: a Radiation Therapy Oncology Group study. Cancer 2007; 110:2568.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/24/3466/abstract/50\">",
"      Meyer F, Fortin A, G&eacute;linas M, et al. Health-related quality of life as a survival predictor for patients with localized head and neck cancer treated with radiation therapy. J Clin Oncol 2009; 27:2970.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/24/3466/abstract/51\">",
"      de Boer MF, Pruyn JF, van den Borne B, et al. Rehabilitation outcomes of long-term survivors treated for head and neck cancer. Head Neck 1995; 17:503.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/24/3466/abstract/52\">",
"      Deshmane VH, Parikh HK, Pinni S, et al. Laryngectomy: a quality of life assessment. Indian J Cancer 1995; 32:121.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/24/3466/abstract/53\">",
"      Gamba A, Romano M, Grosso IM, et al. Psychosocial adjustment of patients surgically treated for head and neck cancer. Head Neck 1992; 14:218.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/24/3466/abstract/54\">",
"      Langius A, Bj&ouml;rvell H, Lind MG. Functional status and coping in patients with oral and pharyngeal cancer before and after surgery. Head Neck 1994; 16:559.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/24/3466/abstract/55\">",
"      Siston, AK, List, MA, Schleser, R, Vokes, E. Sexual functioning in head and neck cancer. J Psychooncol 1997; 15:107.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/24/3466/abstract/56\">",
"      Klozar J, Lischkeov&aacute; B, Betka J. Subjective functional results 1 year after surgery and postoperative radiation for oropharyngeal carcinoma. Eur Arch Otorhinolaryngol 2001; 258:546.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/24/3466/abstract/57\">",
"      Campbell BH, Marbella A, Layde PM. Quality of life and recurrence concern in survivors of head and neck cancer. Laryngoscope 2000; 110:895.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/24/3466/abstract/58\">",
"      Weinstein GS, El-Sawy MM, Ruiz C, et al. Laryngeal preservation with supracricoid partial laryngectomy results in improved quality of life when compared with total laryngectomy. Laryngoscope 2001; 111:191.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/24/3466/abstract/59\">",
"      Bindewald J, Oeken J, Wollbrueck D, et al. Quality of life correlates after surgery for laryngeal carcinoma. Laryngoscope 2007; 117:1770.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/24/3466/abstract/60\">",
"      Borggreven PA, Aaronson NK, Verdonck-de Leeuw IM, et al. Quality of life after surgical treatment for oral and oropharyngeal cancer: a prospective longitudinal assessment of patients reconstructed by a microvascular flap. Oral Oncol 2007; 43:1034.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/24/3466/abstract/61\">",
"      Vartanian JG, Kowalski LP. Acceptance of major surgical procedures and quality of life among long-term survivors of advanced head and neck cancer. Arch Otolaryngol Head Neck Surg 2009; 135:376.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/24/3466/abstract/62\">",
"      Bozec A, Poissonnet G, Chamorey E, et al. Quality of life after oral and oropharyngeal reconstruction with a radial forearm free flap: prospective study. J Otolaryngol Head Neck Surg 2009; 38:401.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/24/3466/abstract/63\">",
"      Stuiver MM, van Wilgen CP, de Boer EM, et al. Impact of shoulder complaints after neck dissection on shoulder disability and quality of life. Otolaryngol Head Neck Surg 2008; 139:32.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/24/3466/abstract/64\">",
"      Kuntz AL, Weymuller EA Jr. Impact of neck dissection on quality of life. Laryngoscope 1999; 109:1334.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/24/3466/abstract/65\">",
"      Donatelli-Lassig AA, Duffy SA, Fowler KE, et al. The effect of neck dissection on quality of life after chemoradiation. Otolaryngol Head Neck Surg 2008; 139:511.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/24/3466/abstract/66\">",
"      Shah S, Har-El G, Rosenfeld RM. Short-term and long-term quality of life after neck dissection. Head Neck 2001; 23:954.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/24/3466/abstract/67\">",
"      Terrell JE, Welsh DE, Bradford CR, et al. Pain, quality of life, and spinal accessory nerve status after neck dissection. Laryngoscope 2000; 110:620.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/24/3466/abstract/68\">",
"      Laverick S, Lowe D, Brown JS, et al. The impact of neck dissection on health-related quality of life. Arch Otolaryngol Head Neck Surg 2004; 130:149.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/24/3466/abstract/69\">",
"      Huguenin PU, Taussky D, Moe K, et al. Quality of life in patients cured from a carcinoma of the head and neck by radiotherapy: the importance of the target volume. Int J Radiat Oncol Biol Phys 1999; 45:47.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/24/3466/abstract/70\">",
"      Jellema AP, Slotman BJ, Doornaert P, et al. Impact of radiation-induced xerostomia on quality of life after primary radiotherapy among patients with head and neck cancer. Int J Radiat Oncol Biol Phys 2007; 69:751.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/24/3466/abstract/71\">",
"      Nutting CM, Morden JP, Harrington KJ, et al. Parotid-sparing intensity modulated versus conventional radiotherapy in head and neck cancer (PARSPORT): a phase 3 multicentre randomised controlled trial. Lancet Oncol 2011; 12:127.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/24/3466/abstract/72\">",
"      Rubin P, Constine LS, Fajardo LF, et al. RTOG Late Effects Working Group. Overview. Late Effects of Normal Tissues (LENT) scoring system. Int J Radiat Oncol Biol Phys 1995; 31:1041.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/24/3466/abstract/73\">",
"      Pavy JJ, Denekamp J, Letschert J, et al. EORTC Late Effects Working Group. Late Effects toxicity scoring: the SOMA scale. Int J Radiat Oncol Biol Phys 1995; 31:1043.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/24/3466/abstract/74\">",
"      Harrison LB, Zelefsky MJ, Pfister DG, et al. Detailed quality of life assessment in patients treated with primary radiotherapy for squamous cell cancer of the base of the tongue. Head Neck 1997; 19:169.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/24/3466/abstract/75\">",
"      Harrison LB, Zelefsky MJ, Armstrong JG, et al. Performance status after treatment for squamous cell cancer of the base of tongue--a comparison of primary radiation therapy versus primary surgery. Int J Radiat Oncol Biol Phys 1994; 30:953.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/24/3466/abstract/76\">",
"      Deleyiannis FW, Weymuller EA Jr, Coltrera MD. Quality of life of disease-free survivors of advanced (stage III or IV) oropharyngeal cancer. Head Neck 1997; 19:466.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/24/3466/abstract/77\">",
"      McDonough EM, Varvares MA, Dunphy FR, et al. Changes in quality-of-life scores in a population of patients treated for squamous cell carcinoma of the head and neck. Head Neck 1996; 18:487.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/24/3466/abstract/78\">",
"      Hanna E, Sherman A, Cash D, et al. Quality of life for patients following total laryngectomy vs chemoradiation for laryngeal preservation. Arch Otolaryngol Head Neck Surg 2004; 130:875.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/24/3466/abstract/79\">",
"      Nguyen NP, Vos P, Karlsson U, et al. Quality of life following chemoradiation and postoperative radiation for locally advanced head and neck cancer. ORL J Otorhinolaryngol Relat Spec 2007; 69:271.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/24/3466/abstract/80\">",
"      Infante-Cossio P, Torres-Carranza E, Cayuela A, et al. Impact of treatment on quality of life for oral and oropharyngeal carcinoma. Int J Oral Maxillofac Surg 2009; 38:1052.",
"     </a>",
"    </li>",
"    <li>",
"     Quality of life (QOL)/performance in head &amp; neck Cancer (HNC): Comparison between paclitaxel-based (P-CT/XRT) and cisplatin-based (C-CT/XRT) concomitant chemoradiotherapy regimens. In: Oral presentation at the American Society of Clinical Oncology, New Orleans 2000.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/24/3466/abstract/82\">",
"      Vokes EE, Kies MS, Haraf DJ, et al. Concomitant chemoradiotherapy as primary therapy for locoregionally advanced head and neck cancer. J Clin Oncol 2000; 18:1652.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/24/3466/abstract/83\">",
"      Ackerstaff AH, Tan IB, Rasch CR, et al. Quality-of-life assessment after supradose selective intra-arterial cisplatin and concomitant radiation (RADPLAT) for inoperable stage IV head and neck squamous cell carcinoma. Arch Otolaryngol Head Neck Surg 2002; 128:1185.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/24/3466/abstract/84\">",
"      Abendstein H, Nordgren M, Boysen M, et al. Quality of life and head and neck cancer: a 5 year prospective study. Laryngoscope 2005; 115:2183.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/24/3466/abstract/85\">",
"      Eisbruch A, Lyden T, Bradford CR, et al. Objective assessment of swallowing dysfunction and aspiration after radiation concurrent with chemotherapy for head-and-neck cancer. Int J Radiat Oncol Biol Phys 2002; 53:23.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/24/3466/abstract/86\">",
"      Staar S, Rudat V, Stuetzer H, et al. Intensified hyperfractionated accelerated radiotherapy limits the additional benefit of simultaneous chemotherapy--results of a multicentric randomized German trial in advanced head-and-neck cancer. Int J Radiat Oncol Biol Phys 2001; 50:1161.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/24/3466/abstract/87\">",
"      List, MA, Haraf, D, Stenson K, et al. Improved 12 month oral function post concurrent chemoradiotherapy (CRT) for head and neck cancer (HNC) (abstract). Proc Am Soc Clin Onc 2003; 22:498a.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/24/3466/abstract/88\">",
"      Akst LM, Chan J, Elson P, et al. Functional outcomes following chemoradiotherapy for head and neck cancer. Otolaryngol Head Neck Surg 2004; 131:950.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/24/3466/abstract/89\">",
"      Bonner JA, Harari PM, Giralt J, et al. Radiotherapy plus cetuximab for squamous-cell carcinoma of the head and neck. N Engl J Med 2006; 354:567.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/24/3466/abstract/90\">",
"      Vermorken JB, Remenar E, van Herpen C, et al. Cisplatin, fluorouracil, and docetaxel in unresectable head and neck cancer. N Engl J Med 2007; 357:1695.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/24/3466/abstract/91\">",
"      Vermorken JB, Mesia R, Rivera F, et al. Platinum-based chemotherapy plus cetuximab in head and neck cancer. N Engl J Med 2008; 359:1116.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/24/3466/abstract/92\">",
"      Nguyen NP, Sallah S, Karlsson U, Antoine JE. Combined chemotherapy and radiation therapy for head and neck malignancies: quality of life issues. Cancer 2002; 94:1131.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/24/3466/abstract/93\">",
"      Fung K, Lyden TH, Lee J, et al. Voice and swallowing outcomes of an organ-preservation trial for advanced laryngeal cancer. Int J Radiat Oncol Biol Phys 2005; 63:1395.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/24/3466/abstract/94\">",
"      Boscolo-Rizzo P, Maronato F, Marchiori C, et al. Long-term quality of life after total laryngectomy and postoperative radiotherapy versus concurrent chemoradiotherapy for laryngeal preservation. Laryngoscope 2008; 118:300.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/24/3466/abstract/95\">",
"      LoTempio MM, Wang KH, Sadeghi A, et al. Comparison of quality of life outcomes in laryngeal cancer patients following chemoradiation vs. total laryngectomy. Otolaryngol Head Neck Surg 2005; 132:948.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/24/3466/abstract/96\">",
"      Capuano G, Gentile PC, Bianciardi F, et al. Prevalence and influence of malnutrition on quality of life and performance status in patients with locally advanced head and neck cancer before treatment. Support Care Cancer 2010; 18:433.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/24/3466/abstract/97\">",
"      Salas S, Baumstarck-Barrau K, Alfonsi M, et al. Impact of the prophylactic gastrostomy for unresectable squamous cell head and neck carcinomas treated with radio-chemotherapy on quality of life: Prospective randomized trial. Radiother Oncol 2009; 93:503.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/24/3466/abstract/98\">",
"      Stevens CS, Lemon B, Lockwood GA, et al. The development and validation of a quality-of-life questionnaire for head and neck cancer patients with enteral feeding tubes: the QOL-EF. Support Care Cancer 2011; 19:1175.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/24/3466/abstract/99\">",
"      El-Deiry MW, Futran ND, McDowell JA, et al. Influences and predictors of long-term quality of life in head and neck cancer survivors. Arch Otolaryngol Head Neck Surg 2009; 135:380.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/24/3466/abstract/100\">",
"      Ronis DL, Duffy SA, Fowler KE, et al. Changes in quality of life over 1 year in patients with head and neck cancer. Arch Otolaryngol Head Neck Surg 2008; 134:241.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/24/3466/abstract/101\">",
"      Hammerlid E, Persson LO, Sullivan M, Westin T. Quality-of-life effects of psychosocial intervention in patients with head and neck cancer. Otolaryngol Head Neck Surg 1999; 120:507.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/24/3466/abstract/102\">",
"      De Boer MF, McCormick LK, Pruyn JF, et al. Physical and psychosocial correlates of head and neck cancer: a review of the literature. Otolaryngol Head Neck Surg 1999; 120:427.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/24/3466/abstract/103\">",
"      de Graeff A, de Leeuw JR, Ros WJ, et al. A prospective study on quality of life of patients with cancer of the oral cavity or oropharynx treated with surgery with or without radiotherapy. Oral Oncol 1999; 35:27.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/24/3466/abstract/104\">",
"      Kelly C, Paleri V, Downs C, Shah R. Deterioration in quality of life and depressive symptoms during radiation therapy for head and neck cancer. Otolaryngol Head Neck Surg 2007; 136:108.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/24/3466/abstract/105\">",
"      Verdonck-de Leeuw IM, de Bree R, Keizer AL, et al. Computerized prospective screening for high levels of emotional distress in head and neck cancer patients and referral rate to psychosocial care. Oral Oncol 2009; 45:e129.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/24/3466/abstract/106\">",
"      Hammerlid E, Ahlner-Elmqvist M, Bjordal K, et al. A prospective multicentre study in Sweden and Norway of mental distress and psychiatric morbidity in head and neck cancer patients. Br J Cancer 1999; 80:766.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/24/3466/abstract/107\">",
"      de Graeff A, de Leeuw JR, Ros WJ, et al. Long-term quality of life of patients with head and neck cancer. Laryngoscope 2000; 110:98.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/24/3466/abstract/108\">",
"      Kohda R, Otsubo T, Kuwakado Y, et al. Prospective studies on mental status and quality of life in patients with head and neck cancer treated by radiation. Psychooncology 2005; 14:331.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/24/3466/abstract/109\">",
"      Lydiatt WM, Denman D, McNeilly DP, et al. A randomized, placebo-controlled trial of citalopram for the prevention of major depression during treatment for head and neck cancer. Arch Otolaryngol Head Neck Surg 2008; 134:528.",
"     </a>",
"    </li>",
"   </ol>",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 3369 Version 10.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.6- C21.56",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     AsanBook Dig. Med. Lib.",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [0504-122.72.76.133-FC043B0C43-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f3_24_3466=[""].join("\n");
var outline_f3_24_3466=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li>",
"     <a class=\"sr_button\" href=\"#H31\" id=\"summRecButton\">",
"      <span>",
"       SUMMARY",
"      </span>",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H1\">",
"      INTRODUCTION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H2\">",
"      DEFINITION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H3\">",
"      AVAILABLE TOOLS FOR ASSESSMENT OF QOL",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H4\">",
"      Generic",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H5\">",
"      Cancer-specific",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H6\">",
"      Head and neck cancer-specific",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H454937277\">",
"      Limitations of QOL data",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H4095337\">",
"      FUNCTIONAL PERFORMANCE AND QOL",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H26096818\">",
"      FINANCIAL DISTRESS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H19\">",
"      QOL AND SURVIVAL",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H4095503\">",
"      IMPACT OF TREATMENT",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H20\">",
"      Surgery",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H21\">",
"      Radiation therapy",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H25\">",
"      RT versus surgery",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H26\">",
"      Systemic therapy",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H26096910\">",
"      Quality of life in head and neck cancer trials",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H27\">",
"      Feeding tubes",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H616616552\">",
"      Rehabilitation",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H29\">",
"      PREDICTORS OF LONG-TERM QOL",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H4095083\">",
"      TREATMENT TARGETING QOL",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H31\">",
"      SUMMARY",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a href=\"#references\">",
"      REFERENCES",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?15/54/16231?source=related_link\">",
"      Alaryngeal speech rehabilitation",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?22/57/23446?source=related_link\">",
"      Definitive radiotherapy for advanced head and neck cancer: Dose and fractionation schedule",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?4/1/4120?source=related_link\">",
"      Evaluation of health-related quality of life",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?17/7/17525?source=related_link\">",
"      General principles of radiation therapy for head and neck cancer",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?29/15/29946?source=related_link\">",
"      Locally advanced squamous cell carcinoma of the head and neck: Approaches combining chemotherapy and radiation therapy",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?22/1/22554?source=related_link\">",
"      Management and prevention of complications of head and neck cancer during initial treatment",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?29/42/30378?source=related_link\">",
"      Management of late complications of head and neck cancer and its treatment",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?29/44/30407?source=related_link\">",
"      Overview of head and neck cancer",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?30/51/31545?source=related_link\">",
"      Speech and swallowing rehabilitation of the patient with head and neck cancer",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?29/4/29770?source=related_link\">",
"      The role of parenteral and enteral/oral nutritional support in patients with cancer",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?39/25/40345?source=related_link\">",
"      Treatment of metastatic and recurrent head and neck cancer",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f3_24_3467="Common causes cholestasis";
var content_f3_24_3467=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=PEDS%2F79511&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=PEDS%2F79511&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\">",
"   <div class=\"ttl\">",
"    Most common causes of neonatal cholestasis",
"   </div>",
"   <div class=\"cntnt\">",
"    <table cellspacing=\"0\">",
"     <tbody>",
"      <tr>",
"       <td>",
"        Extrahepatic biliary atresia",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Idiopathic neonatal hepatitis",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Infectious hepatitis",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Alpha-1-antitrypsin deficiency",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Alagille syndrome",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Progressive familial intrahepatic cholestasis",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Parenteral nutrition-associated",
"       </td>",
"      </tr>",
"     </tbody>",
"    </table>",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Modified from: El-Youself M, Whittington PF. Sem Liver Dis 1998; 18:195 and Mieli Vergani G, Howard ER, Portman B, Mowat AP. Lancet 1989; 1:421.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f3_24_3467=[""].join("\n");
var outline_f3_24_3467=null;
var title_f3_24_3468="Fungi terminology";
var content_f3_24_3468=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=ALLRG%2F50012&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=6\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=ALLRG%2F50012&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=6\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\">",
"   <div class=\"ttl\">",
"    Common fungal terminology",
"   </div>",
"   <div class=\"cntnt\">",
"    <table cellspacing=\"0\">",
"     <tr>",
"      <td>",
"       1. Fungi: plant-like organisms with no chlorophyll, with a definite nuclei and usually rigid cell walls",
"      </td>",
"     </tr>",
"     <tr>",
"      <td>",
"       2. Hyphae: long chains of cells that are aggregated into mats termed mycelium",
"      </td>",
"     </tr>",
"     <tr>",
"      <td>",
"       3. Fungi reproduce by spores which may be sexually (nuclear fusion, meiosis) formed or asexually (mitotically) formed",
"      </td>",
"     </tr>",
"     <tr>",
"      <td class=\"sublist1_start\">",
"       4. Fungal classes according to their method of sexual reproduction",
"      </td>",
"     </tr>",
"     <tr>",
"      <td class=\"sublist2\">",
"       a. Oomycetes produce motile, thick-walled sexual spores, one for each nuclear fusion (eg, the downy mildews). Some Oomycetes produce unispore sacs called \"sporangia\" that become airborne.",
"      </td>",
"     </tr>",
"     <tr>",
"      <td class=\"sublist2\">",
"       b. Zygomycetes produce a single large thick-walled sexual spore with each nuclear fusion. Zygomycete also produce asexual spores in sporangia sacs (eg, Rhizopus, Mucor).",
"      </td>",
"     </tr>",
"     <tr>",
"      <td class=\"sublist2\">",
"       c. Ascomycetes produce eight sexual spores in a sac called an ascus and asexual spores called conidia (eg, Leptosphaeria, Chaetomium, Venturia)",
"      </td>",
"     </tr>",
"     <tr>",
"      <td class=\"sublist2\">",
"       d. Basidomycetes form sexual spores externally on pegs produced on structures called basidia",
"      </td>",
"     </tr>",
"     <tr>",
"      <td class=\"sublist3\">",
"       i. Heterobasidiomycetes produce separate septate basida (eg, rusts and smuts)",
"      </td>",
"     </tr>",
"     <tr>",
"      <td class=\"sublist3\">",
"       ii. Holobasidiomycetes produce single-celled club-shaped basidia (eg, mushrooms and puffballs)",
"      </td>",
"     </tr>",
"     <tr>",
"      <td class=\"sublist2\">",
"       e. Deuteromycetes are fungi for which a sexual stage has not been identified (Aspergillus, Stemphylium, Alternaria, Cladosporium)",
"      </td>",
"     </tr>",
"     <tr>",
"      <td class=\"sublist2\">",
"       f. Myxomycetes are organisms with both plant and animal characteristics (eg, slime molds). The vegetative stage is an amoeba or multinucleate plasmodium that moves and ingests foods.",
"      </td>",
"     </tr>",
"     <tr>",
"      <td class=\"sublist2\">",
"       g. Actinomycetes are filamentous bacteria that produce dry airborne spores",
"      </td>",
"     </tr>",
"    </table>",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f3_24_3468=[""].join("\n");
var outline_f3_24_3468=null;
var title_f3_24_3469="Parkinson disease organizations";
var content_f3_24_3469=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=PC%2F66006&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=PC%2F66006&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\">",
"   <div class=\"ttl\">",
"    Parkinson disease organizations",
"   </div>",
"   <div class=\"cntnt\">",
"    <table cellspacing=\"0\">",
"     <tbody>",
"      <tr>",
"       <td class=\"subtitle2_left\">",
"        American Parkinson Disease Association",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        <p>",
"         135 Parkinson Avenue",
"        </p>",
"        <p>",
"         Staten Island, NY 10305",
"        </p>",
"        <p>",
"         <a href=\"file://www.apdaparkinson.org\" target=\"_blank\">",
"          www.apdaparkinson.org",
"         </a>",
"        </p>",
"        <p>",
"         <a href=\"mailto:apda@apdaparkinson.org\">",
"          apda@apdaparkinson.org",
"         </a>",
"        </p>",
"        <p>",
"         Tel: 1-800-223-2732",
"        </p>",
"        <p>",
"         Fax: 718-981-4399",
"        </p>",
"       </td>",
"      </tr>",
"      <tr class=\"divider_top\">",
"       <td class=\"subtitle2_left\">",
"        European Parkinson's Disease Association",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        <p>",
"         1 Northumberland Avenue, Trafalgar Square",
"        </p>",
"        <p>",
"         London",
"        </p>",
"        <p>",
"         WC2N 5BW",
"        </p>",
"        <p>",
"         United Kingdom",
"        </p>",
"        <p>",
"         <a href=\"file://www.epda.eu.com\" target=\"_blank\">",
"          www.epda.eu.com",
"         </a>",
"        </p>",
"        <p>",
"         <a class=\"oLinkEmail\" href=\"mailto:info@epda.eu.com\" title=\"info@epda.eu.com\">",
"          info@epda.eu.com",
"         </a>",
"        </p>",
"        <p>",
"         Tel: +44 (0) 207 8725510",
"        </p>",
"        <p>",
"         Fax: +44 (0) 207 8725611",
"        </p>",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        <p>",
"         Regus EU Parliament",
"        </p>",
"        <p>",
"         37 Square de Meeus",
"        </p>",
"        <p>",
"         B-1000 Brussels",
"        </p>",
"        <p>",
"         Belgium",
"        </p>",
"        <p>",
"         <a href=\"file://www.epda.eu.com\" target=\"_blank\">",
"          www.epda.eu.com",
"         </a>",
"        </p>",
"        <p>",
"         <a class=\"oLinkEmail\" href=\"mailto:info@epda.eu.com\" title=\"info@epda.eu.com\">",
"          info@epda.eu.com",
"         </a>",
"        </p>",
"        <p>",
"         Tel: +32 (0) 2 791 7747",
"        </p>",
"        <p>",
"         Fax: +32 (0) 2 791 7900",
"        </p>",
"       </td>",
"      </tr>",
"      <tr class=\"divider_top\">",
"       <td class=\"subtitle2_left\">",
"        National Parkinson Foundation, Inc.",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        <p>",
"         1501 NW Ninth Avenue, Bob Hope Road",
"        </p>",
"        <p>",
"         Miami, FL 33136",
"        </p>",
"        <p>",
"         <a href=\"file://www.parkinson.org\" target=\"_blank\">",
"          www.parkinson.org",
"         </a>",
"        </p>",
"        <p>",
"         <a href=\"mailto:contact@parkinson.org\">",
"          contact@parkinson.org",
"         </a>",
"        </p>",
"        <p>",
"         Tel: 1-800-327-4545",
"        </p>",
"        <p>",
"         Fax: 305-243-5595",
"        </p>",
"       </td>",
"      </tr>",
"      <tr class=\"divider_top\">",
"       <td class=\"subtitle2_left\">",
"        Parkinson's Disease Foundation",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        <p>",
"         1359 Broadway, Suite 1509",
"        </p>",
"        <p>",
"         New York, NY 10018",
"        </p>",
"        <p>",
"         <a href=\"file://www.pdf.org\" target=\"_blank\">",
"          www.pdf.org",
"         </a>",
"        </p>",
"        <p>",
"         <a href=\"mailto:info@pdf.org\">",
"          info@pdf.org",
"         </a>",
"        </p>",
"        <p>",
"         Tel: 1-800-457-6676",
"        </p>",
"        <p>",
"         Fax: 212-923-4778",
"        </p>",
"       </td>",
"      </tr>",
"      <tr class=\"divider_top\">",
"       <td class=\"subtitle2_left\">",
"        Parkinson Society Canada",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        <p>",
"         4211 Yonge Street, Suite 316",
"        </p>",
"        <p>",
"         Toronto, Ontario M2P 2A9",
"        </p>",
"        <p>",
"         Canada",
"        </p>",
"        <p>",
"         <a href=\"file://www.parkinson.ca\" target=\"_blank\">",
"          www.parkinson.ca",
"         </a>",
"        </p>",
"        <p>",
"         <a href=\"mailto:general.info@parkinson.ca\">",
"          general.info@parkinson.ca",
"         </a>",
"        </p>",
"        <p>",
"         Tel: 1-800-565-3000",
"        </p>",
"        <p>",
"         Fax: 416-227-9600",
"        </p>",
"       </td>",
"      </tr>",
"     </tbody>",
"    </table>",
"   </div>",
"   <div class=\"lgnd\">",
"    Updated February 2012.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f3_24_3469=[""].join("\n");
var outline_f3_24_3469=null;
var title_f3_24_3470="Incidence colon ca family hx";
var content_f3_24_3470=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=PC%2F57102&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=PC%2F57102&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Incidence of colorectal cancer according to age and family history",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 419px; height: 302px; background-image: url(data:image/gif;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Graphic representation of the cumulative incidence of colorectal cancer demonstrates that in people with a family history, colorectal cancers occur earlier in life, not uncommonly in the 40s or even the 30s.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Data from Fuchs, CS, Giovannucci, EL, Colditz, GA, et al, N Engl J Med 1994; 331:1669.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f3_24_3470=[""].join("\n");
var outline_f3_24_3470=null;
var title_f3_24_3471="TEE pulmonic valve and pulmonary artery color Doppler";
var content_f3_24_3471=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=CARD%2F80660&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=CARD%2F80660&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 500px\">",
"   <div class=\"ttl\">",
"    Pulmonary valve and main pulmonary artery on transesophageal echocardiogam",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 480px; height: 180px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Vertical (90&ordm;) imaging plane demonstrates the pulmonary valve (PV), main pulmonary artery (MPA), and transverse aorta (Ao) (Panel A). Panel B shows color Doppler flow within these structures.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Courtesy of Warren Manning, MD.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f3_24_3471=[""].join("\n");
var outline_f3_24_3471=null;
